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General introduction and outline
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WORLD'S AGING POPULATION  
People live longer than ever before and as a result, the world is expected to 
experience a significant global population aging over the coming years (1,2). 
Essentially every country in the world is encountering growth in the proportion of 
older persons in its population. In 2019, 703 million people were aged over 65 years 
in the global population, and this number is predicted to double to 1.5 billion in 2050 
(3). The share of the worldwide population aged over 65 years increased from 6 
percent in 1990 to 9 percent in 2019 and is expected to rise further to 16 percent in 
2050, meaning that by that time, one in six people worldwide will be aged 65 years 
or older (3). This increase in human longevity reflects the remarkable advances 
achieved in healthcare, nutrition, and biomedicine over the past century. 
Nevertheless, the increase in lifespan is not paralleled by similar gains in health span 
since chronological age is a significant risk factor for chronic diseases such as 
cancers, diabetes, and cardiovascular/respiratory diseases (4–8). As a result, the 
globally aging population implicates significant challenges for health, long-term care, 
and welfare systems. Aging is also associated with a loss of independence, and new 
solutions are urgently needed to sustain self-management at higher ages (1–3,9,10). 
Understanding and targeting the aging process itself, rather than treating the 
symptoms of age-related pathologies, might be the most effective strategy to prevent 
or counteract aging-related health issues. One of the main processes with aging is 
the progressive loss of muscle mass and physical function, known as sarcopenia 
(11). Sarcopenia is often associated with impaired mobility, greater tendency to fall, 
loss of independence, functional limitations, metabolic impairments, and increased 
risk of chronic diseases and causal mortality (12–18).  
Unhealthy aging also relates to frailty, which is defined as a loss of physical function 
and an increased susceptibility to adverse health outcomes (19,20). Although the 
biology of frailty is not yet well understood, skeletal muscle health is critical to 
prevent physical frailty and to maintain health at a higher age (19,21,22). Frailty is 
linked to the loss of muscle mass and muscle strength, and longitudinal studies show 
that in adults aged over 75 years, muscle mass is lost at a rate of 0.64–0.70% per 
year in women and 0.80–0.98% per in men, while in women men aged over 18 years 
this on average is 0.37% per year and 0.47% per year, respectively. Even more 
prominent, muscle strength is lost at a rate of 2.5–3% and 3–4% per year in adult 
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women and men, respectively. The loss of strength is 2–5 times faster than the loss 
of muscle mass and is a more consistent risk for disability (7). In addition, skeletal 
muscle is also a major site of metabolic activity that regulates protein, lipids, and 
carbohydrates homeostasis. For instance, skeletal muscle is responsible for the 
large majority of post-prandial glucose disposal (23,24), and failure in these 
metabolic processes can lead to perturbations in glucose homeostasis, including 
hyperglycemia and insulin resistance. Insulin sensitivity is a significant determinant 
for the risk of many chronic metabolic diseases. 
Moreover, aging is one of the major risk factors for chronic metabolic disorders such 
as obesity, type 2 diabetes, and cardiovascular diseases (25). A functional 
mitochondrial network in skeletal muscle tissue is essential to sustain the metabolic 
demands and maintain insulin sensitivity by regulating fuel utilization and energy 
expenditure. Interestingly, several (pre-) clinical studies suggest that improvements 
in various aspects of mitochondrial function are linked to the preservation of muscle 
mass, metabolism, and muscle function (26–29), putting mitochondria at the center 
of muscle health and physical function. 
ROLE OF MITOCHONDRIA AND PHYSICAL ACTIVITY IN AGING 
Mitochondria are highly dynamic organelles that play an essential role in adjusting 
cellular energy production to metabolic demands (30). In parallel with the 
progressive loss of muscle function, a decrease in skeletal muscle mitochondrial 
respiratory activity and dysregulation of mitochondrial network dynamics have been 
shown with advancing age (31–36). Experimental evidence has liked aberrant 
mitochondrial quality control to elevated reactive oxygen species emission and 
activation of apoptotic pathways thought to contribute to sarcopenia's 
pathophysiology (37). Furthermore, mitochondrial dysfunction has recently been 
indicated as an underlying factor for low physical function (38), slower walking speed 
(39–41), fatigability (42), and loss of exercise efficiency with older age (43). 
However, the age-associated decline in mitochondrial function in humans might not 
be entirely attributable to aging per se. It may also be explained, in part, by an age-
related decline in physical activity (44,45). Thus, evidence indicates a negative 
relationship between age and physical activity (46), and only 23.5% of the aging 
population succeeds in meeting the WHO recommended physical activity levels of at 
least 150 minutes of moderate-intensity aerobic physical activity per week (47). 
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Irrespective of the role of mitochondria in influencing physical function and muscle 
health with aging, physical exercise is a powerful tool to protect against aging-
induced deterioration of muscle health (48) and the onset of numerous age-related 
chronic diseases (49,50).  
THESIS OUTLINE 
The present thesis aims to investigate the role of skeletal muscle mitochondria and 
physical activity in the age-related loss of physical function and metabolic health. 
Such information is instrumental in revealing promising therapeutic strategies to 
promote healthy aging. In recent years it has become clear that mitochondria do not 
operate as individual organelles but as dynamic networks. As such, mitochondrial 
function is not only defined by intrinsic bioenergetic capacity but also includes the 
ability of mitochondria to move and physically interact with each other in dynamic 
reticular networks. This plasticity in mitochondrial morphology enables the 
mitochondria to rapidly adapt to dynamic changes in the cell's metabolic demands 
and is fundamental to a wide variety of cellular functions (51). Recent evidence 
suggests that aberrant changes in mitochondrial network dynamics occur with aging 
and this evidence is examined in the review of chapter 2 of this dissertation.  
Considering these age-related changes in mitochondrial network dynamics, it has 
been suggested that the decline in mitochondrial capacity might explain the 
accelerated loss in muscle health with age. However, it remains unclear to which 
extent age-related physical inactivity and chronological age per se contribute to the 
decline in mitochondrial function and physical function during aging. To investigate 
this relationship between mitochondrial and physical function, in chapter 3, we 
extensively analyzed mitochondrial capacity and muscle function in young and older 
adults with similar habitual physical activity levels. Moreover, we studied older adults 
with a range of habitual physical activity levels and muscle function, i.e. trained older 
adults, older adults with normal physical activity levels, and physically impaired older 
adults. 
A large number of preclinical studies have linked alterations within mitochondrial 
metabolism to the aging process. As mitochondria play a crucial role in energy 
metabolism homeostasis, mitochondrial dysfunction might explain age-related 
metabolic complications such as cardiovascular diseases, obesity, and type 2 
diabetes (52,53). Furthermore, chronological age is associated with distinct plasma 
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metabolic profiles (54,55), providing interesting leads to identify pathways that may 
affect lifespan. However, since the rate at which physiological function decline with 
age is highly variable among individuals (56), these metabolic profiles do not 
necessarily reflect the age-related decline in functional health outcomes and hence 
may not mirror the biological age. To further identify the metabolic changes in 
skeletal muscle related to chronological age, in chapter 4 we studied the muscle 
metabolome in young vs. older adults. Moreover, the impact of biological age on the 
skeletal muscle metabolome was examined by investigating different groups of older 
individuals representing healthy, normal and impaired aging. This examination 
revealed a strong decline of the nicotinamide dinucleotide (NAD+) with age, which 
was exacerbated with impaired aging and nearly entirely prevented in healthy aging, 
indicating NAD+ as a promising therapeutic target to promote healthy aging. To 
further explore the therapeutic potential of NAD+ targeting, chapter 5 of this 
dissertation investigates the efficacy of a nutritional NAD+ pre-cursor 
supplementation on mitochondrial function in older adults with impaired physical 
function. 
One of the most critical consequences of aging is the loss of gait and balance 
control, inducing an increased risk of falls and fall-related consequences such as 
fractures, further functional decline, immobility, and causal mortality (57). The age-
related decline in muscle mass seems to be primarily attributable to atrophy of type II 
muscle fibers, contributing to muscle weakness (58–60). It is commonly assumed 
that muscle strength and power are essential factors for coping with large balance 
disturbances. Nevertheless, muscle strength assessment and training usually only 
moderately correlate to basic balance tests and falls (61–63). To better understand 
the impact of muscle aging on mobility and balance control, chapter 6 focuses on 
the role of muscle fiber type composition in the ability to cope with large balance 
disturbances in young and older adults. Finally, in chapter 7 the findings of all the 
parts of this thesis are summarized and discussed in a broader perspective, and the 
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ABSTRACT 
With global demographics trending towards an ageing population, the numbers of 
individuals with an age-associated loss of independence is increasing. A key 
contributing factor is loss of skeletal muscle mitochondrial, metabolic, and contractile 
function. Recent advances in imaging technologies have demonstrated the 
importance of mitochondrial morphology and dynamics in the pathogenesis of 
disease. In this review, we examine the evidence for altered mitochondrial dynamics 
as a mechanism in age and obesity-associated loss of skeletal muscle function, with 
a particular focus on the available human data. We highlight some of the areas 
where more data are needed to identify the specific mechanisms connecting 
mitochondrial morphology and skeletal muscle dysfunction. 
Keywords: Metabolic disease, sarcopenia, ageing, mitochondria, mitochondrial 
dynamics 
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Skeletal muscle in age and age-associated diseases  
 
Increases in human longevity illustrate the remarkable advances achieved in 
biomedicine, nutrition and healthcare over the past century. Yet as lifespan has 
increased, gains in healthspan - defined as the period of life spent in good health, 
free from the chronic diseases and disabilities of aging [1] - have stagnated [2]. With 
the proportion of elderly among the global population set to reach >20% in the next 
decades [3], the imperative to find new solutions to the problem of age-associated 
loss of independence has become increasingly relevant. 
One of the main obstacles to improvements in healthspan is the contemporaneous 
rise in overweight and obesity in the global population. Although overweight and 
obesity have been associated with an increase in premature death, the impact of 
these on mortality has declined such that recent evidence suggests that elderly 
individuals with overweight or mild obesity now have a life expectancy similar to 
normal weight elderly [4]. However, this group is at increased risk of disability and 
spend more years with limitations in physical function compared to normal weight 
elderly [5, 6].  
Deterioration in skeletal muscle mass, metabolic fitness, and contractile vigour are 
fundamental to the progression of both metabolic disease and age-associated loss of 
independence (Figure 1). Increased adiposity and ectopic lipid deposition, whether 
in the presence of obesity or not, contribute to skeletal muscle insulin resistance [7], 
are common features of ageing [8-10], and strong predictors of both metabolic 
disease progression [11, 12] and muscle strength and mass [9, 10]. Increasing 
adiposity blunts the effectiveness of insulin and amino acid stimulation of muscle 
protein synthesis [13]. Muscle, the primary target tissue for insulin stimulated glucose 
disposal, is a key regulator of whole-body glucose homeostasis. As such, reduced 
muscle mass is also associated with reduced energy expenditure [14]. Age-related 
decline in both physical function and metabolic health can be mitigated, in large part, 
by increased physical activity levels and exercise training. Thus, the underlying 
pathology is one of adaptation to chronic environmental stimuli and allostatic loading 
rather than an obligatory consequence of ageing [7,8]. Progressive deterioration in 
mitochondrial capacity has been linked to age- and obesity- associated muscle 
defects though there remains little consensus on a specific mechanistic pathway to 
Chapter 2
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explain this association. Recent developments in understanding the dynamic 
behaviour of mitochondrial networks and quality control pathways have opened up 
new prospective avenues of mitochondrial involvement in physical and metabolic 
decline. In this review we will examine the evidence for the presence of aberrant 
mitochondrial network dynamics in the pathogenesis of age-associated skeletal 
muscle dysfunction, with a focus, where available, on evidence from human 
research.
Figure 1: Reciprocal relation between muscle mass and metabolic homeostasis.
Both a sedentary behaviour and an excess energy intake during aging negatively influence 
body composition by increasing fat mass. Excess adiposity is associated with increased 
ectopic lipid deposition leading to lipotoxicity and consequent mitochondrial dysfunction. 
Mitochondrial dysfunction has been implicated in the onset of sarcopenia and insulin 
resistance. Sarcopenia and insulin resistance likely interact whereby loss of muscle mass 
results in reduced energy expenditure and reduced capacity for glucose uptake while insulin 
resistance may induce anabolic resistance to insulin and amino acids and reduce insulin 
inhibition of muscle protein breakdown. Collectively these mechanisms further exacerbate 
adiposity in a positive feedback loop resulting a progressive decline in metabolic and 
functional fitness in aged muscle.
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Skeletal muscle mitochondria are an important target for increasing 
healthspan 
One of the early consequences of chronic lipotoxicity (see Glossary) in both 
metabolic disease and ageing is a reduction in mitochondrial content and capacity 
[9]. However, the extent to which reduced mitochondrial capacity contributes to 
impaired muscle function in obesity and ageing is debated. Classically, mitochondrial 
function has been viewed through the prism of mitochondrial density and intrinsic 
bioenergetic capacity, however fresh insights into the varied functions of 
mitochondria necessitates an expansion of the concept. In the present view, 
mitochondrial function also includes the ability of mitochondria to move and 
physically interact with each other in dynamic reticular networks. Mitochondrial 
network architecture,  regulated by the processes of fusion and fission (Figure 2), 
varies widely among cell types, and morphology is intrinsically linked to the energetic 
and functional aspects of a cell. Thus, in dividing cells, and in cells with a high 
mitochondrial turnover, mitochondrial fission  predominates and morphology shifts 
towards a “fragmented” network [15]. On the other hand, skeletal muscle which 
requires rapid conductance of energy potentials forms a vast interconnected 
reticulum that acts as a power grid to distribute membrane potential according to 
energetic requirements [16, 17, 18], though the degree of networking may be less 
apparent in humans compared to mice [16]. Mitochondrial morphology and dynamics 
have been linked to a variety of cellular processes including cell division [19], 
regulation of gene expression [20], apoptosis [14, 21] and autophagy [22], removal 
of damaged mitochondria (mitophagy) [23], calcium homeostasis [24], production of 
reactive oxygen species (ROS) [25], and regulation of cellular bioenergetic 
capacity and efficiency [26]. Mitochondrial morphology also responds to the nutrient 
status of cells with fragmentation observed in conditions of high nutrient availability 
and fusion predominating to maintain higher bioenergetic efficiency where nutrients 
are scarce [27]. The major proteins that regulate mitochondrial morphology are 
described in Table 1. Given the ubiquity of cellular functions in which mitochondrial 
dynamics participate it is hardly surprising that dysregulation of mitochondrial 
network dynamics has been implicated in an increasing number of disease states 





Figure 2: Putative pathways in response to dysregulated mitochondrial dynamics in age-related decline in muscle function and 
metabolism
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Figure 2: Putative pathways in response to dysregulated mitochondrial dynamics in 
age-related decline in muscle function and metabolism Depicted are some of the 
identified putative pathways which may explain the contribution of alteration in mitochondrial 
morphology to the decline in metabolic and functional fitness in aged muscle. Drp1 knock-
out animals represent a model of excessive fusion. Excessive fusion leads to the ER-stress 
mediated downregulation of FGF21 (1). Lower levels of FGF21 result in reduced mitophagy 
and autophagy, which result in excessive levels of mitochondrial DNA mutations, leading to 
inefficient mitochondria, a reduced bioenergetic efficiency, and eventually muscle weakness 
and a higher risk for lipotoxicty-induced insulin resistance. ER-stress also induces the 
expression of the atrogenic genes and Atrogin 1 (2) and MuRF1 (2), which, together with the 
mtDNA damage induced ROS-mediated (4) muscle inflammation, enhances muscle atrophy 
also resulting in a reduced muscle mass and consequent insulin resistance. Opa1 depletion 
represents a model for excessive fission and a fragmented network. The fragmented 
network results in activation of the atrogenic forkhead box O’s (FOXOs) (5), increased stress 
on the ER (6), increased ROS (7), NfkB activation (8), and increased expression of several 
pro-inflammatory genes (9). ER-stress (6) leads to upregulation of MuRF1 expression and 
both the activation of FOXO (5) and increased ER-stress (6) upregulates the expression of 
MuRF1 and Atrogin 1, leading to muscle atrophy mediated decline in muscle mass and 
consequent insulin resistance. ROS (7) additionally mediates the upregulation of BNIP3 and 
Parkin which both result in excessive mitophagy and muscle atrophy. The ROS-mediated (7) 
activation of Parkin also leads to a decline in Mfn2 (10), which impairs muscle protein 
synthesis, resulting in muscle atrophy, a reduced muscle mass and consequent insulin 
resistance. Also, a decline in Mfn2 (10) leads to a decline in mTOR and consequently a 
decline in autophagy, resulting in defective mitochondria, increased mtDNA mutation and 
muscle inflammation. In parallel, increased ROS production (7), NFκB activation (8), and 
increased expression of proinflammatory genes (9) stimulate muscle tissue inflammation, 
together resulting in muscle weakness and insulin resistance. Yme1l depletion stimulates the 
expression of the S-Opa1, leading to aberrant mitochondrial cristae (11), which activates 
AMPK and FOXO (5), both stimulating the expression of MuRF1 and Atrogin 1 and leading 
to an atrogenic mediated reduction in muscle mass and increased insulin resistance. Both 
excessive fusion and excessive fission can impair muscle function and metabolic health. 
Abbreviations: Drp1 = Dynamin related protein 1; ER = endoplasmic reticulum; FGF21 = 
Fibroblast growth factor 21; DNA = deoxyribonucleic acid; MuRF1 = muscle RING-finger 
protein-1; mtDNA = mitochondrial deoxyribonucleic acid; ROS = reactive oxygen species; 
Opa1 = Optic atrophy 1;  FOXOs = forkhead box O’s ; NFκB =  nuclear factor kappa-light-
chain-enhancer of activated B cells; BNIP3 =  BCL2 Interacting Protein 3; Mfn2 = Mitofusin-
2; YME1l = ATP-dependent zinc metalloprotease YME1L;  S-Opa1 = Optic atrophy 1 (short 
form);  AMPK = adenosine monophosphate-activated protein kinase. 
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Table 1: Major fusion and fission proteins that regulate mitochondrial morphology 
 
Protein  Location Function  
Fusion proteins     
Mfn1 Mitofusin-1 Outer 
mitochondrial 
membrane 









Outer mitochondrial membrane 
fusion 
-Facilitating mitochondrial calcium 
influx from ER 
-ER-Mitochondria contact site 
tethering 










Optic atrophy 1 Inner 
mitochondrial 
membrane 













Optic atrophy 1 Mitochondrial 
intermembrane 
space 

















Cleavage of L-Opa1 during 
mitochondrial depolarization  
Fission proteins     






































Mitochondrial receptor for Drp1; 
may regulate the DRP1 and 
maintain its inactive state until 
fission is required 
MiD51 Mitochondrial 
dynamics protein 




Mitochondrial receptor for Drp1; 
facilitates Drp1-mediated 
mitochondrial fission 
(Fis 1 and Mff independent) 
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Mitochondrial network morphology in metabolic disorders 
There is a growing consensus that obesity and metabolic disease are associated 
with mitochondrial network fragmentation in skeletal muscle. Increased mitochondrial 
network fragmentation was first demonstrated in skeletal muscle of Zucker Diabetic 
Fatty rats [30]. Similarly, obese mice that are deficient for leptin receptors and mice 
with high fat diet (HFD)-induced obesity were found to exhibit smaller and shorter 
mitochondria in skeletal muscle compared to lean mice [31]. In line with these 
findings, reduced propagation of mitochondrial matrix-targeted photoactivatable 
green fluorescent protein was observed in skeletal muscle of mice fed a high fat diet 
compared to chow fed controls [32], indicating a reduction in the degree of 
mitochondrial networking. Importantly, the presence of increased mitochondrial 
fragmentation in skeletal muscle has also been observed in humans with obesity and 
type 2 diabetes (T2D) compared to a lean reference group. This morphological 
phenotype was restored 1.5-years after bariatric surgery [33]. Similarly, 
mitochondrial capacity in patients undergoing laparoscopic gastric banding 
surgery was normalized 1-year post-surgery, which was independent of changes in 
mitochondrial content [34]. Taken together, these studies suggest an 
interdependency of mitochondrial form and function in obese patients. In young 
healthy humans, induction of insulin resistance by lipid infusion resulted in skeletal 
muscle mitochondrial fragmentation in association with activation of DRP1 by 
phosphorylation at serine 616 (Drp1ser616) [35]. Strikingly, this effect was observed 
without reduction in mitochondrial capacity or content, which suggests that functional 
defects may be secondary to chronic lipotoxicity.  Primary myotubes cultured from 
skeletal muscle biopsies obtained from severely obese non-diabetic and T2D 
participants retained a more fragmented mitochondrial network, relative to young 
lean healthy individuals [36]. This change in mitochondrial network was associated 
with increased Drp1ser616. Moreover, the number of fragmented mitochondria in 
cultured myotubes from the same population was reduced at 7 months after Roux-
en-Y gastric bypass (RYGB) [37] concomitant with reductions in Drp1ser616. The 
retention of these morphological characteristics in primary myotubes despite 
identical cell culture conditions suggests the involvement of transcriptional 
programming and is therefore not solely an acute response to a positive energy 
balance and lipotoxicity.  
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Regulation of skeletal muscle mitochondrial morphology in metabolic 
disorders 
Mitochondrial Fusion 
Protein expression studies also provide insights into the role of mitochondrial 
dynamics in metabolic disorders. Several lines of evidence support negative 
transcriptional regulation of mitochondrial fusion as an underlying component of 
mitochondrial fragmentation in metabolic disease. Reduced mitofusin-2 (MFN2) 
mRNA and protein expression is observed in skeletal muscle in obese rodents 
relative to lean controls [30, 32, 38, 39] and also in humans [30, 40, 41]. Repression 
of MFN2 in a rat muscle cell line decreased pyruvate and palmitate oxidation [30], 
increased production of ROS, and increased c-Jun N-terminal kinases (JNK) and 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) signaling in 
association with reduced glucose uptake and insulin signaling (Figure 2). 
Conversely, MFN2 gain of function reduced ROS production and restored insulin 
signaling [42, 43]. Similarly, in humans MFN2 mRNA correlated with glucose 
oxidation and increases in mRNA levels following bariatric surgery were positively 
correlated with the percentage change in glucose oxidation between fasted and 
insulin stimulated conditions during a hyperinsulinaemic-euglycaemic clamp 
procedure [40]. In healthy premenopausal women, MFN2 protein expression was 
associated with ROS emitting capacity in permeabilized skeletal muscle fibers [44]. 
Expression of the inner mitochondrial membrane fusion protein Optic Atrophy-1 
(OPA1), along with the mitochondrial fission protein FIS1, was highest in athletes 
when compared to individuals with type 2 diabetes [45].  Enhanced mitochondrial 
networking was also apparent in the athletes [45] perhaps indicating that athletes 
exhibit enhanced mitochondrial turnover through both mitochondrial fusion and 
fission, although with fusion the predominant factor in the resting homeostatic state. 
Provision of a eucaloric diet along with aerobic exercise training in older obese 
individuals induced a significant weight loss and resulted in increased skeletal 
muscle Optic Atrophy-1 (OPA1) [46]. This further supports a pro-fusion mitochondrial 
phenotype in response to exercise and a negative energy balance. In addition, as in 
a rat model [47], RYGB surgery in obese patients increased skeletal muscle MFN2 
gene expression at 3- and 12 months post-surgery in obese individuals [48]. 
However, in contrast to above findings, several studies reported that skeletal muscle 
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mitochondrial fusion gene and/or protein expression were not altered in human 
obesity [49] or T2D [50]. Moreover, single fiber analysis of skeletal muscle in morbid 
obesity revealed that the amount of both MFN1/2 was in fact higher in muscle fibers 
that presented fragmented networks [33]. An alternative explanation for these 
discrepancies may relate to the non-canonical functions of MFN2 such as 
involvement in lipid droplet [51] and Sarcoplasmic reticulum (SR)- mitochondria 
contact sites [52]. In particular, dysregulated SR-mitochondria interactions have 
been implicated in metabolic disease in animals and humans [51, 53, 54]. Moreover, 
a recent study [55] demonstrated that in healthy individuals fat oxidation was 
affected by both mitochondrial size and SR-mitochondria contact sites. It is therefore 
worth acknowledging that alterations in fusion proteins may also influence metabolic 
disease independent of their effects on mitochondrial morphology.  
Mitochondrial Fission 
Besides reduced fusion, excessive mitochondrial fission has also been implicated in 
skeletal muscle metabolic dysfunction. Similar to humans [35], in C2C12 cells and 
rodent muscle excess lipids resulted in mitochondrial fragmentation and reduced 
glucose uptake [31]. This was attenuated by inhibition of DRP1 [31]. Conversely, 
exercise training in obese humans results in a reduction in DRP1 activation which 
was correlated to improvements in insulin sensitivity and fat oxidation [56]. Along the 
same lines, expression of FIS1 was elevated in muscle of obese and T2D humans, 
and reduced by diet and exercise, and RYGB. DRP1-mediated mitochondrial 
fragmentation has also been implicated in ceramide-induced H2O2 production, 
impaired mitochondrial bioenergetics, and insulin resistance in C2C12 myotubes 
[57]. Recent evidence from liver cells support a role for DRP1 adaptor protein MFF in 
mediating ceramide-induced metabolic dysfunction [58]. Ceramide species, 
particularly C16:0 ceramides, are a major lipotoxic lipid class and are thought to be 
significant mediators of insulin resistance [59]. These data further support a link 
between lipotoxicity and mitochondrial fragmentation in skeletal muscle metabolic 
dysfunction observed in metabolic disorders. 
Obviously, mitochondrial morphology is defined by a balance between the rates of 
fusion and fission and it may be that mitochondrial morphology per se modulates 
substrate metabolism and insulin sensitivity regardless of whether shifts in 
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morphology are driven by alterations in either fission or fusion. Development of 
biomarkers of mitochondrial morphology in bigger datasets encompassing healthy 
and obese participants is therefore essential to advance our understanding of the 
role of mitochondrial dynamics in metabolic disorders. In this context, focusing on the 
ratio between fusion and fission protein expression rather than the individual 
proteins, may prove to be a useful strategy. Several attempts to this effect have been 
made such as OPA1-FIS1 [46] or MFN2-FIS1 [60], however further validation may 
be necessary. Nonetheless, imaging remains the gold standard for determining 
mitochondrial morphology, and advances in imaging techniques have been 
instrumental in enhancing our understanding of mitochondrial networks in skeletal 
muscle. Mitochondria in skeletal muscle observed by electron microscopy appear in 
tightly packed clusters, with many mitochondria grouped together in subsarcollemal 
regions and appearing in doublets in the intermyofibrillar regions of the muscle. 3D 
imaging of rodent muscle, and more recently human muscle, indicate that skeletal 
muscle relies on the formation of nanotunnels between mitochondria for the efficient 
transmission of membrane potential and transfer of mitochondrial DNA (mtDNA) and 
proteins[16]. Nanotunneling is reduced in obese mice [32], but data in skeletal 
muscle of obese humans is lacking. Nonetheless, this discovery represents an 
additional challenge to defining the relationship between mitochondrial dynamics and 
mitochondrial morphology in human disease as the finding of increased 
fragmentation, despite increased mitochondrial nanotunneling, observed in humans 
with primary mtDNA mutations illustrates [16].  
Aberrant mitochondrial network morphology is a hallmark of skeletal muscle 
myopathy 
Mitochondrial morphology has long been associated with myopathy [61]. Indeed, 
abnormalities in muscle mitochondrial structure became a diagnostic factor for 
inherited skeletal muscle myopathies [62] in the latter third of the 20th century. Whilst 
it is beyond the scope of the current review to provide an comprehensive overview of 
inherited and developed myopathies with a mitochondrial defect, it is nonetheless 
instructive to highlight some instances which illustrate a clear link between abberant 
mitochondrial morphology and skeletal muscle myopathy. In humans, mutations in 
the MFN2 gene result in Charcot-Marie-Tooth type 2A, a neuropathic disorder which 
is characterized by progressive muscle atrophy [63]. Autosomal dominant optic 
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atrophy (ADOA) mutations in the OPA1 gene results in muscle wasting associated 
with reductions in ATP generating capacity and increased mtDNA mutations in 
skeletal muscle [64]. More recently a novel myopathy caused by a homozygous 
nonsense mutation in the MIEF2 gene encoding the mitochondrial dynamics protein 
of 49 kDa (MID49) was associated with increased fusion, mitochondrial elongation, 
and aberrant cristae structure [65]. In cancer cachexia and chemotherapy-induced 
cachexia, DRP1, OPA1, and MFN2 gene expression were dramatically suppressed 
[66, 67].  
Mitochondrial Morphology in Ageing Muscle 
Sarcopenia is the age-associated loss of muscle mass and strength. In ageing, 
muscle mass begins to decline as early as age 40 at a rate of up to 1% per year 
while strength declines even more rapidly [68]. In aged muscle, reports from rodent 
studies suggest that aged mitochondria are smaller in size, while others suggest an 
increase in mitochondrial networking. Moreover, aged skeletal muscle displays 
impaired mitochondrial energetics [69] and increased mitochondrial-mediated 
apoptosis [70]. However, 2D imaging of human skeletal muscle has identified the 
presence of giant mitochondria in aged muscle indicating that there may be multiple 
mechanisms at play in the regulation of mitochondrial morphology in aged skeletal 
muscle. Interestingly, giant mitochondria in cultured myoblasts display both reduced 
levels of OPA1 and impaired capacity in fusion and autophagy [71]. In addition, 
muscle of aged mice also displayed abnormal mitochondrial structure and cristae 
formation (Figure 2) [72, 73]. These morphological alterations associate with 
reduced muscle cross-sectional area and reduced grip strength concomitant with 
reduced levels of OPA1 and DRP1 protein expression [73]. Consistent with this 
finding, grip strength is reduced in mice with a muscle-specific OPA knockout [74]. 
The discrepancies in mitochondrial morphologies reported in studies of ageing may 
relate to non-linear changes in fission and fusion over the lifespan [75]. These 
morphological alterations correlated with changes in muscle function evidenced at 
the different stages of mice life. Taken together these data illustrate a potential 
causal relationship between mitochondrial morphology and age-associated diseases 
of muscle weakness. 
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Mitochondrial dynamics and age-associated sarcopenia 
Several studies have indicated similar mitofusin gene [76] and protein [10, 77, 78] 
expression in skeletal muscle biopsies of young versus old volunteers. In addition, 
skeletal muscle OPA1 expression was unchanged [10] or decreased [77, 79] in 
elderly skeletal muscle, however the degree to which these elderly participants were 
sarcopenic is not apparent. In a recent study [80], MFN2 protein expression was 
lower in elderly patients with sarcopenia relative to non-sarcopenic elderly. This 
suggests that clearer characterization of sarcopenia status, or long term prospective 
studies in elderly, may be needed to determine the degree to which altered 
mitochondrial fusion is related to age-associated physical decline in humans. In spite 
of this, data from pre-clinical studies provide robust support for a link between 
altered mitochondrial fusion and age-related decline in muscle health. A reduction in 
both MFN1 and MFN2 has been demonstrated in aged mice, while global Mfn2 
knockout in mice resulted in mitochondrial dysfunction, increased oxidative stress, a 
reduction in ambulatory activity, and reduced muscle cross-sectional area. Notably 
Mfn2 knockout in mice resulted in muscle atrophy by downregulation of protein 
synthesis via the mTOR pathway and an accumulation of autophagosomes (Figure 
2) [81]. This is indicative of a reduction in autophagy,  the cellular mechanism that 
maintains tissue quality by removal of damaged cellular components. Indeed, 
reduced autophagy is a common feature of muscle atrophy [82, 83] and ageing [84], 
and has been linked to reduced MFN2 in muscle cells [85]. MFN2 repression was 
also associated with the accumulation of defective mitochondria despite increased 
mitophagy signaling via ROS-dependent upregulation of BNIP3 and Parkin (Figure 
2) [81]. Interestingly, Parkin mediated ubiquitination and degradation of MFN2 also 
induces muscle disuse atrophy through excessive mitochondrial fragmentation and 
mitophagy (Figure 2). This can be rescued by increasing mitochondrial mass 
through overexpression of the mitochondrial biogenesis activator Peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) [86].  
Opa1 depletion leads to reduced grip strength and muscle atrophy in rodents via 
elevated production of ROS [87], enhanced expression of pro-inflammatory genes 
[87], activation of the atrogenic forkhead box O’s (FOXOs) class of transcription 
factors [88], and increased muscle inflammation characterized by NFκB activation 
(Figure 2). Moreover, depletion of the OPA1 cleavage factor ATP-dependent zinc 
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metalloprotease YME1L (YME1L) in myotubes results in accumulation of the OPA1 
short form and the activation of AMP-activated protein kinase (AMPK) and FOXO3, 
thereby leading to increased muscle RING-finger protein-1 (MuRF1) (Figure 2) [88]. 
Reduced OPA1 has also been implicated in skeletal muscle atrophy via both ER-
stress mediated translational inhibition and upregulation of atrogenic genes such as 
MuRF1, Atrogin 1 and Fibroblast growth factor 21 (FGF21) in rodent models (Figure 
2) [79]. Collectively, these data illustrate how down-regulation of pro-fusion proteins 
in skeletal muscle can activate catabolic systems and ultimately cause muscle mass 
loss. However, whether these findings translate to age-associated declines in muscle 
protein synthesis and sarcopenia in human ageing remains an open question. 
The evidence supporting increased mitochondrial fission in skeletal muscle 
sarcopenia in humans is limited, with studies showing similar protein expression of 
DRP1 and FIS1 in young and old sedentary adults [10, 77] and following 10 days of 
bed rest in older adults [89]. Nonetheless, there is evidence for both knockout and 
overexpression of Drp1 resulting in muscle atrophy, albeit through activation of 
separate atrogenic pathways (Figure 2) [90]. Intriguingly, muscle-specific Opa1 and 
Drp1 DKO mice had a less severe phenotype than Opa1 knockout mice, despite 
persistent mitochondrial dysfunction. This effect was primarily through a blunted 
atrogenic transcriptional activity and reduced FGF21, though at the cost of 
translational inhibition via increased ER stress and reduced autophagy and 
mitophagy (Figure 2) [90]. In contrast, data in mouse cardiomyocytes [91] and C. 
elegans suggests that co-deletion of fission and fusion protein expression results in 
decreases in lifespan and metabolic health. Nonetheless, these data highlight the 
need to maintain the appropriate balance between fission and fusion for preservation 
of skeletal muscle mass and function. Interestingly, muscle cells incubated with 
palmitate lose skeletal muscle integrity via modulation of mitochondrial fission gene 
expression, pro-inflammatory cytokines, and atrogenes, yet this effect was 
attenuated by co-incubation with oleate [92]. This suggests that the fatty acid-
mediated mitochondrial redox state is a significant factor in the regulation of myotube 
atrophy. This finding is consistent with the effects of lipids on skeletal muscle 
mitochondrial fragmentation in insulin resistance in cells and animals [31] and 
humans [35] and therefore highlights the potential interconnectedness between 
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muscle mitochondrial dynamics in both skeletal muscle metabolic function and 
quality. 
Concluding Remarks 
There is growing evidence for impaired mitochondrial network dynamics in the 
aetiology of skeletal muscle health in metabolic disorders and ageing. Yet what this 
review highlights is that there remains a scarcity of detailed mechanistic studies, 
particularly in human models. Such studies will be essential for understanding the 
role of altered mitochondrial networks in the pathogenesis of muscle dysfunction and 
for developing new therapeutics to target mitochondrial dynamics in human disease. 
Nonetheless, new technologies that have emerged including advances in imaging 
technology with increasing application to human tissue have shed new light on the 
organization of mitochondrial networks in muscle; these approaches open the 
possibility for deeper insights into the role of skeletal muscle mitochondrial dynamics 
in metabolic disorders and ageing. 
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GLOSSARY 
Lipotoxicity: The deleterious effects of lipid accumulation in non-adipose tissue. 
Mitochondrial Fusion: The physical merging of the outer and then the inner 
mitochondrial membranes of two originally distinct mitochondria.  
Mitochondrial Fission: The division of a single mitochondria into two or more 
independent structures. 
Apoptosis: Programmed cell death 
Autophagy (macroautophagy): The process in which cellular contents are degraded 
by lysosomes or vacuoles and recycled.  
Mitophagy: The selective degradation of mitochondria by autophagy. 
Reactive oxygen species (ROS): are oxygen-containing radicals such as 
superoxide anion (O2−), hydrogen peroxide (H2O2), and hydroxyl radical (HO•) that 
can be generated by aerobic metabolism. ROS may serve as cell signaling 
molecules for normal biologic processes, however excessive production of ROS can 
result in damage to multiple cellular organelles and processes. 
Type 2 diabetes (T2D): Type 2 diabetes mellitus is a metabolic disorder that results 
in hyperglycaemia due to reduced effectiveness of the hormone insulin (insulin 
resistance) and an inability of the pancreas to produce enough insulin to over come 
insulin resistance. 
Bariatric surgery: covers a variety of weight loss surgeries including  
Laparoscopic gastric banding surgery: is a surgical procedure that involves the 
placement of an adjustable belt around the upper portion of the stomach using a 
laparascope. The belt limits the expansion of the stomach conferring increased 
satiety in the patient. 
Roux-en-Y gastric bypass (RYGB): is a surgical procedure that involves creating a 
small gastric pouch connected to a roux limb which bypasses a large portion of the 
small intestine.  This results in the food bypassing the majority of the stomach, the 
duodenum, and the first 40 to 50 cm of jejunum. 
Mitochondrial nanotunnels: thin double-membrane protrusions that connect the 
matrices of non-adjacent mitochondria.  
Cachexia: A complex metabolic syndrome associated with underlying illness and 
characterized by loss of muscle with or without loss of fat mass. 




• Mitochondria are multifaceted organelles that participate in a variety of cellular 
functions far beyond simple energy provision.  
• The ability of mitochondria to adapt to environmental stimuli and support 
metabolism and cellular homeostasis is governed by shifts in mitochondrial 
morphology, however increasing evidence suggests that aberrant 
mitochondrial morphology is present in numerous pathological conditions, 
including metabolic disease and age-associated skeletal muscle dysfunction. 
In addition, animal studies suggest that dysregulation of mitochondrial 
morphology may be mechanistically linked to pathogenesis 
• Currently there are no pharmaceutical agents available to target these 
pathways, however, diet and exercise, and bariatric surgery in humans and 
animals have been effective at normalizing mitochondrial morphology and 






Table 2. Summary of literature linking mitochondrial morphology and dynamics in humans to age- and obesity- associated skeletal muscle 
dysfunction. 
 







Functional Outcomes Refs 
Morbid obesity with 
and without T2D vs 
Lean Controls 
  ↑ Fragmentation in obese groups 
↑ Mfn1/2 in 
Obese 
↑ Drp1 in Obese 
and T2D 
• Reduced insulin sensitivity 
in obese and T2D 
[33] Roux-en-Y Gastric 
Bypass 
 ↓ Fragmentation in 
some obese and T2D 
patients 
  ↓ Fis1 • ↑ Insulin Sensitivity after RYGB 
Young Healthy Lipid Infusion ↑ Fragmentation No Change ↑ Drp1ser616 
• Reduced insulin 
sensitivity. 
• No change in 
mitochondrial capacity. 




from severely obese 
and T2D patients vs 
young lean healthy 
  ↑ Fragmentation in Obesity and T2D   
↑ Drp1ser616 in 
Obesity and T2D   [36] 
Cultured Myotubes 
from severely obese 




following surgery   
↓ Drp1ser616 
following surgery   [37] 
Obese and T2D vs 
lean controls     
↓ Mfn2 in Obese 
and T2D     [30] 
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[40] 
Elderly with Heart 
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 No Change No Change • Association between Mfn2 expression and ROS [44] 
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Obese, T2D, Athletes 
 
↑ Fragmentation in 
T2D relative to 
athletes 
OPA1 highest in 
athletes and 
lowest in T2D. 
Fis1 highest in 
athletes and 
lowest in T2D. 
 [45] 
Older Obese 
individuals 12wk diet and exercise 
 ↑ OPA1 following 
intervention 










• Association between 
Increased MFN2 and 
glucose uptake following 
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[48] 
Obese vs age 
matched lean 
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T2D patients vs 
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  No Difference 
Drp1 mRNA 
(DNM1L) was 










• Association between 
changes in Drp1ser616 
and improvements in 
insulin sensitivity and fat 
oxidation 
[56] 
Young active, Young 
sedentary, Middle-
aged sedentary, and 
Older sedentary 
  
↑ OPA1 and 
Mfn2 in Young 
active 
↑ Fis1 and Drp1 
in Young active 
↓ Drp1 in Middle 
aged sedentary 
• Negative relationship 
between Fusion and 
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no effect of 
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No Difference  [77] 
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↓ Mfn 2 in 
sarcopenic 
elderly 
No change  [80] 
Older adults 
10 days bed rest 
followed by 8wk 
Resistance Training 
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ABSTRACT 
The relationship between the age-associated decline in mitochondrial function and 
its effect on skeletal muscle physiology and function remain unclear. In the current 
study, we examined to what extent physical activity contributes to the decline in 
mitochondrial function and muscle health during aging and compared mitochondrial 
function in young and older adults, with similar habitual physical activity levels. We 
also studied exercise-trained older adults and physically impaired older adults. Aging 
was associated with a decline in mitochondrial capacity, exercise capacity and 
efficiency, gait stability, muscle function, and insulin sensitivity, even when 
maintaining an adequate daily physical activity level. Our data also suggest that a 
further increase in physical activity level, achieved through regular exercise training, 
can largely negate the effects of aging. Finally, mitochondrial capacity correlated with 
exercise efficiency and insulin sensitivity. Together, our data support a link between 




A large portion of the world’s population is of middle to older age, and in high-income 
countries, the proportion of people over the age of 60 is growing faster than any 
other age group (1). Since aging is associated with a variety of comorbidities 
resulting in rapidly increasing health care costs, this demographic change is one of 
the major societal challenges of the current decade (2).  
One of the distinctive features of aging is the progressive loss of muscle mass and 
physical function, collectively known as sarcopenia (3). The loss of skeletal muscle 
mass and tissue function has been related to mobility impairments (4), such as 
difficulties walking short distances or standing up from a chair (5,6), an increased 
risk of falls (7,8), physical frailty (9), and metabolic impairments (10), ultimately 
leading to a loss of physical independence and increased care need (11). Improving 
balance and mobility are important factors for public health in older adults in order to 
reduce fall-related consequences such as fractures, further functional decline, 
immobility, and death (12). 
In parallel with the progressive loss of muscle function, mitochondrial respiratory 
activity in human skeletal muscle has been shown to decrease with advancing age in 
healthy men and women (13,14). Furthermore, protein levels of the mitochondrial 
master regulator peroxisome proliferator-activated receptor gamma co-activator 1α 
(PGC-1α) were found to correlate with walking speed in healthy older adults (15). 
Some preclinical studies indeed suggest that the reduction in muscle mitochondrial 
function may underlie the decline in muscle health during aging. Thus, an 
accelerated manifestation of sarcopenia is seen in transgenic mice lacking the 
antioxidant enzyme superoxide dismutase 1 (SOD1), which are characterized by 
both a diminished mitochondrial bioenergetic function and an induction of 
mitochondrial-mediated apoptosis (16). In addition, in rats, age-related increases in 
mitochondrial abnormalities have been associated with muscle fiber splitting and 
atrophy (17). Therefore, it is tempting to speculate that augmenting mitochondrial 
function could be a potential strategy to counteract aging-associated decline in 
physical function. 
Although some human studies have addressed age-related alterations in muscle 
mitochondrial function in relation to the decline in skeletal muscle function (5,18–21), 
the available data in humans is scarce and the few available studies often focus on 
either the decline in muscle function or concentrate primarily on the mitochondrial 
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alterations. Additionally, the age-associated decline in mitochondrial function is not 
completely attributable to aging per se and may also be explained, in part, by an 
age-related decline in physical activity (PA) (19,20). Decreased PA can adversely 
affect mitochondrial capacity (24), while exercise training stimulates mitochondrial 
biogenesis through increases in the master regulator PGC-1α (25). Older adults are 
more inactive with advancing age which in turn decreases functional fitness (26). 
Therefore, it remains unclear to what extent chronological age and physical inactivity 
contribute to the decline in mitochondrial function and muscle health during aging. 
To delineate these relationships, we conducted a cross-sectional study with detailed 
phenotyping in groups of young versus older human participants, with a range in 
oxidative capacity and physical function. The first aim of the study was to assess if 
mitochondrial function is reduced in older compared to young participants with a 
similar level of habitual PA, and to examine how mitochondrial function relates to 
muscle function. To this end, we performed a wide array of assessments of skeletal 
muscle function (including strength, volume, insulin sensitivity, gait stability and 
adaptability, exercise capacity, and exercise efficiency) as well as in and ex vivo 
measurements to characterize mitochondrial capacity. The second aim of the study 
was to investigate the potential of regular exercise training in older adults for the 
maintenance of mitochondrial function, and if this is associated with maintained 
muscle health. Using the methods described above, the older adults with normal PA 
levels were also compared to older adults with a high PA level (trained individuals) 
and older adults with low physical function (physically impaired individuals, low PA). 
We also performed correlation analyses between skeletal muscle mitochondrial 




Mitochondrial function and muscle health decrease with age  
To assess the effect of age on mitochondrial function and muscle health, we 
compared young (Y) versus older (O) individuals with comparable levels of PA. 
Table 1 summarizes the main participant characteristics. Average age was 24 (3) 
years for the young individuals (Y) and 71 (4) years for the older participants (p < 
0.001). Sex distribution was identical between the two groups (8 male and 9 female 
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participants in both groups, p > 0.999). Older individuals had an increased BMI (p = 
0.007) and an increased body fat percentage (p = 0.007) as compared to young 
individuals. Fat free mass (FFM) was similar in young adults and old individuals and 
(p = 0.471). Both age groups performed a comparable amount of steps per day (p = 
0.146) and showed no significant difference in time spent on high PA level or low PA 
level (p = 0.496 and p = 0.737, respectively) indicating comparable levels of PA in 
daily life between young and older participants. Furthermore, no significant 
differences were observed in the balance test, the 4-meter walk test, and chair-stand 
test, assessed during screening as part of the short physical performance battery 
(SPPB, p > 0.05). 
Table 1 Participant body composition, physical activity, and physical function 
Young, normal 
physical activity (Y) 
Older adults, normal 
physical activity (O) 
N 17 17 
Gender F/M† 8/9 8/9 
Age (years) 24 (3)* 71 (4) 
BMI (kg m-2) 22.7 (2.9)* 25.8 (3.3) 
Body weight (kg) 69.0 (10.2) 74.0 (11.9) 
Fat mass (%) 24.4 (8.2)* 33.1 (9.2) 
Fat mass (kg) 16.8 (6.1)* 24.5 (7.9) 
Fat free mass (kg) 52.2 (9.9) 49.5 (10.8) 
Steps/day 9,983 (2,781) 10,207 (2,832) 
HPA time (% of wake time) 2.2 (1.2) 2.2 (1.2) 
LPA time (% of wake time) 11.4 (2.4) 11.7 (2.6) 
SPPB 4m walk speed (m s-1) 
)
1.1 (0.2) 1.1 (0.2) 
SPPB Chair-stand test (s) 9.1 (2.6) 10.1 (1.4) 
Data are presented as mean (SD) * indicates significant difference between 2 groups (p < 
0.05 two-sided, independent samples t-test). † Sex distribution across groups was tested by 
χ2 test (p > 0.999). Body composition and physical activity could not be measured in one 
participant of the Y group due to the implications of the SARS-CoV-19 crisis. BMI = body 
mass index; HPA = high-intensity physical activity; LPA = low-intensity physical activity; 
SPPB = short physical performance battery. 
Lower muscle strength, volume, and endurance in older adults 
During the 6-minute walk test (6MWT), older adults covered ∼9% less distance, in 
comparison with the young participants (p = 0.032, Figure 1a). Older adults also had 
a lower cardiorespiratory fitness, as indicated by a ∼26% lower maximal aerobic 
capacity (VO2max), in comparison with the young individuals (p < 0.001, Figure 1b). 
Likewise, maximal power output was lower in older individuals as compared to young 
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(p < 0.001, Figure 1c). In addition, a lower isokinetic muscle strength was observed 
in older adults as compared to young (p < 0.001, Figure 1d). In line with the similar 
FFM, muscle volume, measured in the upper leg by MRI, was comparable between 
young and older individuals (p = 0.151, Figure 1e). 
Reduced exercise efficiency in older adults 
Besides maximal exercise capacity, we also assessed exercise efficiency and 
substrate utilization during a submaximal exercise test. Resting energy expenditure 
was found to be comparable between young and old (p = 0.275, Figure 1f) and no 
differences were observed in respiratory exchange rate (RER) between old and 
young, both when measured during the submaximal exercise (p = 0.624 Figure 1g) 
and resting conditions (p = 0.852, Figure 1g). Both gross (p < 0.001) and net (p < 
0.001) exercise efficiency were found to be lower in the older individuals as 
compared to the young participants (Figure 1h).  
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Figure 1 Effect of aging on muscle health and exercise efficiency. 
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Figure 1 Effect of aging on muscle health and exercise efficiency. a Walking distance 
during the 6MWT performed on the Caren-system (Y, n = 14; O, n = 17). b Maximum 
rate of oxygen consumption measured during graded cycling exercise corrected for FFM 
(Y, n = 16; O, n = 17). c Maximal power output measured during graded cycling test (Y, n 
= 16; E, n = 17). d Muscle strength expressed as the extension and flexion peak torque 
during an isokinetic protocol on the Biodex system and corrected for fat-free mass (Y, n = 
16; O, n = 17). e Upper leg muscle volume measured by MRI (Y, n = 17; O, n = 17). f 
Resting energy expenditure adjusted for fat-free mass (Y, n = 15; O, n = 17). g Respiratory 
exchange rate measured before, in resting conditions, and during submaximal exercise (Y, 
n = 15; O, n = 17). h Exercise efficiency measured during the submaximal cycle test and 
expressed as gross efficiency and net efficiency (Y, n = 15; O, n = 17). Dark grey bars 
represent the young individuals (Y), light grey bars represent the older individuals (O). 
FFM could not be measured in one Y due to the implications of the SARS-CoV-19 
outbreak. For the same reason, 6MWT data and muscle volume data are missing in the 
same Y participant. Another participant from Y did not perform the 6MWT due to 
scheduling issues. The reported 6MWT distance from one Y participant was invalid and 
therefore excluded for analysis. One Y participant failed to complete the submaximal 
cycle test due to exhaustion. In another Y participant, the test could not be performed 
due to the implications of the SARS-CoV-19 outbreak. Values are presented as mean ± 
SD (with individual data points), * denotes significant differences between the two 
groups (p < 0.05, two-sided, independent samples t-test). 6MWT = 6-minute walk test; 
VO2max = maximal oxygen flow; Nm = newton meters; FFM = fat-free mass; RER = 
respiratory exchange rate; REE = resting energy expenditure; EE = exercise efficiency. 
Lower whole-body insulin sensitivity in older adults 
To further characterize skeletal muscle health, insulin sensitivity was determined 
during a hyperinsulinemic-euglycemic clamp. During the clamp, the M-value required 
to maintain euglycemia, was ∼22% lower in older in comparison with young 
individuals (p = 0.050, Figure 2a), suggesting a lower whole body insulin sensitivity 
in older adults. Plasma insulin levels during the clamp were different between young 
and older adults (Y: 75.61 (9.83) mU l-1 vs. O: 88.29 (10.73) mU l-1), p = 0.001). 
Peripheral insulin sensitivity, defined as the insulin-stimulated glucose uptake (Rd) 
corrected for differences in insulin and glucose levels (Si), was also significantly 
lower in older vs. young individuals when expressed per kg body weight (O: 0.050 
(0.028) µmol kgBW-1 min-1 vs. Y: 0.073 (0.024) µmol kgBW-1 min-1, p = 0.014). This 
difference was largely retained when Si was corrected for FFM, although it no longer 
reached statistical significance (p = 0.069, Figure 2b). This may suggest that a small 
part of the difference in peripheral insulin sensitivity between young and old adults is 
related to lean mass. Insulin-mediated suppression of endogenous glucose 
production (%EGP suppression, p = 0.850, Figure 2c) was not different between 
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young and old. RER in basal conditions was also comparable between older and 
young individuals (p = 0.174, Figure 2d). Likewise, upon insulin stimulation, RER 
was found to be equal between the older and young groups (p = 0.740, Figure 2d).
As a result, the change in RER upon insulin stimulation (known as metabolic 
flexibility) was also not different between older and young individuals (0.10 (0.05) vs.
0.09 (0.03), respectively, p = 0.603).
Figure 2 Effect of aging on insulin sensitivity and substrate selection. a Whole-body insulin 
sensitivity based on the M-value measured during a hyperinsulinemic-euglycemic clamp. b
Insulin-stimulated glucose uptake, corrected for plasma insulin and glucose levels (Si) and 
expressed per kg FFM. c EGP suppression, calculated as the percentage insulin-
suppressed EGP from the basal EGP d Respiratory exchange ratio measured before, in 
resting conditions (Basal), and during insulin stimulation (Insulin). Dark grey bars represent 
the young individuals (Y, n = 17), light grey bars represent older individuals (O, n = 15). One 
participant from O was excluded for analysis due to a violation of the protocol instructions.
For one O participant, tracer data could not be analyzed. Values are presented as mean ± 
SD (with individual data points), p = 0.05 denotes a significant difference between the two 
groups (two-sided, independent samples t-test). M-value = Mean glucose infusion rate; BW 
= body weight; Si = insulin-stimulated glucose disposal; FFM = fat-free mass; EGP = 
endogenous glucose production.
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Less gait stability but comparable adaptability in older adults  
To further determine physical function, walking stability was examined via step 
variability during unperturbed walking trials at multiple speeds on a treadmill and via 
stability of the body configuration (margin of stability; MoS; (27)) in response to 
treadmill belt acceleration perturbations causing forward balance loss during walking 
(see Methods for protocol details). Compared to young, older participants had a 
larger step length variability during unperturbed walking (F(1, 30) = 7.077, p = 0.012; 
significant pairwise comparisons at 1.2, 1.4, and 1.6 m s-1; Supplementary Figure 1), 
but no other significant differences were found. During the walking perturbation 
assessments, group comparisons for the entire perturbation trial revealed a 
significant difference in the margin of stability (MoS) during the first perturbation (F(1, 
28) = 7.7, p = 0.010) but not the second and ninth perturbations, indicating that older 
adults initially perform poorer than young adults, but the ability of older adults to 
adapt gait in response to repeated perturbations is intact (Supplementary Figure 2a). 
More detailed results regarding gait stability and stepping behavior can be found in 
the supplementary notes and accompanying figures. 
Lower ex vivo and in vivo mitochondrial function in older adults 
Skeletal muscle mitochondrial capacity was determined both ex vivo in 
permeabilized muscle fibers and in vivo via non-invasive assessment of PCr 
recovery rates using 31P-MR spectroscopy. In permeabilized muscle fibers, 
mitochondrial state 2 respiration (i.e., respiration in the presence of substrate alone) 
was similar between young and older adults on most substrate combinations, apart 
from malate + octanoyl-carnitine, which showed lower respiration rates in older 
individuals (MO, p = 0.044, Figure 3a). ADP-stimulated (state 3) respiration, fueled 
by complex I-linked substrates (malate + glutamate, MG, p = 0.032, Figure 3b), was 
lower in older participants whereas state 3 respiration upon a lipid substrate (MO, 
Figure 3c) was not significantly different between young and old (p > 0.05). ADP-
stimulated respiration upon parallel electron input to both Complex I and II was also 
lower in older compared to young individuals. Thus, state 3 respiration upon malate 
+ octanoyl-carnitine + glutamate (MOG, p = 0.014, Figure 3d), malate + octanoyl-
carnitine + glutamate + succinate (MOGS, p = 0.006, Figure 3d) and malate + 
glutamate + succinate (MGS, p = 0.077, Figure 6d) was ∼11–15% lower in the older 
adults as compared to the young individuals, although the latter did not reach 
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statistical significance. Maximal FCCP-induced uncoupled respiration, reflecting the 
maximal capacity of the electron transport chain, was ∼17% lower in older adults 
compared to young (State 3u, p = 0.008, Figure 3e). State 4o respiration, reflecting 
mitochondrial proton leak, was similar between the young and older individuals (p = 
0.379, Figure 3f). The negligible increase in oxygen consumption upon cytochrome 
C (2.30 (3.24) vs. 2.27 (2.26) % in young vs. old, respectively) underscores the 
viability and quality of the muscle fibers and was similar in both groups (p = 0.976). 
  
Assessment of in vivo mitochondrial function revealed a ∼16% lower PCr recovery 
rate constant in older adults as compared to young (p = 0.003, Figure 3g), further 
confirming a decreased mitochondrial oxidative capacity in older individuals. The 
exercise-induced PCr depletion and end-exercise pH were similar between young 
and old (p > 0.05) and pH remained above 6.9, indicating no substantial exercise-
induced acidification in either group.  
To complement the in vivo and ex vivo mitochondrial function measurements, 
mitochondrial content was estimated by mitochondrial Oxidative Phosphorylation 
(OXPHOS) protein expression. However, young and older adults displayed a similar 
expression of each of the five OXPHOS proteins (p > 0.05, Figure 3h). 
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Figure 3 Effect of aging on skeletal muscle mitochondrial function and density
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Figure 3 Effect of aging on skeletal muscle mitochondrial function and density. a 
Mitochondrial respiration upon substrates only (state 2) (Y, n = 15; O = 17). b ADP-
stimulated respiration (state 3) respiration fueled by Complex I-linked substrates (Y, n = 15; 
O = 17). c State 3 upon a lipid substrate (Y, n = 15; O = 17). d Maximal ex vivo state 3 
respiration upon parallel electron input into Complex II and I (Y, n = 15; O = 17). e Maximal 
uncoupled respiration upon FCCP (Y, n = 15; O = 17). f Mitochondrial respiration uncoupled 
from ATP synthesis (state 4o) (Y, n = 15; O = 17). g 31P-MRS in vivo assessment of 
mitochondrial oxidative capacity () (Y, n = 15; O, n = 16). h Mitochondrial protein 
expression of oxidative phosphorylation (OXPHOS) complex I, complex II, complex III , 
complex IV, and complex V (Y, n = 15; O, n = 17). Dark grey bars represent the young 
individuals (Y); light grey bars represent older individuals (O). In one Y no biopsy was 
performed due to technical issues and, in another Y, due to the implications of the SARS-
CoV-19 outbreak. For the latter reason, also PCr recovery data is missing in the same Y 
participant. PCr data from one O has been excluded from analysis due to a pH decline 
below 6.9. PCr data from a Y participant has been excluded due to issues regarding the 
analysis. Values are presented as mean ± SD (with individual data points), * denotes 
significant differences between the two groups (p < 0.05, two-sided, independent samples t-
test). M = malate; O = octanoyl-carnitine; G = glutamate; S = succinate;  = phosphocreatine 
resynthesizes rate constant. 
Exercise training affects mitochondrial function and muscle health  
Next, we compared muscle function and mitochondrial capacity of the same older 
adults with normal PA (O, n = 17) to trained older adults (TO, n = 19) as well as to 
older adults with a low physical function (IO, n = 6). Table 2 summarizes the main 
participant characteristics of these three older groups. Sex distribution was 
comparable across the groups (p = 0.982). Average age was 71 (4) years for the 
older participants with normal PA (O) and 72 (5) years for the physically impaired 
older adults (IO), whereas TO were slightly younger at 68 (2) years in comparison 
with O (p = 0.023). In accordance with their training status, TO displayed a lower 
BMI and a lower body fat mass percentage as compared to both O (p = 0.046 and p 
= 0.050, respectively) and IO (p = 0.024 and p = 0.021, respectively). FFM was 
comparable (p > 0.05) across the three groups. TO displayed a higher average step 
count per day as compared to O (p = 0.050) and IO (p = 0.004), further underscoring 
their active lifestyle. TO also spent a significantly higher proportion of their waking 
time at a high intensity level of PA compared to O (p = 0.049) and IO (p = 0.005). 
Proportion of the waking time spent at a low intensity level of PA was similar 
between TO and O and between TO and IO (p > 0.05) and higher in O compared to 
IO (p = 0.038). As anticipated, IO performed significantly poorer on the chair-stand 
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test as compared to O (p = 0.015) and TO (p = 0.001). Walking speed during the 4-
meter walk test was also lower in IO when compared to TO (p = 0.009) but not to O 
(p = 0.227). 









N 17 19 6 
Gender F/M† 8/9 8/11  3/3 
Age (years) 71 (4) 68 (2)b 72 (5)a,b 
BMI (kg m-2) 25.8 (3.3)a 23.6 (1.9)b 27.0 (2.3)a 
Body weight (kg) 74.0 (11.9) 68.3 (8.8) 79.0 (7.2) 
Fat mass (%) 33.1 (9.2) 26.2 (7.7)b 37.4 (9.0)a 
Fat mass (kg) 24.5 (7.9)a 17.6 (7.1)b 29.4 (7.9)a 
Fat free mass (kg) 49.5 (10.8) 50.7 (9.7) 49.6 (10.8) 
Steps/day 10,207 (2,832) 13,815 (5,934)b 6,608 (1,765)a 
HPA time (% of wake time) 2.2 (1.2)a 5.3 (3.9)b 1.0 (0.6)a 
LPA time (% of wake time) 11.7 (2.6)a 10.8 (2.9) 8.3 (1.5)b 
SPPB 4m walk speed (m s-1) 1.1 (0.2) 1.3 (0.2)a 1.0 (0.3)b 
SPPB Chair-stand test (s) 10.1 (1.4) 9.0 (2.1)a 13.30 (4.8)b 
Values are presented as mean (SD). Age and HPA time were analyzed by two-sided 
Kruskal-Wallis tests followed by Bonferroni correction; other data were analyzed by one-way 
ANOVA with Tukey’s post-hoc test. a,b Groups that do not share the same letter are 
significantly different from each other (p < 0.05). † Sex distribution across groups was tested 
by χ2 tests (p = 0.982). BMI = body mass index; HPA = high-intensity physical activity; LPA = 
low-intensity physical activity; SPPB = short physical performance battery. 
Higher muscle strength, volume, and endurance in trained older adults 
During the 6MWT, IO covered ∼22% less distance compared to the O group (p = 
0.013, Figure 4a) and ∼29% less distance compared to the TO group (p = 0.005, 
Figure 4a). Not surprisingly, the trained older individuals displayed the highest 
cardiorespiratory fitness levels, as exemplified by an average VO2max which was 
∼1.2-fold and ∼1.4-fold higher in comparison with O (p = 0.003) and IO (p = 0.004),
respectively (Figure 4b). Accordingly, maximal power output was higher in TO as 
compared to O and IO (p < 0.001 and p < 0.001 respectively, Figure 4c). TO 
participants also showed the highest muscle strength, whereas muscle strength was 
lowest in the physically impaired older adults. Thus, isokinetic extension peak torque 
(Figure 4d) was ∼24% and ∼27% lower in the IO group as compared to O (p = 
0.026) and TO (p = 0.006), respectively. Furthermore, the isokinetic flexion peak 
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torque (Figure 4d) was found to be highest in the TO group compared to the O group 
(∼1.1-fold, p = 0.046) and IO group (∼1.5-fold, p < 0.001). Muscle volume, measured 
in the upper leg by MRI, was not significantly different between the three groups (p > 
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Figure 4 Effect of exercise training and physical impairment on muscle health and exercise 
efficiency in older adults.
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Figure 4 Effect of exercise training and physical impairment on muscle health and exercise 
efficiency in older adults. a Walking distance during the 6MWT performed on the Caren-
system (O, n = 17; TO, n = 17; IO, n = 6). b Maximum rate of oxygen consumption 
measured during graded cycling exercise (O, n = 17; TO, n = 19; IO, n = 6). c Maximal 
power output measured during graded cycling test (O, n = 17; TO, n = 19; IO, n = 6). d 
Muscle strength expressed as the extension and flexion peak torque during an isokinetic 
protocol on the Biodex system and corrected for fat-free mass (O, n = 17; TO, n = 19; IO, n = 
6). e Upper leg muscle volume measured by MRI (O, n = 17; TO, n = 18; IO, n = 6). f 
Resting energy expenditure adjusted for FFM (O, n = 17; TO, n = 19; IO, n = 5). g 
Respiratory exchange rate measured before, in resting conditions, and during submaximal 
exercise (O, n = 17; TO, n = 19; IO, n = 5). h Exercise efficiency measured during a 
submaximal cycle test and expressed as gross efficiency and net efficiency (O, n = 17; TO, n 
= 19; IO, n = 5). Light grey bars represent normally active older adults (O); dark grey bars 
represent trained older adults (TO); white bars represent physically impaired older adults 
(IO). Upon the advice of the responsible medical doctor, one IO participant did not perform a 
maximal and submaximal. One TO participant did not perform the 6MWT due to scheduling 
issues. The reported 6MWT distance from another TO was invalid and therefore excluded 
for analysis. Data presented in panels a and c were analyzed by two-sided Kruskal-Wallis 
tests followed by Bonferroni correction. Data presented in panels b, d-h were analyzed by 
one-way ANOVA with Tukey's post-hoc test. Values are presented as mean ± SD (with 
individual data points), * denotes significant differences between two groups (p < 0.05). 
6MWT = 6-minute walk test distance; VO2max = maximal aerobic capacity; Nm = newton 
meters; FFM = fat-free mass; RER = respiratory exchange rate; REE = resting energy 
expenditure; EE = exercise efficiency.  
 
Higher exercise efficiency in trained older adults 
Resting energy expenditure was comparable across the three older adult groups (p > 
0.05, Figure 4f) and RER was also similar between the groups (p > 0.05, Figure 4g). 
Furthermore, during the 1-hour submaximal cycling test at 50% of Wmax, no 
differences were observed in RER in TO as compared to O and IO (p > 0.05, Figure 
4g). TO showed a higher gross exercise efficiency in comparison to O (p = 0.001) 
and in comparison with IO (p < 0001, Figure 4h) Likewise, the net exercise efficiency 
was higher in TO compared to both the O individuals (p = 0.006) and the IO group (p 
= 0.002, Figure 4h).  
Higher whole-body insulin sensitivity in trained older adults  
Glucose infusion rate during the clamp (M-value) was ∼1.3-fold higher in TO when 
compared to O (p = 0.023, Figure 5a), indicating a higher whole-body insulin 
sensitivity in TO. Peripheral insulin sensitivity (Si) was also higher in TO compared to 
O when expressed per kg body weight, which tended to be significant (TO: 0.066 
(0.025) µmol kgBW min-1 vs. O: 0.050 (0.028) µmol kgBW min-1, respectively, p = 
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0.072). When Si was corrected for FFM, no significant difference was observed 
between TO and O (p = 0.165, Figure 5b). Insulin-mediated suppression of EGP 
(Figure 5c) was similar in TO and O. Also RER was comparable between TO and O, 
both in the basal state (p = 0.839, Figure 5d) and upon insulin stimulation (p = 0.353,
Figure 5d). As a result, metabolic flexibility was also comparable between TO and O 
(0.11 (0.04) vs. 0.10 (0.05), respectively, p = 0.261).
Figure 5 Effect of exercise training on insulin sensitivity and substrate selection in older 
adults. a Whole-body insulin sensitivity based on the M-value measured during a 
hyperinsulinemic-euglycemic clamp. b Insulin-stimulated glucose uptake corrected for 
plasma insulin and glucose levels (Si) and expressed per kg FFM c EGP suppression,
calculated as the percentage insulin-suppressed EGP from the basal EGP. d Respiratory 
exchange ratio measured before, in resting conditions (Basal), and during insulin stimulation 
(Insulin). Light grey bars represent normally active older adults (O, n = 15); dark grey bars 
represent trained older adults (TO, n = 19). Because only 3 IO participants could undergo 
the clamp, these results were not considered. One O participant was excluded for analysis 
due to violation of the protocol instructions. For one O participant tracer data could not be 
analyzed. Values are presented as mean ± SD (with individual data points), * denotes 
significant differences between the two groups (p < 0.05 two-sided, independent samples t-
test). M-value = Mean glucose infusion rate; BW =  body weight; Si = insulin-stimulated 
glucose disposal; FFM = fat-free mass; EGP = endogenous glucose production.
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Comparable gait stability in normally active and trained older adults 
When comparing O, TO and IO, no significant differences were observed for gait 
variability during unperturbed walking (Supplementary Figure 3 and 4). During the 
gait stability assessments, when considering the entire perturbation trial 
(Supplementary Figure 5a), MoS was not significantly different between O and TO 
for perturbation 1, 2 and 9, indicating no significant stability or stepping behavior 
difference between O and TO. More detailed results regarding the gait variability, gait 
stability, and adaptability can be found in the supplementary notes and 
accompanying figures. 
 
Higher mitochondrial function in trained older adults 
In permeabilized muscle fibers, mitochondrial state 2 respiration was significantly 
higher in the TO individuals compared to O on all of the substrate combinations 
studied (Figure 6a, p < 0.05). Also, ADP-stimulated (state 3) respiration on complex 
I-linked substrates as well as a lipid substrate was higher in TO compared to O. 
Thus, state 3 respiration fueled by malate + glutamate (MG) and malate + 
octanoylcarnitine (MO) were ∼1.2-fold and ∼1.4-fold higher in TO as compared to O 
(p = 0.049 and p < 0.001, respectively (Figure 6b–c). ADP-stimulated respiration 
upon parallel electron input to both Complex I and II was also higher in TO compared 
to O. Thus, state 3 respiration upon malate + octanoyl-carnitine + glutamate (MOG, p 
= 0.001), malate + octanoyl-carnitine + glutamate + succinate (MOGS, p = 0.002) 
and malate + glutamate + succinate (MGS, p = 0.018) was ∼1.2-1.3-fold higher in 
TO compared to O (Figure 6d). Maximal FCCP-induced uncoupled respiration was 
∼1.4-fold higher in TO compared to O (state 3u, p = 0.001, Figure 6e). State 4o 
(leak) respiration was higher in the TO group compared to both O (∼1.3-fold, p = 
0.006, Figure 14f) and IO individuals (∼1.3-fold higher, p = 0.026, Figure 6f). Across 
the different respiratory states, oxygen consumption in permeabilized muscle fibers 
derived from IO appeared to be comparable to the respiration rates observed in O. 
However, due to the small sample size and large variation of the IO group, the 
differences between the IO and TO groups did not reach statistical significance in all 
respiratory states except for state 4o.  
The negligible increase in oxygen consumption upon cytochrome C (2.61 (1.85) % 
vs. 2.27 (2.26) % vs. 0.33 (1.54) %, in TO vs. O vs. IO, respectively) underscores the 
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viability and quality of the muscle fibers and was similar between the study groups (p 
> 0.05).   
Similar to the observed mitochondrial respiration rates in permeabilized muscle 
fibers, the TO group also displayed a ∼1.2-fold and ∼1.3-fold higher PCr recovery 
rate constant as compared to O and IO, respectively, although these differences did 
not reach statistical significance (TO vs. O p = 0.169; TO vs. OI, p = 0.135; O vs. IO 
p = 0.815; Figure 6g). The exercise-induced PCr depletion and pH was similar 
across the three study groups (p > 0.05) and pH remained above 6.9 indicating no 
substantial exercise-induced acidification.  
Protein expression of OXPHOS complex I and III was higher in TO compared to O (p 
= 0.010 and p = 0.042, respectively, Figure 6h). Furthermore, protein expression of 
complex II (p = 0.003 and p = 0.025, respectively) and complex IV (p < 0.001 and p = 
0.003, respectively) was higher in TO compared to both O and IO.  
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Figure 6 Effect of exercise training and physical impairment on skeletal muscle 
mitochondrial respiration and density in older adults.
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Figure 6 Effect of exercise training and physical impairment on skeletal muscle 
mitochondrial respiration and density in older adults. a Mitochondrial respiration upon 
substrates only (state 2) (O, n = 17; TO, n = 19; IO, n = 6). b ADP-stimulated respiration 
(state 3) fueled by Complex I-linked substrates (O, n = 17; TO, n = 19; IO, n = 6). c State 3 
respiration upon a lipid substrate (O, n = 17; TO, n = 19; IO, n = 6). d Maximal ex vivo state 
3 respiration upon parallel electron input into Complex I and II (O, n = 17; TO, n = 19; IO, n = 
6). e Maximal uncoupled respiration upon FCCP (O, n = 17; TO, n = 19; IO, n = 6). f 
Mitochondrial respiration uncoupled from ATP synthesis (state 4o) (O, n = 17; TO, n = 19; 
IO, n = 6). g In vivo 31P-MRS estimate of mitochondrial oxidative capacity κ (O, n = 16; TO, n 
= 18; IO, n = 6). h Mitochondrial protein expression of oxidative phosphorylation (OXPHOS) 
complex I, complex II, complex III, complex IV, and complex V (O, n = 17; TO, n = 18; IO, n 
= 6). Light grey bars represent normally active older adults (O); dark grey bars represent 
trained older adults (TO); white bars represent physically impaired older adults (IO). PCr 
data from one O participant has been excluded from analysis due to a pH decline below 6.9. 
PCr from a TO participant has been excluded due to issues regarding the analysis. From 
one TO not enough muscle tissue was available for the OXPHOS analysis. Data presented 
in panels a and g were analyzed by two-sided Kruskal-Wallis tests followed by Bonferroni 
correction.  Data presented in panels b-f and h were analyzed by one-way ANOVA with 
Tukey's post-hoc test. Values are presented as mean ± SD (with individual data points), * 
denotes significant differences between two groups (p < 0.05). M = malate; O = octanoyl-
carnitine; G = glutamate; S = succinate;  = phosphocreatine resynthesis rate constant 
 
Mitochondrial and muscle function and exercise efficiency are related  
To further explore the relationship between mitochondrial energetics, muscle quality 
and physical function, correlations were performed based on the combined data from 
the entire study cohort. Pearson correlation outcomes are summarized in 
Supplementary Table 2 and illustrated in Figure 7. As anticipated, correlations were 
observed between the different measures for mitochondrial function and oxidative 
capacity (ex vivo respiration, in vivo PCr recovery rate and VO2max, Figure 7a). 
Furthermore, measures for ex vivo mitochondrial capacity – but not in vivo PCr 
recovery rate constant – were found to significantly correlate with 6MWT, M-value 
and steps per day as markers for walking performance, insulin sensitivity, and 
physical activity, respectively (Supplementary Table 2, Figure 7b-c). Both step length 
variability and double support time variability correlated with measures of in vivo and 
ex vivo mitochondrial function (Supplementary Table 2, Figure 7e-f). Additionally, ex 
vivo mitochondrial coupled respiration rates were found to correlate significantly with 
gross exercise efficiency (Supplementary Table 2, Figure 7d). Interestingly, gross 
and net exercise efficiency showed the strongest correlations with multiple aspects 
of muscle health including endurance, physical function, muscle strength, insulin 
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sensitivity, gait stability, and physical activity, as illustrated by the significant 
correlations with VO2max, 6MWT, the chair-stand test, isokinetic extension, M-value, 
Si, recovery steps after perturbation, and steps per day (Supplementary Table 2, 
Figure 7g-h), respectively. 
Partial correlation analyses adjusted for age, sex, and BMI are shown in Table 3. 
Also, after adjustment, correlations were observed between the different measures 
for mitochondrial function and oxidative capacity (ex vivo respiration, in vivo PCr 
recovery rate and VO2max).  
Interestingly, maximal ex vivo mitochondrial respiration rates were found to 
significantly correlate with steps per day, a marker for PA. In addition, ex vivo 
mitochondrial capacity – but not in vivo PCr recovery rate constant – were 
significantly correlated with gait stability assessed by double step support variability 
and insulin sensitivity as assessed by the M-value. Moreover, ex vivo mitochondrial 
coupled respiration rates were found to correlate significantly with gross exercise 
efficiency. Interestingly, gross and net exercise efficiency showed, also after 
adjustment, the strongest correlations with multiple aspects of muscle health 
including endurance, physical function, insulin sensitivity, and PA. The correlation 
between exercise efficiency and step variability was no longer present after 
adjustment for age and BMI.  
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Figure 7 Bivariate correlations between mitochondrial function and physical muscle function. 
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Figure 7 Bivariate correlations between mitochondrial function and physical muscle function. 
a Correlation between maximal exercise capacity and maximal coupled mitochondrial 
respiration. b Correlation between physical activity and maximal coupled mitochondrial 
respiration. c Correlation between whole-body insulin sensitivity and maximal uncoupled 
mitochondrial respiration. d Correlation between gross exercise efficiency and maximal 
uncoupled mitochondrial respiration. e Correlation between step variability and maximal 
uncoupled mitochondrial respiration f Correlation between step variability and in vivo PCr 
recovery rate constant. g Correlation between walking performance and gross exercise 
efficiency. h Correlation between SPPB chair-stand test and gross exercise efficiency. Dark 
grey diamonds indicate young normally active individuals (Y), light grey squares indicate 
normally active older adults (O), white triangles indicate physically impaired older adults 
individuals (IO), and dark grey circles indicate trained older adults (TO). * indicates the 
correlation is significant at the 0.05 level (2-tailed, p < 0.05); Best-fit trend line and 95% 
confidence intervals are included. MOGS3 = state 3 respiration upon malate + octanoyl-
carnitine + glutamate + succinate; 3u = state 3 uncoupled respiration upon FCCP;  = 
phosphocreatine resynthesis rate constant; 6MWT = 6-minute walk test; VO2max = maximal 
aerobic capacity; FFM = fat-free mass; Nm = newton meters; M-value = Mean glucose 
infusion rate; r = Pearson correlation coefficient 
 
 
Table 3 Partial analysis to explore the relationships between energetics and physical muscle function 
Data are from all groups (total n > 51). Correlations are adjusted for †age, sex, and BMI.* indicates the partial correlation is significant at the 
0.05 level (two-sided, p < 0.05); † indicates variables that were log transformed; # indicates the correlations corrected for only †age and BMI. 
MOGS3 = state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate; 6MWT = 6-minute walk test; VO2max = maximal 
oxygen flow; FFM = fat-free mass; Nm = newton meters; M-value = mean glucose infusion rate; Si = insulin-stimulated glucose uptake, r = 













































(pmol s-1 mg-1) 
r 0.165 -0.084 0.416* 0.049 -0.054 0.253 0.062 0.363* -0.094 -0.293* 0.232 
 





(pmol s-1 mg-1) 
r 0.109 -0.140 0.512* 0.077 -0.036 0.317* 0.169 0.422* -0.170 -0.378* 0.304* 
 
p 0.458 0.318 <0.001 0.584 0.798 0.026 0.250 0.002 0.258 0.010 0.030 
 
PCr recovery 
rate constant  
(s-1)  
r 0.191 -0.037 0.363* 0.035 -0.024 0.238 0.124 0.305* -0.216 -0.271 0.233 
 






r 0.597* -0.478* 0.570* 0.110 0.052 0.424* 0.224 0.361 -0.132 -0.152  
 





r 0.521* 0.418* 0.470* 0.003 -0.040 0.397* 0.235 0.273 -0.103 -0.215  
 




Skeletal muscle mitochondrial function has been shown to decline with age and may 
underlie the decline in muscle health and performance during aging. Although the 
origins of reduced mitochondrial function with age are a matter of ongoing debate, 
recent data suggest that PA levels may be a key determinant of mitochondrial 
energetics in aging (6). Although the data presented here support a role for PA in 
mitigating the negative effects of sedentary behavior in older adults, we nevertheless 
show that older adults with normal PA when compared to young adults with 
equivalent habitual PA levels, display lower mitochondrial capacity despite 
comparable mitochondrial content. Additionally, the older participants had lower 
muscle strength, aerobic capacity, exercise efficiency, and gait stability compared to 
similarly active young adults. Conversely, trained older participants exhibited higher 
mitochondrial capacity than older adults with normal PA and older adults with 
impaired physical function, which was associated with improved functional 
outcomes. Notably, the increase in mitochondrial capacity in the trained older adults 
was largely accounted for by an increase in mitochondrial content. These data 
suggest a role for aging-associated reductions in mitochondrial function independent 
of PA levels or mitochondrial content and may be a contributory factor in physical 
function decline. These effects appear to be mitigated by exercise training-induced 
increases in mitochondrial content.  
 
In this study, the young and older adult groups were not engaged in structured 
exercise activities and both recorded approximately 10,000 steps daily. This is well 
above the average daily step count reported for older untrained adults in previous 
studies (6,28) and indicates an overall active lifestyle and adequate levels of PA for a 
healthy adult (29). Despite similar habitual PA, walking performance and maximal 
aerobic capacity was lower in the older adults compared to the young controls. 
These findings are in line with previous observation from a study comparing adults < 
65 years and > 65 years, which observed the peak VO2 and 400 m gait speed to be 
lower with higher age (5). 
 
With an average of more than 12,500 steps per day and at least 3 exercise sessions 
per week, the trained older participants in the current study are considered to be 
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highly physically active, whereas physically impaired older adults averaged less than 
7,500 steps per day, reflecting a sedentary lifestyle (29). The differences in habitual 
PA levels between the groups of older adults were reflected in walking performance 
and maximal aerobic capacity, confirm previous evidence (6,20) and support the 
notion that at advanced age, increasing PA by exercise training can help to preserve 
physical function and performance. 
 
We could not detect a statistical difference in muscle volume between young and 
older adults with similar levels of PA, indicating that habitual PA may be an important 
factor in the age-associated loss in muscle volume that has been observed 
previously (30). In our study, however, training status did not affect muscle volume in 
older adults, although this may be explained by the fact that the cohort consisted 
primarily of endurance-trained athletes and endurance training is less likely to 
improve lean mass compared to strength training (31). Despite the lack of difference 
in muscle volume, muscle strength was lower in older participants and differences in 
muscle strength corresponded to habitual PA stratification applied to the three older 
adults groups, which is in agreement with previous comparisons between active and 
sedentary older adults (6,32). 
 
Exercise efficiency refers to the energetic cost of physical activities such as walking 
and decreases in exercise efficiency likely contribute to the age-related inefficiency 
of locomotion and daily activities (21). As expected, lower net exercise efficiency was 
observed in the older participants compared to young adults in the present study, 
underlining an increased energy expenditure during exercise in the presence of 
comparable resting metabolic rate. This observation is in line with the findings from 
Distefano et al. (6), showing a lower exercise efficiency in older adults when 
compared to young adults with comparable levels of PA (∼8,500 vs. ∼10,500 steps 
per day, respectively).  
The relative difference of ∼15% in exercise efficiency in the trained older adults 
compared to the older adults with normal PA are similar to two previous studies 
suggesting that exercise training interventions have the potential to reverse age-
related reductions by increasing exercise efficiency up to ∼30% in sedentary (33) 
and endurance-trained volunteers (34). These findings are further supported by a 
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cross-sectional study observing a higher exercise efficiency in athletic adults when 
compared to sedentary older adults (20). Interestingly, mitochondrial dysfunction has 
been implicated as a key factor in the reduced exercise efficiency with age which 
indicates mitochondria as the target for intervention to reverse this source of 
debilitation in older adults (20,21). We observed a strong positive correlation 
between maximal mitochondrial capacity and gross exercise efficiency suggesting 
that mitochondrial capacity is indeed a determinant of exercise efficiency in aging. 
 
Older adults responded in a less effective manner to the first perturbation when 
compared to the young participants, underlining the higher risk of falls in this 
population (7), even when PA is comparable. This observation confirms numerous 
other studies demonstrating age related differences in the ability to cope with such 
perturbations (for example: (35,36)). As PA was comparable between young and 
older adults in this study, it might be inferred that an increased fall risk with age 
cannot be entirely attributed to a decrease in PA, as is often suggested. During 
unperturbed walking, most spatiotemporal parameters and their variability were not 
affected by age, indicating that perhaps steady-state walking is more readily 
preserved with PA. Nevertheless, this only seems to be confirmed to a certain 
extent, as the trained older adults in the current study did not have significantly 
different unperturbed gait outcomes, compared to the normally active older adults. 
 
One previous study reported that in a mixed group of older and younger adults, 
those who were recreational runners performed better on a forward falling task than 
the non-active participants (37). This pattern was not observed in the current study, 
as there were no clear differences between the TO and O groups on the perturbation 
tasks. It could be argued that this may be partly due to the fact that the O group 
actually had quite a high habitual PA but this did not seem to result in a lack of 
difference to the young adults. Another possibility is that the current gait perturbation 
task, which is more dynamic and in which it is practically impossible to predict and 
prepare for the perturbations, is simply more complex than the ‘forward lean and 
release task’ in such a way that high levels of PA do not benefit the performance of 
the task as much.  
The ability to improve stability recovery following repeated gait perturbations was 
preserved in older adults with normal PA when compared to young adults. 
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Furthermore, both the O and TO groups significantly reduced their required recovery 
steps by the ninth perturbation. These results confirm many previous reports of 
adaptability to gait perturbations being preserved in older age and reinforce the 
potential value of perturbation-based balance training in this population (38–41). 
However, it does appear that exercise training in older participants does not lead to a 
better ability to adapt to perturbations. A recent review paper (82) highlighted that 
reduced adaptability to perturbations is mainly seen in populations with disrupted 
sensory and nervous systems. As the O and TO participants of the present study 
were in good health, adaptability may have already been sufficient in both groups, 
with little room for improvement through physical activity.  
 
In the current study, we found that both in vivo PCr recovery rate constant and ex 
vivo mitochondrial respiration in skeletal muscle was lower in older compared to 
young adults. It is important to note that in the present study the decrease in 
mitochondrial function has been observed in older adults with PA levels being well 
above the general recommendations (42). These results suggest that maintaining a 
healthy level of PA is not sufficient to prevent an age-related decline in mitochondrial 
function. These findings are in line with the age-related decline in the mitochondrial 
ATP production rate (MAPR) observed in young and older adults who exercised less 
than 30 min a week (14,43). An even more prominent age-related decline in MAPR 
was observed comparing young and older adults who were similarly endurance-
trained (43), further hinting at an independent, aging-induced decline in skeletal 
muscle mitochondrial function. Nevertheless, findings of the present study are in 
contrast with previous observations by Distefano et al. (6,22), who found no 
chronological age effect on mitochondrial function in deeply phenotyped young and 
older adults. This discrepancy could be explained by gender differences, as we 
included 9 male and 8 female volunteers in both groups while Distefano et al. 
included 8 male and 2 female participants in each group. Further research is needed 
to clearly define the effect of aging on skeletal mitochondrial function at different 
levels of PA and examine if that is different in male versus female volunteers (44).  
 
Interestingly, ex vivo ADP-stimulated mitochondrial respiration in permeabilized 
muscle fibers was ∼15% lower in older adults when compared to young adults, 
whereas trained older adults displayed a ∼30% higher respiration in comparison to 
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older adults with normal PA. These findings support the retainment of skeletal 
muscle plasticity in response to exercise with aging and indicate that mitochondrial 
respiratory function can be preserved through exercise (6,43). In line with the 
present study, other reports indicate that exercise intensity is an important 
determinant of ameliorating age-related biological functions since rigorous exercise 
programs (such as high-intensity interval training) - but not modest aerobic activity - 
was able to prevent age-related decline in mitochondrial respiration (45). In contrast 
with ex vivo assessed mitochondrial respiration results, in vivo mitochondrial 
function, assessed by the 31PCr recovery rate constant, was not found to be different 
between the older adult groups. This discrepancy could be explained by the fact that 
31P-MRS may be confounded by limiting systemic factors such as adequate 
perfusion and oxygen delivery during and after exercise (46), and other 
characteristics of the microenvironment. Interestingly, mitochondrial density, 
estimated by OXPHOS protein levels, appeared to be similar between young and 
older participants, indicating that the age-related loss in mitochondrial function is not 
explained by a lower mitochondrial mass. In trained older adults, however, OXPHOS 
proteins were higher, suggesting that increased levels of mitochondrial content do 
underlie the positive effect of exercise training on mitochondrial function in older 
individuals. These results suggest that aging and exercise training affect 
mitochondrial function via distinct mechanisms. We did not observe a difference in 
either ex vivo or in vivo skeletal muscle mitochondrial capacity in physically impaired 
older individuals as compared to healthy older adults with normal PA. Due to the 
small sample size of this group, however, these outcomes should be interpreted with 
caution.  
 
To further explore the relation between mitochondrial oxidative capacity and multiple 
aspects of muscle health, we subjected the entire cohort (n = 59) to correlative 
analyses. We found that besides ex vivo mitochondrial capacity also in vivo 
mitochondrial function associated with maximal aerobic capacity and exercise 
efficiency, which further supports that mitochondrial energetics are likely important 
factors in loss of muscle function with aging. Similar results have recently been found 
by Distefano et al. (6) and Gonzalez-Freire et al. (47). Moreover, mitochondrial 
function correlated with measures of gait variability, indicating that mitochondrial 
function potentially influences the efficiency and consistency of the gait pattern. 
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Interestingly, we found that exercise efficiency correlated strongly with mitochondrial 
respiratory capacity, as well as with physical function parameters such as the 6MWT 
and the chair stand test. Taken together, our data support a role for mitochondrial 
capacity and in maintaining muscle function and indicate that exercise efficiency may 
be a good proxy for skeletal muscle mitochondrial capacity and muscle health.  
 
The isolated impact of aging on skeletal muscle is difficult to unravel from the many 
other factors that change concurrently with aging, including decreased PA and 
increased adiposity (48). Despite similar levels of habitual of PA in the current study, 
body fat was higher and (whole-body) insulin sensitivity was lower in the older 
participants when compared to young. In comparison with older adults with normal 
PA, trained older adults displayed higher levels of whole-body insulin sensitivity, 
underscoring the ability of exercise training to improve insulin sensitivity and glucose 
uptake, also at an older age. However, since young and trained older adults also 
featured a lower adiposity, differences in body composition may (partly) mediate the 
observed differences in insulin sensitivity, independent of mitochondrial function. 
Increased adiposity in older participants has also been negatively associated with 
muscle function, independent of muscle mass (49). Furthermore, unhealthy aging is 
characterized by an augmented accumulation of intramyocellular lipids (6,28), which 
could influence muscle function (6) and insulin sensitivity (50). Moreover, differences 
in BMI and body composition, inherent to the different study group characteristics, 
have been suggested to also influence skeletal muscle mitochondrial capacity 
(22,51). Taken together, our data indicate that body fat accumulation with increasing 
age may be a contributing factor in potentiating the loss of muscle quality in older 
adults and suggest that high-intensity physical activity may be necessary to minimize 
changes in body composition over the lifespan and to mitigate muscle aging. 
Our results suggest that, despite maintaining an adequate physical activity level, 
aging is associated with low in vivo and ex vivo mitochondrial capacity, maximal 
aerobic capacity, exercise efficiency, gait stability, muscle strength, insulin 
sensitivity, physical function, and increased body fat. Nevertheless, increasing 
physical activity through regular exercise training partially protects against these 
age-related declines in (mitochondrial) oxidative capacity and muscle health. Finally, 
we showed that mitochondrial capacity was positively associated with exercise 
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efficiency and insulin sensitivity, supporting the idea that mitochondria represent a 
promising therapeutic target to negate the aging-associated deterioration of skeletal 





Fifty-nine participants, including 17 young (9 male and 8 female) and 42 older 
individuals (23 male and 19 female), were recruited in the community of Maastricht 
and its surroundings through advertisements placed on the Maastricht University 
campus, in newspapers, supermarkets, and at sports clubs. The study was 
conducted in accordance with the principles of the declaration of Helsinki and 
approved by the Ethics Committee of the Maastricht University Medical Center+. All 
participants provided their written informed consent, and the study was registered at 
clinicaltrials.gov with identifier NCT03666013.  
Prior to inclusion, all participants underwent a medical screening that included a 
medical questionnaire, a physical examination by a physician, and an assessment of 
physical function by means of the Short Physical Performance Battery, which 
includes a standing balance test, a 4-m walk test, and a chair-stand test. The SPPB 
score was calculated according to the cut-off points determined by Guralnik et al. 
(52). A sitting blood pressure measurement and an electrocardiogram (ECG) were 
also performed. After the screening procedure, participants were assigned to the 
following study groups: young individuals with normal physical activity (Y, 20–30 
years), older adults with normal physical activity (O, 65–80 years), trained older 
adults (TO, 65–80 years) and physically impaired older adults (IO, 65–80 years). 
Participants were considered normally physically active if they completed no more 
than one structured exercise session per week, whereas participants were 
considered trained if they engaged in at least three structured exercise sessions of at 
least 1 hour each per week for an uninterrupted period of at least the past year. 
Participants were classified as older adults with impaired physical function (IO) in 
case of an SPPB score of ≤ 9. Upon inclusion, further details on habitual physical 
activity levels were obtained during the study using accelerometry (ActivPAL). 
Exclusion criteria were contra-indications for MRI examination, uncontrolled 
hypertension, the use of medication that could interfere with the results of the study, 
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medical history of cardiovascular disease, type 2 diabetes mellitus, or other health 
problems that may hamper the safety of the individual during participation. 
Impairments in parameters of liver and kidney function were examined via 
determination of plasma aspartate aminotransferase (ASAT), alanine 
aminotransferase (ALAT), gamma-glutamyltransferase (γGT), bilirubin, and creatine. 
Experimental design 
This cross-sectional study was conducted at the Maastricht University Medical 
Centre+, The Netherlands, between September 2017 and March 2020. 
The detailed assessment of muscle health consisted of various measurements 
divided over five study visits, equally distributed over a period of 5 weeks to allow for 
sufficient recovery between each visit and prevent interference between the various 
measurements (Supplementary Table 1). During their participation, participants were 
instructed to maintain their habitual diet and physical activity pattern, and in the three 
days preceding the test days, participants refrained from strenuous physical activity. 
Hyperinsulinemic-euglycemic clamp 
A hyperinsulinemic-euglycemic clamp was performed to assess peripheral insulin 
sensitivity, as previously described (53). Briefly, participants reported to the 
laboratory at 8 AM after an overnight fast from 10 PM. A fasted blood sample was 
taken and subsequently, a primed-continuous infusion of d-[6,6–2H2]-glucose 
(0.04 ml kg-1 min-1) was initiated (54). After 3 hours (t = 180 min), infusion of insulin 
(40 mU m-2 min-1) was started for a period of 2.5 hours. Based on the continuously 
monitored plasma glucose concentrations, the glucose infusion rate (GIR) was 
adjusted to maintain a steady-state plasma glucose level of approximately 5.0 mmol 
L-1. Subsequently, whole-body insulin sensitivity was determined by calculating the 
M-value (mg kg-1 min-1). During the last 30 minutes of basal sampling (t = 150–
180 min) and during the last 30 min of the insulin infusion (t = 300–330min), blood 
samples were collected and indirect calorimetry (Omnical, IDEE, Maastricht, The 
Netherlands) was performed. Based on the measured oxygen and carbon dioxide 
concentrations, substrate oxidation rates were calculated using equations with the 
assumption that protein oxidation was negligible (55). Steele’s single pool non-
steady state equations were used, allowing small differences in glucose 
concentrations to calculate glucose appearance (Ra) and (insulin-stimulated) 
glucose disposal (Rd) (54). The change in Rd (from baseline to clamp steady-state) 
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was corrected for plasma insulin and glucose levels during the clamp (Si), as 
described in Remie et al. (53). Endogenous glucose production (EGP) was 
calculated as Ra minus exogenous glucose infusion rate.  
Three individuals in the IO group were excluded from participation in the clamp on 
the grounds of safety. As a result, the small number (n = 3) remaining made a 
comparison unviable and we therefore excluded the IO group from the final insulin 
sensitivity comparisons. 
Maximal aerobic capacity 
Maximal aerobic capacity (V̇O2max) was assessed with concurrent ECG during a 
graded cycling test until exhaustion, as described previously (56). Briefly, after a 
warming-up period of 5 minutes at 50 Watt, the power output was increased every 
2.5 minutes by 50 Watt until levels above 80% of the predicted maximal heart rate (= 
220 years – age) were observed. After this point, the test continued, and power 
output was increased every 2.5 minutes by 25 Watt until the participant could no 
longer pedal above 60 revolutions per minute. Consumed O2 and expired CO2 were 
measured continuously throughout the test using indirect calorimetry (Omnical, 
IDEE, Maastricht, The Netherlands) to determine V̇O2max. 
Habitual physical activity 
Habitual physical activity was determined using an ActivPAL3 monitor (PAL 
Technologies, Glasgow, Scotland) for a consecutive period of 5 days, including two 
weekend days. The monitor was wrapped and attached to the skin on the anterior 
aspect of the upper leg using Tegaderm (3M™) in a waterproof fashion; non-wear 
was therefore not an issue. Data were uploaded using the software provided by 
ActivPAL and processed using customized software written in MATLAB R2013b 
(MathWorks, Natick, MA, USA). Besides the total amount of steps per day, the total 
stepping time was calculated in proportion to waking time per day. Stepping time (i.e. 
physical activity) was further classified into high-intensity physical activity (HPA; 
minutes with a step frequency > 110 steps min-1 in proportion to waking time) and 
lower-intensity physical activity (LPA; minutes with a step frequency ≤ 110 steps min-
1 in proportion to waking time) (42). Waking time was determined according to Van 
der Berg et al. (57). 
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Body composition 
Body composition (fat and fat-free mass) was determined at 8 AM after an overnight 
fast from 10 PM the previous evening using air displacement plethysmography 
(BodPod®, COSMED, Inc., Rome, Italy).  
Muscle strength  
Muscle contractile performance was measured using the Biodex System 3 Pro 
dynamometer (Biodex® Medical Systems, Inc., Shirley, NY, USA). For the 
measurements, the participants were stabilized in the device with shoulder, leg, and 
abdominal straps to prevent compensatory movement. The test was performed with 
the left leg in all participants. To measure maximal muscle strength, each participant 
performed 30 consecutive knee extension and flexion movements (range of motion 
120 degrees s-1). The peak torque of each extension and flexion was recorded and 
maximal isokinetic knee-extensor and knee-flexor torque was defined of the highest 
peak torque and corrected for fat-free mass (Nm kgFFM-1). 
Resting energy expenditure 
Resting energy expenditure (REE) and substrate utilization were measured at 8 AM, 
after an overnight fast from 10 PM the preceding evening. Gas exchange was 
measured by open-circuit respirometry with an automated ventilated hood system for 
45 minutes. During the measurement, participants lay on a bed in a supine position. 
Data from the first 5 and last 5 minutes were omitted. REE data was adjusted for fat-
free mass by calculating 'REE residuals', essentially according to Ravussin et al. 
(58). 
Submaximal exercise test and exercise energy expenditure 
After assessing resting energy expenditure, participants performed a 1-hour 
submaximal exercise bout in the fasted state on an electronically braked cycle 
ergometer. To reach equal levels of exercise intensity, submaximal cycle test was 
performed at 50% of Wmax as measured during the maximal aerobic cycling test. 
Participants were instructed to pedal at a controlled cadence between 60 and 70 
revolutions per minute. To calculate exercise energy expenditure (EEE) and 
substrate oxidation, O2 consumption and CO2 production were recorded using 
indirect calorimetry for 15 minutes at two time points (t = 15 min and t = 45 min). The 
submaximal cycle test was performed at, on average, 109 (29) Watt versus 74 (23) 
Watt in young versus older adults, respectively (p < 0.001). The TO individuals 
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performed the submaximal cycle test at higher absolute power (on average 97 (28) 
Watt) in comparison with O (74 (23) Watt, p = 0.030) and IO (60 (26) Watt, p = 
0.017).
Calculations of energy expenditure and exercise efficiency 
Energy expenditure was measured in rest, upon insulin stimulation during the 
hyperinsulinemic-euglycemic clamp, and during the submaximal cycle test using 
indirect calorimetry. The Weir equation (59) was used to calculate whole-body 
energy expenditure from measurements of O2 consumption and CO2 production. 
Carbohydrate and fat oxidation rates were calculated using the non-protein 
equations by Péronnet and Massicotte (55).
During submaximal exercise test, gross energy efficiency (GEE) was computed as 
the power output (watts converted to kJ min-1) over exercise energy expenditure (in 
kJ min-1) during the 1-hour submaximal bike test and expressed as a ratio (Eq. 1) as 
described previously (60). Mean values of work, VO2, VCO2 were averaged over 15-
minute periods at two time points (t = 15 min and t = 45 min). Data from the first 5
min and last 2 min were omitted.
Eq 1:
Net energy efficiency (NEE) was measured from the submaximal test as power 
output (watts converted to kJ min-1) over EE during exercise (EEE) minus resting EE 




Prior to the submaximal exercise test, a muscle biopsy was taken from the m. vastus 
lateralis under local anesthesia (1.0% lidocaine without epinephrine) according to the 
Bergström method (61). Part of the biopsy was immediately placed in an ice-cold 
preservation medium (BIOPS, OROBOROS Instruments, Innsbruck, Austria) and 
used to measure ex vivo mitochondrial oxidative capacity. The remaining part of the 
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muscle biopsy was immediately frozen in melting isopentane and stored at –80°C 
until further analysis. 
Western blot analysis 
Mitochondrial content was assessed by mitochondrial OXPHOS protein expression 
using western blot analyses in Bioplex-lysates of human muscle tissue as previously 
described (62). Equal amounts of protein were loaded 4–12% Bolt gradient gels 
(Novex, Thermo Fisher Scientific, Bleiswijk, The Netherlands). Proteins were 
transferred to nitrocellulose with the Trans-Blot Turbo transfer system (Bio-Rad 
Laboratories). Primary antibodies contained a cocktail of mouse monoclonal 
antibodies directed against human OXPHOS (dilution 1:10,000; ab110411, Abcam, 
Cambridge, UK). The hOxPHOS proteins were detected using secondary antibodies 
conjugated with IRDye680 or IRDye800 and were quantified with the CLx Odyssey 
Near-Infrared Imager (Li-COR, Westburg, Leusden, The Netherlands). 
Ex vivo high-resolution respirometry 
Permeabilized skeletal muscle fibers were immediately prepared from the muscle 
tissue collected in the preservation medium, as described previously (63). 
Subsequently, the permeabilized muscle fibers (∼2.5 mg wet weight) were analyzed 
for mitochondrial function using an oxygraph (OROBOROS Instruments, Innsbruck, 
Austria), according to Hoeks et al. (63). To prevent oxygen limitation, the respiration 
chambers were hyper-oxygenated up to ∼400 μmol L-1 O2. Subsequently, two 
different multi-substrate/inhibition protocols were used in which substrates and 
inhibitors were added consecutively at saturating concentrations. State 2 respiration 
was measured after the addition of malate (4 mmol L-1) plus octanoyl-carnitine (50 
μmol L-1) or malate (4 mmol L-1) plus glutamate (10 mmol L-1). Subsequently, an 
excess of 2 mmol L-1 of ADP was added to determine coupled (state 3) respiration. 
Coupled respiration was then maximized with convergent electron input through 
Complex I and Complex II by adding succinate (10 mmol L-1). Finally, the chemical 
uncoupler carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP) was 
titrated to assess the maximal capacity of the electron transport chain (state 3u 
respiration) or oligomycin (2 μg ml-1) was added to assess the respiration not 
coupled to ATP synthesis (state 4o respiration). The integrity of the outer 
mitochondrial membrane was assessed by the addition of cytochrome C (10 μmol L-
1) upon maximal coupled respiration. If cytochrome C increased oxygen consumption 
Chapter 3 
84  
> 15%, the measurement was excluded to assure the viability and quality of the 
muscle mitochondrial measurement. All measurements were performed in 
quadruplicate. 
Magnetic resonance spectroscopy (Muscle volume and PCr recovery)  
All magnetic resonance (MR) experiments were performed on the same day on a 3T 
whole body MRI scanner (Achieva 3T-X; Philips Healthcare, Best, The Netherlands). 
To standardize food intake, participants consumed a light lunch at noon and 
remained fasted until completion of all MR experiments. Participants reported to the 
university at 2:30 PM and were seated in the waiting room for at least 30 minutes to 
minimize the possible effect of prior muscle activity. At 3 PM, participants were 
positioned supine in the MR scanner to determine muscle volume with a series of 
T1-weighted images of the upper leg (slice thickness = 10.0 mm, no gap between 
slices, in‐plane resolution = 0.78 x 0.78 mm). A custom-written MATLAB 2016a script 
(The Mathworks Inc. Natick, MA, USA) was used to semi-automatically segment 
adipose tissue and muscle and quantify muscle volume. The muscle segmentation 
was performed in the consecutive slices between the lower end of the m. rectus 
femoris and the lower end of the m. gluteus maximus.  
Subsequently, phosphorus magnetic resonance spectroscopy (31P-MRS) was 
performed to measure in vivo mitochondrial function in m. vastus lateralis as 
previously described (64), using a 6 cm surface coil. A series of 150 unlocalized 31P-
spectra was acquired using the following parameters: single acquisitions (NSA = 1); 
repetition time (TR) = 4000 ms; spectral bandwidth = 3000 Hz; number of points = 
1024. The 150 spectra were divided into 10 spectra at rest, 70 spectra during knee-
extension exercise, and 70 spectra during recovery. Exercise within the scanner was 
performed to an auditory cue (0.5 Hz) in a custom-built knee-extension device with 
adjustable weight. The intensity was chosen to correspond to 50–60% of the 
predetermined maximum weight (determined on a separate day). Spectra were 
analyzed with a custom-made MATLAB 2016a script. PCr, ATP, and inorganic 
phosphate peaks were fitted, and pH was determined. The PCr recovery was fitted 
with a mono-exponential function and the rate constant ( in s-1) was determined as 
previously described (64). The rate constant  of PCr resynthesis is almost entirely 
dependent on ATP produced by oxidative phosphorylation and can therefore be 
used as a parameter of in vivo oxidative capacity (65).  
Aging and Skeletal Muscle and Mitochondrial Health 
85 
Walking performance and unperturbed and perturbed walking stability  
To further determine physical function, walking performance and stability were 
quantitatively assessed during a self-paced 6MWT, during multiple fixed-speed gait 
trials, and during a repeated balance disturbance trial. All tasks were measured 
using a dual-belt, force plate-instrumented (1000 Hz) treadmill within a virtual 
environment (Computer Assisted Rehabilitation Environment Extended, CAREN; 
Motekforce Link, Amsterdam, The Netherlands) and a 12-camera motion capture 
system (100 Hz; Vicon Motion Systems, Oxford, UK).  
The 6MWT began with an explanation and one familiarization session (including two 
“start-ups” to let participants become accustomed to the self-paced function) on the 
CAREN prior to completing the recorded 6MWT. The 6-minute walk distance was 
taken to represent performance (66). To assess gait variability, the means and 
coefficients of variation of step time, step length, step width, and double support time 
were measured during fixed-speed trials. This session again began with 
familiarization trials, followed by recorded trials (2-3 minutes – minimum of 120 
steps) at speeds of 0.4–1.8 m s-1 in 0.2 m s-1 steps (67). These trials were then 
analyzed to calculate a stability-normalized walking speed for each participant 
individually for use in the gait perturbation trial, set for a margin of stability (MoS – 
see below; (27)) of 0.05 m as described previously (68), ensuring a comparable 
baseline gait stability for all groups (69).  
The perturbation trial included 3 to 4 minutes of unperturbed walking, followed by 10 
unannounced unilateral treadmill belt acceleration perturbations (every 30 to 90 
seconds) as reported previously (38). The first perturbations to each limb were 
analyzed (Pert1R and Pert2L), representing novel disturbances, as well as the ninth 
perturbation (final left leg perturbation; Pert9L) to indicate adaptation in gait following 
eight repeated perturbations. The anteroposterior MoS at foot touchdown were 
calculated (27), adapted for our validated reduced kinematic model (70). The MoS 
was calculated for the following steps: the mean MoS of the eleventh to second last 
step before each perturbation (Base); the final step before each perturbation (Pre); 
and the first eight recovery steps following each perturbation (Post1–8).  
The number of steps needed to return to pre-perturbation stability was determined by 
calculating the number of steps within 0.05m of the MoS value of Base for each 
individual, counting back from the eighth recovery step, using custom written R code 
(R version 3.6.0).  
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For all three gait tasks, initial data processing was conducted in MATLAB 2016a. 
The three-dimensional coordinates of the markers were filtered using a low pass 
second-order Butterworth filter (zero-phase) with a 12Hz cut-off frequency. Foot 
touchdown and toe-off were detected using a combined method of force plate data 
(50 N threshold) and foot marker data, as described in detail previously (67). Only 
three individuals in the IO group were able to complete the perturbation trial; as such 
the IO group was excluded from the perturbation analyses. 
Statistics 
Statistical analyses were performed using SPSS 26.0 (IBM, Chicago, IL, USA). Data 
are reported as mean (SD) unless stated otherwise. Analyses were performed for n 
= 59 unless specified otherwise in the table and the figure descriptions. The 
distribution of sex across groups was determined by χ2 test. In relation to the first 
research aim, differences between Y and O were tested by two-sided, independent 
samples t-test. To address the second research aim, group differences between O, 
TO, and IO were determined by means of a one-way analysis of variance (ANOVA) 
with Tukey’s post-hoc test or by a two-sided Kruskal-Wallis test with Bonferroni 
correction, as appropriate. Of note: the same group of older adults with normal 
physical activity (O) was included in both comparisons. 
GraphPad Prism version 8.02 for Windows was used for statistical analysis of the 
gait tasks (GraphPad Software Inc., La Jolla, California, USA). For the fixed-speed 
gait trials, mixed-effects models using the restricted maximum likelihood method with 
group (Y and O or O and TO) and walking speed (repeated measure: 0.4, 0.6, 0.8, 
1.0, 1.2, 1.4, and 1.6 m s-1) as factors were conducted for the mean gait parameters 
and their variability. For the perturbation trials, two-way repeated measures ANOVAs 
with group (Y and O or O and TO) and step (repeated measures; Base, Pre, Post1–
8) as factors were conducted for perturbations Pert1R, Pert2L and Pert9L with 
Dunnett’s or Sidak’s tests for multiple comparisons. Regarding the number of 
recovery steps required, Wilcoxon matched-pairs signed rank tests were used to test 
for differences between the perturbations with the groups and Mann-Whitney tests 
were used to compare the groups to each other.  
To assess associations between variables, we conducted bivariate Pearson or 
Spearman correlation and partial correlation analyses corrected for sex, age, and 
BMI. For all tests p < 0.05 was considered statistically significant. 
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Source data for all figures and tables have been provided with this paper 
(Supplementary Data). All other data supporting the findings of this study are 
available from the corresponding author upon reasonable request. 
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SUPPLEMENTARY MATERIAL FOR CHAPTER 3 
 
Comparable gait variability during unperturbed walking in older adults  
Fourteen out of fifteen young participants completed all walking speed trials, with 
one person not able to walk at 1.8 m s-1 for two minutes. Twelve of seventeen old 
participants completed all speeds, with five unable to complete the 1.8 m s-1 speed. 
These differences between groups in the walking speeds generally align with the 
6MWT results. When compared to young, older participants had a larger step length 
variability (F(1, 30) = 7.077, p = 0.012; significant pairwise comparisons at 1.2, 1.4, and 
1.6 m s-1; Supplementary Figure 1), but no other significant differences were found.  
Less gait stability but comparable adaptability during balance disturbances in 
older adults 
All participants were able to recover from the gait perturbations without harness 
assistance. When considering group differences for the entire perturbation trial, the 
first perturbation (Pert1R) had a significantly larger effect on the margin of stability 
(MoS) in the older adults compared to the young participants (Pert1R: F(1, 28) = 7.7, p 
= 0.010). For the second (Pert2L) and ninth (Pert9L) perturbations, no significant 
group differences were observed (Pert2L: F(1, 29) = 0.6, p = 0.435; Pert9L: F(1, 29) = 
0.001, p = 0.976), indicating that older adults initially perform poorer than young 
adults, but the ability of older adults to adapt gait in response to repeated 
perturbations is intact. Furthermore, significant step by age group interaction effects 
on MoS were found for Pert1R and Pert2L but not Pert9L (Pert1R: F(9, 252) = 6.3, p < 
0.001; Pert2L: F(9, 261) = 3.539, p < 0.001; Pert9L: F(9, 261) = 1.413, p = 0.182), 
indicative of different age-related recovery stepping behavior in the first two but not 
ninth perturbation. For all perturbations, the older adults’ recovery steps, in 
comparison to the young adults, were more frequently different to Base and these 
differences also occurred in later recovery steps (significant results indicated by * in 
Supplementary Figure 2a).   
When considering group differences at step level, the MoS in the first and second 
step after Pert1R and in the first step after Pert2L were observed to be significantly 
different between young and old (significant results indicated by # in Supplementary 
Figure 2a). These results indicate that the largest age group effect is seen in the first 
1–2 recovery steps of the first two perturbations . 
Chapter 3 
90 
The young group required averages of 5.7 (1.8), 5.7 (1.6), and 3.6 (2.1) recovery 
steps and the older group required averages of 6.2 (2.4), 6.2 (2.1), and 4.2 (2.1) 
recovery steps for Pert1R, Pert2L, and Pert9L, respectively (Supplementary Figure 
2b). Both the young and older group required significantly fewer recovery steps 
during Pert9L than both Pert1R and Pert2L (Supplementary Figure 2b). No significant 
group differences were observed in the number of recovery steps for each 
perturbation.  
Comparable gait variability during unperturbed walking in trained older adults  
In O, twelve out of seventeen participants completed all speeds, with five participants 
unable to complete the 1.8 m s-1 speed. Of TO, all eighteen participants could 
complete all speeds. For IO, one participant completed all speeds, one completed all 
except 1.8 m s-1, two reached 1.4 m s-1, and one reached 1.2 m s-1. These 
differences between groups in the walking speeds successfully achieved generally 
align with the 6MWT results. When comparing O and TO, no significant differences 
were observed for gait variability, including step time, step length, step width, and 
double support (Supplementary Figure 3).   
A second set of similar analyses were conducted for the speeds 0.4 m s-1 up to 1.2 
m s-1 including the O, TO, and IO groups. Here, a significant effect of group was 
found for double support time variability (F(2, 37) = 4.045, p = 0.0258), with the IO 
group showing (non-significantly) more variability than the other two groups. No 
other group effects or pairwise comparisons were significant. Data shown in 
Supplementary Figure 4 also indicate non-significant increases in step width, step 
time variability, and (to a lesser extent) step length variability in IO. Together, the 
results indicate a less stable gait in IO, despite the insignificant findings due to the 
small sample size. 
Comparable gait stability and adaptability in trained older adults 
During the gait stability assessments, all measured participants were able to recover 
from the gait perturbations without harness assistance. When considering the entire 
perturbation trial (Supplementary Figure 5a), MoS was not significantly different 
between O and TO for Pert1R, Pert2L, and Pert9L (Pert1R: F(1, 32) = 0,066, p = 0.8; 
Pert2L: F(1, 32) = 0.019, p = 0.892; Pert9L: F(1, 33) = 0.95, p = 0.338). Furthermore, no 
significant step by group interaction effects on MoS were found for Pert1R, Pert2L, or 
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Pert9L (Pert1R: F(9, 288) = 0.62, p =0.784; Pert2L: F(9, 288) = 0.88, p = 0.544; Pert9L: F(9, 
297) = 1.64, p = 0.102). These results indicate no significant stability or stepping 
behavior difference between O and TO. No significant differences in MoS between 
the groups at step level were observed (Supplementary Figure 5a).   
Following Pert1R, Pert2L, and Pert9L, O required 6.2 (2.4), 6.2 (2.1), and 4.2 (2.1) 
recovery steps, respectively (Figure 13b). Following the same perturbations, TO 
required 6.1 (2.2), 5.2 (2.1), and 4.4 (2.5) recovery steps, respectively 
(Supplementary Figure 5b). O participants required significantly fewer recovery steps 
during Pert9L than both Pert1R and Pert2L, while the TO adults required significantly 
fewer recovery steps during Pert9L than Pert1R (Supplementary Figure 5b). No 
significant group differences on number of recovery steps for each perturbation were 
revealed. Three participants of the IO group started and completed the perturbation 
trial, while three IO participants were unable to walk fast enough to maintain the 
stability-normalized walking speed. Therefore, they were not included in the previous 
analyses. Following Pert1R, Pert2L, and Pert9L, IO required 7.6, 6.0, and 4.6 
recovery steps, respectively, with all three IO participants reducing their number of 






Supplementary Figure 1 
Effect of aging on gait variability at different walking speeds (0.4–1.6 m s-1). a-d Absolute 
values for step time, step length, step with, and double support time. e-h Coefficients of 
variation (CV) of step time, step length, step width, and double support time. Dark grey bars 
represent the young individuals (Y, n = 14); light grey bars represent older individuals (O, n = 
17). One Y participant was excluded due to issues in data collection and two Y participants 
were not measured (one due to technical issues and one due to SARS-CoV-19 restrictions). 
Mixed-effects models using the restricted maximum likelihood method with age group and 
walking speed (repeated measure) as factors were conducted with pairwise Šídák's multiple 
comparisons test between groups at each speed. Values are presented as mean ± SD (with 
individual data points), * denotes age group effect denotes significant age group effect (p < 
0.05) and # with line indicates pairwise differences between the two groups (p < 0.05).   




Supplementary Figure 2 
Effect of aging on gait stability. a Mean and SD (with individual data points) of the 
anteroposterior margins of stability during the first, second, and ninth perturbations (Pert1R, 
Pert2L, and Pert9L, respectively), including unperturbed walking prior to each perturbation 
(Base), the final step prior to each perturbation (Pre) and the first eight recovery steps 
following the perturbations (Post1 – 8) for young and older adults. Two-way repeated 
measures ANOVAs with group and step (repeated measures) as factors with within group 
pairwise comparisons to Base and between group pairwise comparisons were conducted. 
Dark grey* and light grey* indicate significant difference to Base for the young (Y, dark grey 
dots, n = 12) and older (O, light grey dots, n = 13) groups, respectively (p < 0.05, adjusted 
using Dunnett’s multiple comparisons test). # indicates significant difference between the 
young and older groups (p < 0.05; adjusted using Šídák's multiple comparisons test). b The 
number of recovery steps (means and individual values) required by the young (dark grey 
dots, n = 12) and older adults (light grey dots, n = 13) for the first, second, and ninth 
perturbations (Pert1R, Pert2L, and Pert9L, respectively). 1,2 indicate significant within-group 
difference to Pert1R and Pert2L, respectively (p < 0.05, Wilcoxon matched-pairs signed rank 
tests). One Y participant was excluded due to an issue in data collection and two Y 
participants were not measured (one due to technical issues and one due to SARS-CoV-19 
restrictions). Due to a technical issue with the treadmill, the data from the first perturbation of 





Supplementary Figure 3 
Effect of exercise training on gait variability at different walking speeds (0.4–1.6 m s-1). a-d 
Absolute values for step time, step length, step with and, double support time. e-h 
Coefficients of variation (CV) of step time, step length, step width, and double support time. 
Light grey bars represent normally active older adults (O, n = 17); dark grey bars represent 
trained older adults (TO, n = 18). One TO participant was not measured due to scheduling 
difficulties. Mixed-effects models using the restricted maximum likelihood method with group 
and walking speed (repeated measure) as factors were conducted with pairwise Šídák's 
multiple comparisons test between groups at each speed. Values are presented as mean ± 
SD (with individual data points).  




Supplementary Figure 4 
Effect of exercise training and physical impairment on gait variability at different walking 
speeds (0.4–1.2 m s-1). a-d Absolute values for step time, step length, step width, and 
double support time. e-h Coefficients of variation (CV) of step time, step length, step width, 
and double support time. Light grey bars represent normally active older adults (O, n = 17); 
dark grey bars represent trained older adults (TO, n = 18); white bars represent physically 
impaired older adults (IO, n = 5). One TO and one IO participant were not measured due to 
scheduling difficulties. Mixed-effects models using the restricted maximum likelihood method 
with group and walking speed (repeated measure) as factors were conducted with pairwise 
Šídák's multiple comparisons test between groups at each speed. Values are presented as 





Supplementary Figure 5 
Effect of exercise training on gait stability. a Means and ± SD (with individual data points) of 
the anteroposterior margins of stability during the first, second, and ninth perturbations 
(Pert1R, Pert2L, and Pert9L, respectively), including unperturbed walking prior to each 
perturbation (Base), the final step prior to each perturbation (Pre) and the first eight recovery 
steps following the perturbations (Post1 – 8) for normally active older and trained older 
adults. Two-way repeated measures ANOVAs with group and step (repeated measures) as 
factors with within group pairwise comparisons to Base and between group pairwise 
comparisons were conducted. Dark grey * and light grey * indicate significant difference to 
Base for the O (light grey dots, n = 13) and TO (dark grey, dots n = 15) groups, respectively 
(p < 0.05, adjusted using Dunnett’s multiple comparisons test). b The number of recovery 
steps (means and individual values) required by the normally active older (light grey dots, n 
= 13) and trained older adults (dark grey, dots n = 15) for the first, second, and ninth 
perturbations (Pert1R, Pert2L, and Pert9L, respectively). 1,2 indicate significant within-group 
difference to Pert1R and Pert2L, respectively (p < 0.05, Wilcoxon matched-pairs signed rank 
tests). One TO participant was not measured due to scheduling difficulties. Due to a 
technical issue with the treadmill, the data from the first perturbation of one of the O 
participants and from the second perturbation of one of the TO participants were excluded 
from the analyses. Only three individuals in the IO group were able to complete the 



















Medical questionnaire 1-step hyperinsulinemic 
euglycemic 
6MWT (Caren) Body-composition 
(bodpod) 
Resting metabolic rate Muscle volume (MRI) 
Physical examination  VO2max cycle test Gait variability and 
dynamic balance test 
(Caren) 










Ex vivo respirometry 
    Submaximal cycle test  
Visit #1 consisted of a 1-step hyperinsulinemic euglycemic clamp. On visit #2, participants completed a 6-minute walk test (6MWT) and a 
VO2max measurement. Furthermore, an ActivPAL accelerometer was provided to determine free-living physical activity over a period of 5 days. 
On visit #3, participants completed a body composition measurement, a dynamic balance test, and quadriceps strength tests. On study visit #4, 
fasting blood samples were drawn, and resting energy expenditure was determined by indirect calorimetry followed by the muscle biopsy 
procedure. Participants then completed the submaximal exercise test on a cycle ergometer. On visit #5, participants completed the magnetic 
resonance imaging (MRI)/magnetic resonance spectroscopy (MRS) 
 
 
















































(pmol s-1 mg-1) 
r 0.335* -0.111 0.436* 0.080 0.126 0.379* 0.174 0.326* 0.105 -0.177 -0.258 0.345* 
 





(pmol s-1 mg-1) 
r 0.310* -0.146 0.512* 0.102 0.150 0.407* 0.232 0.372* 0.035 -0.228 -0.324* 0.402* 
 
p 0.025 0.282 <0.001 0.454 0.269 0.003 0.101 0.005 0.812 0.103 0.019 0.003 
 
PCr recovery rate 
constant k (s-1)  
r 0.240 -0.075 0.482* 0.178 0.105 0.228 0.144 0.258 -0.124 -0.283* -0.313* 0.315* 
 






r 0.679* -0.485* 0.711* 0.349* 0.356* 0.495* 0.337* 0.268* -0.368* -0.277* -0.193 
 
 






r 0.596* 0.454* 0.623* 0.276* 0.261 0.480* 0.356* 0.207 -0.349* -0.253 -0.249 
 
 
p <0.001 <0.001 <0.001 0.039 0.052 <0.001 0.009 0.127 0.013 0.068 0.072 
 
Data are from all groups (total n > 51). * indicates the correlation is significant at the 0.05 level (two-sided, p < 0.05); † indicates variables that 
were log transformed. MOGS3 = state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate; 6MWT = 6-minute walk test; 
VO2max = maximal oxygen flow; FFM, = fat-free mass; Nm = newton meters; Pert1 = first perturbation during the balance challenge; M-value, = 
mean glucose infusion rate; Si = insulin-stimulated glucose uptake; r = pearson or #spearman correlation coefficient as appropriate
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Healthy aging and muscle function are positively 
associated with NAD+ abundance in humans
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Skeletal muscle is greatly affected by aging, resulting in a loss of metabolic and 
physical function. However, the underlying molecular processes and how (lack of) 
physical activity is involved in age-related metabolic decline in muscle function in 
humans is largely unknown. Here we investigated the muscle metabolome 
comparing young to older adults, whereby the older adults were either exercise-
trained, had normal physical activity levels, or were physically impaired. Intriguingly, 
metabolites to decline with age in human skeletal muscle, in line with preclinical 
models. This decline was exacerbated in impaired older individuals and was nea rly 
fully prevented in the exercise-trained older individuals. NAD+ was so intimately tied 
to muscle health levels that a correlation existed between muscle NAD+ content, 
average steps-per-day, and mitochondrial and muscle functioning. Our work 
demonstrates the importance of exercise to promote healthy aging of human muscle 
and suggests a crucial role of NAD+ therein 
Keywords 
Healthy longevity, muscle aging, metabolomics, exercise, NAD+ 




KYNA   Kynurenic acid 
KYNU   Kynurenine 
NaAD   Nicotinic acid adenine dinucleotide 
NAD+   Nicotinamide adenine dinucleotide  
NAM    Nicotinamide 
NaMN   Nicotinic acid mononucleotide 
NAMPT   Nicotinamide phosphoribosyltransferase 
NMN    Nicotinamide mononucleotide 
NR   Nicotinamide riboside 
NRH    Dihydronicotinamide riboside  
PARPs  Poly(ADP-ribose) polymerases 
PBMC   Peripheral blood mononuclear cell 
PPP   Pentose phosphate pathway 
PRPP   Phosphoribosyl pyrophosphate 
QA   Quinolinic acid 
SPPB   Short physical performance battery 
Trp    L-Tryptophan 






Over the past few decades, remarkable achievements in healthcare have led to a 
dramatic increase in the average life expectancy in most economically developed 
countries1,2. However, this increased lifespan is not paralleled by an increase in 
health span, as aging is accompanied by the development of various age-related 
pathologies including metabolic disorders3. Understanding and targeting the aging 
process itself, rather than treating the symptoms of these age-related pathologies, 
may be the most effective strategy to prevent or counteract aging-related health 
decline4.  
 
The development of many age-related diseases has been associated with 
disturbances in mitochondrial metabolism, a hallmark of the aging process5. In that 
context, we and others have previously shown in both muscle and liver that 
pathways involved in oxidative phosphorylation (OXPHOS), fatty acid oxidation, and 
mitochondrial biogenesis are impaired in aged mice6,7. In addition, we also reported 
that aged C. elegans are characterized by a prominent accumulation of most fatty 
acid species, which appeared to be controlled, at least in part, by the mitochondrial 
metabolic regulator AMPK8. Together, these preclinical studies highlight that 
alterations in various metabolic pathways, particularly within mitochondrial 
metabolism, are linked to the aging process and could therefore explain age-related 
metabolic complications. 
 
Skeletal muscle is highly affected by the aging process9 and age-induced loss of 
skeletal muscle mass and function have been related to mobility impairments10,11, an 
increased risk of falls12,13 and physical frailty14. Aging is also associated with a 
decline in muscle metabolism, as exemplified by a decrease in insulin sensitivity, 
metabolic inflexibility, increased oxidative damage, and the occurrence of skeletal 
muscle mitochondrial dysfunction15–17. On the other hand, regular exercise positively 
impacts muscle metabolism and function, and regular exercise training has been 
shown to protect against aging-induced deterioration of muscle health18,19.  
 
Based on these considerations, the aims of the present study were to investigate the 
muscle metabolome comparing young and aged individuals, and to identify how 
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differences in the aged individuals may be associated to muscle and mitochondrial 
function. This comparison was expanded upon by evaluating changes in three 
groups of older individuals recruited according to their 'muscle health' states; aged 
individuals who 1) were exercise-trained (‘trained’ older adults), 2) who possessed 
normal physical activity abilities (‘normal’ older adults), or 3) who displayed an 
impaired physical function (‘impaired’ older adults). Our results show that 
nicotinamide adenine dinucleotide (NAD+) was one of the most depleted metabolites 
with age and that age-related NAD+ depletion followed a 'healthy aging' trend, 
whereby physically impaired older individuals were marked by significantly lower 
NAD+ levels and exercise-trained older individuals could maintain NAD+ abundance 
to levels nearly as high as in the young. Furthermore, we found that in the older 
adults NAD+ muscle abundance positively correlated with muscle and mitochondrial 
health parameters. Taken together, these results provide a first-time account that 
NAD+ declines in aging human muscle and that NAD+ abundance is directly 





The metabolome of human muscle aging 
  
In order to better understand which metabolites were associated to aging and to 
establish a 'healthy aging' muscle signature, we turned to an extensively 
characterized cohort of young and aged individuals, which we previously established 
(clinicaltrials.gov identifier NCT03666013). This mixed-gender cohort consisted of 
individuals that were either young (n=12) or belonged to one of three aged groups; 
trained older adults (n=17), older adults with normal physical activity levels (n=17), or 
physically impaired older adults (n=6). Participants were assigned to different study 
groups based on age, their levels of self-reported physical exercise training, and 
their levels of physical function. Participants were considered normally physically 
active if they completed no more than one structured exercise session per week. 
Older participants were considered exercise-trained if they engaged in at least three 
structured exercise sessions of at least one hour each per week for an uninterrupted 
period of at least one year prior to inclusion. Older participants were classified as 
physically impaired in case of a Short Physical Performance Battery (SPPB) score of 
≤ 9 (Table S1). Upon inclusion, further details on habitual physical activity levels 
were obtained using accelerometry. Over the course of five days, young individuals 
took an average of ~10K steps per day and spent 2.5% of their active time in high-
intensity activities (Figure 1A). The normal older adults group possessed similar 
(~10K steps/day and 2.2% active time in high-intensity activities), ensuring that 
changes observed between these groups were age-related rather than fitness-
related. Meanwhile, trained older adults were more active (~13K steps/day on 
average) with more time spent in high-intensity activities (5.2%), whereas the 
physically impaired older adults displayed a lower average daily step count (~6K) 
and a lower amount of their active time spent in high-intensity activities (1.0%) 
(Figure 1A). 
 
Using the muscle biopsies collected from each participant in these groups, we 
performed ultra-high performance liquid chromatography coupled to high-resolution 
mass spectrometry (UPLC-HRMS)-based metabolomics (Table S2). The results 
were used to establish a baseline understanding of the differences occurring 
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between young and older adults with normal and equivalent levels of physical 
activity, taking into account all 137 metabolites we were able to annotate. Comparing 
the muscle metabolomes of these two groups using a principal component analysis, 
we found a general separation between the groups to exist within the first two 
principal components, suggesting aging to impart large changes in the muscle 
metabolome (Figure S1A).  
 
To better understand what metabolites were contributing to the differences occurring 
with aging, we compared the accumulated and depleted metabolites (Figure 1B, 
Figure S1B). We found a clear signature of changes to occur with normal aging 
(Figure 1B). Intriguingly, when considering the top five metabolites either 
accumulating or depleting in older vs. young adults with normal and equal physical 
activity, we found older adults to possess higher levels of ophthalmic acid, an 
oxidative stress marker20,21, and dihydroxyacetone-phosphate and 3-
methoxytyramine, two metabolite families negatively associated to mitochondrial 
respiration22,23. Moreover, we found a significant age-related decline of NAD+ to 
occur with aging. Together these changes suggest an age-related change in 








Figure 1: The metabolome of human muscle aging 
(A) Study participants consisted of either young or older adults, whereby older adults were 
segmented into three categories: either 'exercise-trained,' ‘normally physically active,’ or 
‘physically impaired’ with respect to their muscle health (Table S1). Group averages are 
presented for BMI, steps-per-day, and high-intensity physical active time, (B) Volcano plot of 
fold change (x-axis, log2 scale) versus p-value (y-axis, -log10 scale) for older adults 
compared to young individuals with equal physical activity levels (‘young’ vs ‘normal older 
adults’)., illustrating significantly depleted (blue) or accumulated (red) metabolites with age. 
The horizontal line indicates significance (p<0.05). Significance was determined using an 
empirical Bayes moderated t-test. (C) Top 5 accumulating and depleted metabolites in 
normal older adults compared to young, depicted as a heatmap with higher (red) or lower 
(blue) relative abundances of metabolites.  
 
 
NAD+ abundance is directly related to healthy aging muscle 
 
Having established the metabolic changes occurring with aging in muscle, which 
pointed towards alterations in oxidative metabolism, we next asked which of these 
changes were not only linked to aging but were also related to muscle health levels. 
To do so, we ranked metabolites based on the degree to which their abundance 
level followed a health trend with the four groups, from young adults to trained older 
adults, to normally active older adults, to physically impaired older adults. This 
approach was designed to highlight metabolites that may decrease with normal 
aging, with a decline that can be either (partially) prevented by regular exercise 
training or exacerbated by belonging to a physically impaired aging group. Plotting 
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these correlations against the normal aging changes served to highlight the age-
related changes that are important also on a health and exercise related axis. 
Remarkably, we found that changes in normal older adults and changes that follow a 
‘health trend’ are highly correlated, implying that most metabolic changes that occur 
with age in the muscle can be reversed with regular exercise training (Figure 2A). 
 
In line with this observation, we found that NAD+ was not only one of the most 
depleted molecules in older adults when compared to young individuals, (Figure 1C) 
but also displayed the strongest association to healthy aging (Figure 2A). Indeed, 
age-related NAD+ (Figure 1B) was exacerbated in the impaired older adults (Figure 
2B, Figure S2A). Furthermore, according to the Venn diagram analysis, a significant 
age-related decline in NAD+ content was only found in common between the normal 
aging and the impaired aging groups (Figure S2B). Meanwhile, possessing an 
athletic lifestyle resulted in only a negligible age-related decline of NAD+ in the 
trained older adults when compared to NAD+ levels in the young (Figure 2B, Figure 
S2B).  
 
Interestingly, we found ophthalmic acid, a marker of oxidative stress and one of the 
top-five accumulated metabolites (Figure 1C), to display the opposite trend as 
observed for NAD+, namely, an increase in older adults compared to young that 
became exacerbated in physically impaired older adults and was attenuated in 
trained older adults (Figure 2A, Figure 2C). In addition, we found that oxiglutathione, 
another marker of oxidative stress, followed the same trend as ophthalmic acid 
(Figure 2A), suggesting that NAD+ depletion with aging may occur in parallel with 






Figure 2: Muscle NAD+ levels relate to muscle health during aging 
(A) Comparison of: (x-axis) the correlation a metabolite has to the four muscle health groups 
(young adults, trained older adults, older adults with normal physical activity levels, and 
physically impaired older adults), where the size of point on the graph indicates p-value of 
the correlation (-log10 scale), and correlation and significance were determined using 
Pearson’s product-moment correlation coefficient, and (y-axis) the fold change the 
metabolite undergoes in older vs. young adults with normal physical activity, where the color 
of the point indicates the p-value of aging fold change (with directionality represented as 
either increasing, red, or decreasing, blue) and significance was determined using an 
empirical Bayes moderated t-test. The metabolite's name is depicted when the aging fold 
change had a significance of p<0.05. The graph reveals NAD+ to be both depleted in aging 
and to follow the strongest correlation to a healthy aging trend. (B) Abundance levels of 
NAD+ in the four muscle health groups. (C) Abundance levels of ophthalmic acid in the four 
muscle health groups. Significance was determined using an empirical Bayes moderated t-
test (* p<0.05, ** p<0.01, *** p<0.001, n.s. = not significant). 
 
 
Modulation of the NAD+-pathway with aging 
 
Our untargeted metabolomics data pointed towards oxidative metabolism as a 
central player in aging muscle. Having observed that NAD+ was both declined in 
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normal aging and also possessed the strongest correlation to healthy aging, we next 
asked how the NAD+-pathway itself was modulated in our older adults relative to the 
young. To do so, we considered all NAD+-related metabolites (Figure S3A-L) and 
mapped out how they changed in each older adult group relative to young, onto the 
NAD+ synthesis pathway (Figure 3). The depletion of NAD+, observed per aged 
group, was mirrored by a depletion of NADH, although to a lesser extent. 
Furthermore, we observed a lack of modulation of NADP+ and NADPH in the aged 
groups, which points towards an aging and exercise-dependent modulation of 
NAD(H), but not of their phosphorylated forms.    
 
Having established NAD(H)’s associations to healthy aging, we next turned our 
attention to other metabolites involved in NAD+ de novo synthesis and recycling. We 
found a strong correlation between kynurenic acid accumulation and the healthy 
aging trend (Figure 3, Figure S3B). Kynurenic acid is produced by kynurenine 
aminotransferase (KAT)-mediated irreversible transamination of kynurenine, a 
downstream metabolite of tryptophan in the NAD+ de novo synthesis pathway, or 
through ROS-mediated oxidative degradation of kynurenine24. This latter explanation 
is in line with our previously noted increase in the oxidative damage markers 
ophthalmic acid and oxiglutathione20,21 in the older adults (Figure 2A, Figure 2C), 
supporting the hypothesis that kynurenic acid is produced via ROS-mediated 




Figure 3: Major NAD+ metabolites and changes in healthy muscle aging 
Changes in the three older adult groups (trained, normally active, and physically impaired) 
relative to young are depicted for each NAD+-related metabolite in the map. The color 
indicates the fold change (blue=decreased, red=increased), the size indicates the p-value of 
the significance (-log10 scale), and the shape denotes a significance threshold (square, 
p<0.05). Significance was determined using an empirical Bayes moderated t-test.  
 
 
NAD+ metabolism is related to mitochondrial function and muscle health 
 
Our cohort possessed extensive phenotyping of muscle health parameters, which 
offered an unprecedented opportunity to better understand how the age-related 
decline of NAD+ related to various outcomes of muscle health, an unexplored 
domain in human physiology. To address this, we performed a cross correlation of 
the abundances of NAD+-related metabolites to muscle-related parameters 
previously measured (clinicaltrials.gov identifier NCT03666013) in three older adult 
groups (Figure S4A). Phenotypical parameters consisted of molecular 
measurements of mitochondrial abundance (OXPHOS subunit abundances), 
mitochondrial respiration (oxygen consumption measurements in permeabilized 
muscle fibers), and in vivo mitochondrial function (PCr recovery), in addition to 
physiological parameters, including muscle energetics (net exercise efficiency %), 
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muscle volume (MRI), muscle strength (isokinetic function), and habitual physical 
activity (accelerometry) (Figure S4B). By comparing and focusing our analyses on 
the metabolite abundances that correlate or anti-correlate with these molecular and 
physiological parameters, we reasoned that a correlation network could map the 
landscape of NAD+-related interactions associated with healthy muscle aging. 
 
This approach revealed that a network existed that strongly linked NAD+ metabolites 
to aging muscle function. Intriguingly, within this network kynurenic acid acted as a 
hub of negative associations, while NAD+ was positively associated with many 
functional parameters of the muscle (Figure 4A). For example, we found that NAD+ 
abundance had a strong positive association to maximum ADP-stimulated (state 3) 
mitochondrial respiration (Figure 4B). Likewise, and quite remarkably, NAD+ 
abundance in muscle was also correlated to the average daily step count (Figure 
4C). Meanwhile, when considering negative correlations, we observed that kynurenic 
acid was inversely associated with isokinetic muscle strength (Figure 4D) and 
kynurenine was inversely associated with net exercise efficiency (Figure 4E). Taken 
together, this approach revealed a first-time view of the significant relationship the 
NAD+ pathway has to the healthy aging muscle functioning of older individuals. 
 
Numerous preclinical studies have indicated NAD+ depletion as the primary cause of 
disease and disability during aging25. While we have seen that boosting NAD+ 
metabolism in humans only induced very minor physiological changes26–28, 
increasing NAD+ in animal models improved, amongst others, muscle recovery, 
endurance capacity, mitochondrial function, oxidative metabolism, insulin sensitivity, 
and lipid profiles, and extended lifespan17,29–35. In line with these preclinical studies, 
our NAD+-related metabolite and muscle physiology network supports that NAD+ 






Figure 4: Molecular-physiological and NAD+-related healthy aging network 
(A) Network of significant associations between molecular-physiological parameters (light 
blue nodes) and NAD+-related metabolites (dark blue nodes). Positive associations are in 
orange and negative associations in blue, where correlation and significance was 
determined in the older adults using Pearson’s product-moment correlation coefficient 
(p<0.05). (B-E) Examples of correlations within the network, highlighting the positive 
associations between (B) NAD+ and mitochondrial respiration, and (C) NAD+ and average 
daily steps, and highlighting the negative associations between (D) Kynurenic acid and 
muscle strength and (E) Kynurenine and exercise efficiency. 
 
 
CONCLUSIONS AND FUTURE PERSPECTIVES  
 
In the current study we investigated age-related muscle metabolomic changes 
comparing young and aged individuals. We identified how metabolomic differences 
in aged individuals relate to muscle and mitochondrial function by evaluating 
changes across a healthy (muscle) aging trend. Out of the 137 detected metabolites, 
NAD+ was one of the most depleted metabolites upon aging, a finding which itself 
fills a void in the literature between preclinical animal research and clinical human 
research. Namely, to date, very few studies have established that NAD+, which 
declines in laboratory animals, also declines in human tissues36. Moreover, our study 
found that not only does NAD+ decline with age, but also that its decline is 
associated with the health state of the aged individual. Specifically, it is more 
severely depleted in the impaired older adults, exercised-trained older adults nearly 
fully prevent this age-related loss, and NAD+ abundance was directly positively 
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associated with mitochondrial respiration and physiological muscle functioning when 
considering all individual older adults.  
 
In this study, the young and normal aging groups were not engaged in structured 
exercise activities, and both recorded approximately 10,000 steps daily. Although 
this is well above the general recommendations37, our results suggest that 
maintaining a healthy physical activity level in older people comparable to the young 
is not sufficient to prevent an age-related decline in NAD+. However, endurance-
trained older participants who had 12,500 steps/day and performed at least three 
exercise training sessions per week, did not show the decline in NAD+ levels that 
occurred during normal aging. In contrast, physically impaired older adults in our 
study averaged less than 7,500 steps/day, reflecting a more sedentary lifestyle 
relative to the other participants38. The differences in habitual physical activity levels 
between the aging groups were directly reflected in NAD+ metabolism, whereby quite 
strikingly, daily step counts correlated strongly with muscle NAD+ levels. Taken 
together, our results demonstrate that the best therapy to maintain youthful and 
physiologically important levels of NAD+ during aging may simply involve highly 
structured exercise regimes, though this may not be realistic for all aging individuals. 
 
While an age-related decline of NAD+ and the benefits of boosting NAD+ levels have 
been extensively demonstrated in model organisms17,29–35, relatively little evidence 
exists relating NAD+ to aging and health in humans36. To our knowledge, to date, an 
age related decline in NAD+ levels in humans has only been demonstrated to occur 
in the brain (using magnetic resonance spectroscopy)39,40 and pelvic skin samples 
(measured spectrophotometrically)41. Here we further demonstrate that NAD+ 
declines with human aging in skeletal muscle. Interestingly, it has previously been 
shown in human skeletal muscle that levels of nicotinamide 
phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD+ salvage 
pathway, decreases with aging and that both aerobic and resistance exercise 
training can increase NAMPT levels42. While the study was not designed to directly 
measure NAD+, the findings are in line with ours, suggesting that an aging lifestyle 




Transcriptomic and metabolomic studies in human skeletal muscle have extensively 
been studied in the context of frailty and sarcopenia, with key findings demonstrating 
changes in mitochondrial function, muscle growth, and cell turnover43–45. One study 
has demonstrated that NAD+ (measured enzymatically) and mitochondrial oxidative 
capacity is decreased in sarcopenic older men relative to age-matched controls46. 
While the study was not designed to investigate whether older adults had lower 
levels of NAD+ than young individuals in the first place, their findings are in line with 
our findings that impaired older adults have lower NAD+ levels compared to normal 
older adults. Taken together, our work complements these recent findings and 
incorporates both young and old individuals, possessing both athletic and impaired 
aging states, to solidify our understanding of NAD+ in skeletal muscle healthy aging. 
 
In summary, our study advances our understanding of the relevance of NAD+ 
metabolism to human muscle aging, characterizing NAD+ metabolism in extensively 
phenotyped young and older adults. Specifically, novel findings of our study include 
that (i) aging is associated with a depletion in skeletal muscle’s NAD+ abundance, 
occurring despite older adults maintaining adequate physical activity, (ii) lower NAD+ 
levels relate to impaired aging and a high intensity athletic aging lifestyle results in 
muscle NAD+ levels similar to those seen in the young, and (iii) NAD+ metabolism 
strongly correlates with human skeletal muscle health during aging as assessed 
through mitochondrial and physical functioning, whereby the average daily step 
count an older adult takes directly associates with their muscle NAD+ levels. 
Together this work affirms the relation of NAD+ with overall health status in aging 
individuals and highlights the NAD-pathway as a promising target to promote healthy 
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Human subjects and procedures 
Fifty-two participants, including 12 young (7 male and 5 female) and 40 older 
individuals (23 male and 17 female) were recruited in the community of Maastricht 
and its surroundings through advertisements at Maastricht University, in local 
newspapers, supermarkets, and at sports clubs. The study protocol was approved by 
the institutional Medical Ethical Committee and conducted in agreement with the 
declaration of Helsinki. All participants provided their written informed consent, and 
the study was registered at clinicaltrials.gov with identifier NCT03666013. 
Physiological data from this clinical trial has been reported in our previous study as 
part of a different analysis (manuscript accepted, Nature Communications 2021). 
Prior to inclusion, all subjects underwent a medical screening that included a 
physical examination by a physician and an assessment of physical function using 
the Short Physical Performance Battery (SPPB), comprised of a standing balance 
test, a 4-m walk test, and a chair-stand test. After the screening procedure, 
participants were assigned to the following study groups: Young individuals with 
normal physical activity (Y, 20 – 30 years), older adults with normal physical activity 
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(NA, 65 – 80 years), athletic older adults (AA, 65 – 80 years) and physically impaired 
older adults (IA, 65 – 80 years). Participants were considered normal, physically 
active (NA) if they completed no more than one structured exercise session per 
week. Participants were considered trained (AA) if they engaged in at least 3 
structured exercise sessions of at least 1 hour each per week for an uninterrupted 
period of at least one year. Participants were classified as older adults with impaired 
physical function (IA) in case of an SPPB score of ≤ 9. The SPPB score was 
calculated according to the cut-off points determined by47. Subject characteristics are 
summarized in Table S1. 
 
Muscle biopsy  
At 9 AM, after an overnight fast from 10 PM the preceding evening, a muscle biopsy 
was taken from the m. vastus lateralis under local anesthesia (1.0% lidocaine without 
epinephrine) according to the Bergström method48. Part of the biopsy was 
immediately placed in an ice-cold preservation medium (BIOPS, OROBOROS 
Instruments, Innsbruck, Austria) and used for the preparation of permeabilized 
muscle fibers and measurement of ex vivo mitochondrial oxidative capacity, as 
described earlier 49,50. The remaining part of the muscle biopsy was immediately 
frozen in melting isopentane and stored at –80°C until further analysis.  
 
Mitochondrial respiration  
Permeabilized muscle fibers (∼2.5 mg wet weight) were used for the assessment of 
mitochondrial capacity using a 2-chamber oxygraph (OROBOROS Instruments), 
according to51. To prevent oxygen limitation, the oxygraph chambers were hyper-
oxygenated up to ∼400 μmol/L O2. Subsequently, two different multi-
substrate/inhibition protocols were used in which substrates and inhibitors were 
added consecutively at saturating concentrations. State 2 respiration was measured 
after the addition of malate (4 mmol/L) plus octanoyl-carnitine (50 μmol/L) or malate 
(4 mmol/L) plus glutamate (10 mmol/L). Subsequently, an excess of 2 mmol/L of 
ADP was added to determine coupled (state 3) respiration. Coupled respiration was 
then maximized with convergent electron input through Complex I and Complex II by 
adding succinate (10 mmol/L). Finally, the chemical uncoupler carbonylcyanide-4-
(trifluoromethoxy)-phenylhydrazone (FCCP) was titrated to assess the maximal 
capacity of the electron transport chain (state 3u respiration). The integrity of the 
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outer mitochondrial membrane was assessed by the addition of cytochrome C (10 
μmol/L) upon maximal coupled respiration. If cytochrome C increased oxygen 
consumption > 15%, the measurement was excluded to assure the viability and 
quality of the respiration measurement. All measurements were performed in 
quadruplicate. 
 
Mitochondrial content  
Mitochondrial content was assessed by mitochondrial OXPHOS protein expression 
using western blot analyses in Bioplex-lysates of human muscle tissue as previously 
described52. Equal amounts of protein were loaded onto 4–12% Bolt gradient gels 
(Novex, Thermo Fisher Scientific, Bleiswijk, The Netherlands). Proteins were 
transferred to a nitrocellulose membrane using the Trans-Blot Turbo transfer system 
(Bio-Rad Laboratories, Hercules, CA, USA). Primary antibodies contained a cocktail 
of mouse monoclonal antibodies directed against structural subunits of human 
OXPHOS (dilution 1:10,000; ab110411, Abcam, Cambridge, UK). The hOxPHOS 
proteins were detected using secondary antibodies conjugated with IRDye680 or 
IRDye800 and were quantified with a CLx Odyssey Near-Infrared Imager (Li-COR, 
Westburg, Leusden, The Netherlands). 
  
Magnetic resonance imaging and spectroscopy (Pcr recovery and muscle volume)  
All MR experiments were performed on a 3T whole-body MRI scanner (Achieva 3T-
X; Philips Healthcare, Best, The Netherlands). Participants were positioned supine in 
the MR scanner to determine muscle volume with a series of T1-weighted images of 
the upper leg (slice thickness = 10.0 mm, no gap between slices, in‐plane resolution 
= 0.78 x 0.78 mm). A custom-written MATLAB 2016a script (The Mathworks Inc. 
Natick, MA, USA) was used to segment adipose tissue and muscle and quantify 
muscle volume semi-automatically. The muscle segmentation was performed in 
consecutive slices between the lower end of the m. rectus femoris and the lower end 
of the m. gluteus maximus. Phosphorus magnetic resonance spectroscopy (31P-
MRS) was performed to measure in vivo mitochondrial function in m. vastus lateralis, 
as previously described 53, using a 6 cm surface coil. A series of 150 unlocalized 31P-
spectra was acquired using the following parameters: single acquisitions (NSA = 1); 
repetition time (TR) = 4000 ms; spectral bandwidth = 3000 Hz; number of points = 
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1024. The 150 spectra were divided into 10 spectra at rest, 70 spectra during knee-
extension exercise, and 70 spectra during recovery. Exercise within the scanner was 
performed to an auditory cue (0.5 Hz) in a custom-built knee-extension device with 
adjustable weight. The intensity was chosen to correspond to 50–60% of the 
predetermined maximum weight. Spectra were analyzed with a custom-made 
MATLAB 2016a script. PCr, ATP, and inorganic phosphate peaks were fitted, and 
pH was determined. The PCr recovery was fitted with a mono-exponential function 
and the rate constant (k in s-1) was determined as previously described53. The rate 
constant k of PCr resynthesis is almost entirely dependent on ATP produced by 
oxidative phosphorylation and can be used as a parameter of in vivo oxidative 
capacity54.  
 
Muscle function (exercise efficiency)  
Exercise efficiency was measured during a 1-hour submaximal exercise bout in the 
fasted state on an electronically-braked cycle ergometer. The submaximal cycle test 
was performed at 50% of Wmax, as determined during a maximal aerobic cycling 
test. To calculate exercise energy expenditure (EEE), O2 consumption and CO2 
production were recorded using indirect calorimetry for 15 minutes at two timepoints, 
T = 15 and T = 45 (Omnical, IDEE, Maastricht, The Netherlands). EEE was 
calculated as the average of T = 15 and T = 45. Before the submaximal exercise 
test, resting energy expenditure (REE) was measured using indirect calorimetry. The 
Weir equation55 was used to calculate whole-body energy expenditure (EE). Net 
energy efficiency was computed as power output (watts converted to kJ/min) over 
EE during exercise (EEE) minus resting EE (REE) (Eq. 1) as described by56. 
 
Eq 1: NEE (%) = (Work (kJ/min)/ (EEE (kJ/min) – REE (kJ/min)) *100 
 
Muscle strength  
Muscle contractile performance was measured using the Biodex System 3 Pro 
dynamometer (Biodex® Medical Systems, Inc., Shirley, NY, USA). The participants 
were stabilized in the device with shoulder, leg, and abdominal straps to prevent 
compensatory movement for the measurements. The test was performed with the 
left leg in all participants. To measure maximal muscle strength, each participant 
performed 30 consecutive knee extension and flexion movements (range of motion 
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120 degrees/s). The peak torque of each extension and flexion was recorded. The 
maximal isokinetic knee-extensor and knee-flexor torque was defined as the highest 
peak torque and corrected for body weight (Nm/kg) and muscle volume (Nm/m3). 
 
Habitual physical activity 
Habitual physical activity was determined in all participants using an ActivPAL 
monitor (PAL Technologies, Glasgow, Scotland) for a consecutive period of 5 days, 
including two weekend days. Besides the total amount of steps per day, the total 
stepping time was calculated in proportion to waking time, determined according 
to57. Stepping time (i. e., physical activity) was then further classified into high-
intensity physical activity (HPA; minutes with a step frequency > 110 steps/min in 
proportion to waking time) and lower-intensity physical activity (LPA; minutes with a 
step frequency ≤ 110 steps/min in proportion to waking time)37. 
 
Metabolomics 
Metabolomics was performed as previously described, with minor adjustments58. In a 
2 mL tube, the following amounts of internal standard dissolved in water were added 
to each sample of approximately 5 mg of freeze-dried muscle tissue: adenosine-
15N5-monophosphate (5 nmol), adenosine-15N5-triphosphate (5 nmol), D4-alanine 
(0.5 nmol), D7-arginine (0.5 nmol), D3-aspartic acid (0.5 nmol), D3-carnitine (0.5 
nmol), D4-citric acid (0.5 nmol), 13C1-citrulline (0.5 nmol), 13C6-fructose-1,6-
diphosphate (1 nmol), guanosine-15N5-monophosphate (5 nmol), guanosine-15N5-
triphosphate (5 nmol), 13C6-glucose (10 nmol), 13C6-glucose-6-phosphate (1 nmol), 
D3-glutamic acid (0.5 nmol), D5-glutamine (0.5 nmol), D5-glutathione (1 nmol), 13C6-
isoleucine (0.5 nmol), D3-lactic acid (1 nmol), D3-leucine (0.5 nmol), D4-lysine (0.5 
nmol), D3-methionine (0.5 nmol), D6-ornithine (0.5 nmol), D5-phenylalanine (0.5 
nmol), D7-proline (0.5 nmol), 13C3-pyruvate (0.5 nmol), D3-serine (0.5 nmol), D6-
succinic acid (0.5 nmol), D5-tryptophan (0.5 nmol), D4-tyrosine (0.5 nmol), D8-valine 
(0.5 nmol). After adding the internal standard mix, a 5 mm stainless-steel bead and 
polar phase solvents (for a total of 500 µL water and 500 µL MeOH) were added and 
samples were homogenized using a TissueLyser II (Qiagen, Hilden, Germany) for 
5 min at a frequency of 30 times/sec. Chloroform was added for a total of 1 mL to 
each sample before thorough mixing. Samples were then centrifuged for 10 minutes 
at 18.000g. The top layer, containing the polar phase, was transferred to a new 1.5 
Chapter 4 
126 
mL tube and dried using a vacuum concentrator at 60°C. Dried samples were 
reconstituted in 100 µL 3:2 (v/v) methanol:water. Metabolites were analyzed using a 
Waters Acquity ultra-high performance liquid chromatography system coupled to a 
Bruker Impact II™ Ultra-High Resolution Qq-Time-Of-Flight mass spectrometer. 
Samples were kept at 12°C during analysis and 5 µL of each sample was injected. 
Chromatographic separation was achieved using a Merck Millipore SeQuant ZIC-
cHILIC column (PEEK 100 x 2.1 mm, 3 µm particle size). Column temperature was 
held at 30°C. Mobile phase consisted of (A) 1:9 (v/v) acetonitrile:water and (B) 9:1 
(v/v) acetonitrile:water, both containing 5 mmol/L ammonium acetate. Using a flow 
rate of 0.25 mL/min, the LC gradient consisted of: 100% B for 0-2 min, reach 0% B at 
28 min, 0% B for 28-30 min, reach 100% B at 31 min, 100% B for 31-32 min. Column 
re-equilibration is achieved at a flow rate of 0.4 mL/min at 100% B for 32-35 min. MS 
data were acquired using negative and positive ionization in full scan mode over the 
range of m/z 50-1200. Data were analyzed using Bruker TASQ software version 
2.1.22.3. All reported metabolite intensities were normalized to dry tissue weight, as 
well as to internal standards with comparable retention times and response in the 
MS. Metabolite identification has been based on a combination of accurate mass, 
(relative) retention times and fragmentation spectra, compared to the analysis of a 
library of standards (Sigma-Aldrich MSMLS). 
 
Statistical analyses and data visualization  
Data was processed and analyses were performed with R version 3.5.159 and 
Bioconductor version 3.760. Data was processed in part with the R package dplyr 
version 1.0.261. Principal Component Analysis (PCA) was performed using the R 
package MixOmics version 6.6.262. Significance was assessed using an empirical 
Bayes moderated t-test on log2 transformed data within limma’s linear model 
framework, taking participant groups into account63,64. Networks were constructed 
and visualized using igraph version 1.2.4.265. Unless implemented through an 
aforementioned R package or base R graphics, visualization of data was performed 
using ggplot2 version 3.2.166, ggpubr v 0.2.567, ggrepel version 0.8.168, with colors 
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Data availability 
Metabolomics data are available as supplementary materials accompanying this 
manuscript as both summary statistics and processed abundance values per 
individual.
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SUPPLEMENTARY MATERIAL FOR CHAPTER 4 
Table S1: Inclusion criteria per study group. Participants were assigned to different study 
groups based on age, self-reported exercise levels, and physical function. Participants were 
considered normally physically active if they completed no more than one structured 
exercise session per week. Participants were considered exercise-trained if they engaged in 
at least three structured exercise sessions of at least 1 hour each per week for an 
uninterrupted period of at least one year prior to inclusion. Physical function was measured 
using the Short Physical Performance Battery, which includes a standing balance test, a 4-m 
walk test, and a chair-stand test. The SPPB score was calculated according to the cut-off 
points determined by (Guralnik et al. 1994). Participants were classified as physically 






Older adults, normal 
physical activity  
Physically impaired 
older adults 
20-30 years old 65-80 years old 
Normal physical 
activity 




≥ 3 times exercise 
per week 
Normal physical activity 
Max 1h exercise per week 
Normal physical function 
SPPB score >9 
Impaired physical 
function 





Figure S1: Global metabolomics changes of human muscle aging  
(A) Principal Component Analysis (PCA) of metabolomes of young and older individuals 
possessing equal physical activity levels (‘young’ vs ‘normal older adults’). (B) Volcano plot 
of fold change (x-axis, log2 scale) versus p-value (y-axis, -log10 scale) for older adults 
compared to young individuals with equal physical activity levels, illustrating significantly 
depleted (blue) or accumulated (red) metabolites with age. The horizontal line indicates 
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Figure S2: Comparison of age-related changes in each aging group 
(A) Volcano plots of fold change (x-axis, log2 scale) versus p-value (y-axis, -log10 scale) for 
trained older adults (top), and physically impaired older adults (bottom) compared to young 
individuals, illustrating significantly depleted (blue) or accumulated (red) metabolites with 
age. Line indicates significance (p<0.05). Significance was determined using an empirical 
Bayes moderated t-test. (B) Venn diagram of the overlap of significantly accumulating or 
depleting metabolites in each aged group (trained older adults, older adults with normal 


























Figure S3: NAD+-related metabolites of healthy aging groups (A-L) Abundance levels of 
NAD+-related metabolites in the four muscle health groups, for (A) ADP-ribose, (B) 
Kynurenic acid, (C) Kynurenine, (D) Methyl-NAM, (E) NAD+, (F) NADH, (G) NADP+, (H) 
NADPH, (I) Nicotinamide mononucleotide (NMN), (J) Dihydronicotinamide riboside (NRH), 
(K) Ribose-5P, and (L) Tryptophan. Significance was determined using an empirical Bayes 
moderated t-test (* p<0.05, ** p<0.01, *** p<0.001, n.s. = not significant).  
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Figure S4: Correlation of molecular-physiological phenotypes with metabolites 
involved in NAD+ synthesis 
(A) Correlation matrix comparing the paired metabolome (dark blue) and muscle health 
parameters (light blue) in the older adults (Pearson’s product-moment correlation 
coefficient). The scale ranges from blue (negative correlation), to yellow (no correlation), to 
red (positive correlation). Inset and cartoon: correlation between metabolites and muscle 
health parameters are used to reconstruct the network. (B) Abbreviations and 
measurements of the molecular-physiological phenotypes assessed in this analysis. Note: 
MOGS3, state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate, 
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1H-MRS 1H-Magnetic resonance spectroscopy 
ADP Adenosine diphosphate 
ADPr Adenosine diphosphate riboside 
AMPK 5' adenosine monophosphate-activated protein kinase 
ATP Adenosine triphosphate 
BMI Body mass index 
BMR Basal metabolic rate 
CytC Cytochrome C 
DBP Diastolic blood pressure 
ETC Electron transport chain 
FCCP Carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone 
FFA Free fatty acids 
GEE Gross exercise efficiency 
INT Intervention 
MAP Mean arterial pressure 
NA Nicotinic acid 
NAAD Nicotinic acid adenine dinucleotide 
NAD(H) Nicotinamide adenine dinucleotide 
NADP(H) Nicotinamide adenine dinucleotide phosphate 
NAM Nicotinamide 
NE Niacin equivalent 
NEE Net exercise efficiency 
NR Nicotinamide riboside 
PCr Phosphocreatine 
QA Quinolinic acid 
SBP Systolic blood pressure 
SPPB Short physical performance battery 
TG Triglycerides 
L-Trp L-Tryptophan 
RER Respiratory exchange ratio 
UCP1 Uncoupling protein 1
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ABSTRACT 
Background: Boosting nicotinamide dinucleotide (NAD+) via supplementation with 
niacin equivalents has been proposed as a potential modality capable of promoting 
healthy aging and negating age-dependent decline of skeletal muscle mass and 
function.  
Objective: We investigated the efficacy the efficacy of NAD+-precursor 
supplementation (tryptophan, nicotinic acid, and nicotinamide) on skeletal muscle 
mitochondrial function in physically compromised older adults. 
Methods: A randomized, double-blind, controlled trial was conducted in fourteen 
(female/male: 4/10) community-dwelling, older adults with impaired physical function 
(age: 72.9 (4.0) y; BMI: 25.2 (2.3) kg/m2). Participants were supplemented with 207.5 
mg niacin equivalents/day (intervention, INT) and a control product (CON) that did 
not contain niacin equivalents, each for 32 days. The primary outcomes tested were 
mitochondrial oxidative capacity and exercise efficiency and was analyzed by means 
of paired student’s T-test. Secondary outcomes such as NAD+ concentrations were 
analyzed accordingly. 
Results: Following supplementation, skeletal muscle NAD+ concentrations (7.5 (1.9) 
vs 7.9 (1.6) AU in intervention (INT) vs control (CON)) were not significantly different 
compared to the control condition, whereas skeletal muscle methyl-nicotinamide 
(MeNAM) levels were significantly higher under NAD+-precursor supplementation 
(INT 0.098 (0.063) vs CON 0.025 (0.014); p = 0.001), suggesting increased NAD+ 
metabolism. Conversely, both ADP-stimulated (INT 82.1 (19.0) vs CON 84.0 (19.2); 
p = 0.716) and maximally uncoupled mitochondrial respiration (INT 103.4 (30.7) vs 
CON 108.7 (33.4); p = 0.495) did not improve under NAD+-precursor 
supplementation; neither did net exercise efficiency during the submaximal cycling 
test (INT 20.2 (2.77) vs CON 20.8 (2.88); p = 0.342).  
Conclusions: Our findings are consistent with previous findings on NAD+ efficacy in 
humans and we show in community-dwelling, older adults with impaired physical 
function that NAD+-precursor supplementation through L-tryptophan, nicotinic acid, 





Aging has been defined as the time-dependent decline of function (1), with one of 
the most striking features of the aging process being the progressive loss of skeletal 
muscle mass (sarcopenia), and in turn, the decline of skeletal muscle physical 
function (2). The loss of skeletal muscle mass and function leads to mobility 
impairments, increased risk of falls, physical frailty, and metabolic impairments (3). 
Hence, a compromised physical function increases the risk of dependency in 
activities of daily living and care needs. With society confronted with an ever-aging 
population, a large effort of research has focused on identifying strategies to promote 
healthy aging. 
Interestingly, the loss of skeletal muscle function is paralleled by an age-dependent 
decline in mitochondrial function (1), an established hallmark of aging that is 
considered to be a driving force behind skeletal muscle aging (4-6). Therefore, 
promoting mitochondrial metabolism may be a promising strategy to negate the 
metabolic and functional disturbances seen in skeletal muscle during aging (7). 
 
One pathway that has received much attention in this context is the nicotinamide 
adenine dinucleotide (NAD+) - sirtuin (SIRT)-axis (8-11). The SIRT enzyme family is 
comprised by NAD+-dependent deacetylases involved in the regulation of 
mitochondrial metabolism (12) and act as sensors to the bioavailability of NAD+ (13). 
The co-enzyme NAD+ and its reduced form NADH are critical to the cellular redox 
potential and are the predominant electron donor in the electron transport chain 
(ETC). NAD+, however, is the rate-limiting substrate in SIRT activity, and NAD+ 
bioavailability has been shown to decline with increasing age in mice (4, 10) and 
humans (14, 15). The human body derives NAD+ from various dietary sources, as it 
can be synthesized de novo from the essential amino-acid L-tryptophan (L-Trp), or 
from niacin compounds such as nicotinic acid (NA) through the Preiss-Handler 
pathway or salvaged from nicotinamide (NAM) and nicotinamide riboside (NR) (16). 
From a dietary perspective, NR is a trace element, whereas L-Trp, NA, and NAM are 
more abundantly available in our diets (17). 
 
Preclinical work in murine models of aging has demonstrated the efficacy of 
supplementing with NAD+-precursors, such as NR and nicotinamide mononucleotide 
(NMN), to negate the effects of aging-induced by declining NAD+ levels (4, 18), 
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promote longevity (18), and improve energy metabolism, body weight, and 
mitochondrial oxidative metabolism (11). Following suit, several human intervention 
studies have focused on the use of the NAD+-precursor NR to improve 
cardiovascular health in middle-aged to older adults (19), to combat metabolic 
dysfunction in middle-aged obese individuals (20, 21), and to improve skeletal 
muscle metabolism in older adults (22). Although these studies provide some 
evidence on the efficacy of supplementation with NAD+-precursors in older adults to 
increase NAD+ levels in blood and skeletal muscle through NR supplementation, 
evidence stemming from studies involving older adults with a compromised physical 
function and focusing on skeletal muscle function are still lacking. 
 
Furthermore, other than through supplementation with high doses of NR or NA, there 
is only limited evidence discerning NAD+-precursor supplementation at lower doses. 
Dietary supplements bearing more resemblance of increased dietary intake may also 
has the potency to increase NAD+ bioavailability in humans (23, 24). Moreover, 
increasing NAD+ synthesis from L-Trp by inhibiting the ACMSD enzyme also leads to 
activation of SIRT1 and its downstream health benefits (25). Here, we aim to 
elucidate the efficacy of NAD+-precursor supplementation through a novel 
combination of L-Trp, NA, and NAM on skeletal muscle mitochondrial function in 
community-dwelling, older adults with impaired physical function.  
 
 
METHODS AND MATERIALS 
 
Participants 
Fourteen physically compromised, older adults (65 years and older, BMI 20 – 30 
kg/m2) were recruited from the general population in the vicinity of Maastricht 
through advertisements. The study was conducted in accordance with the principles 
of the declaration of Helsinki and approved by the Ethics Committee of the 
Maastricht University Medical Center+. All participants provided written informed 
consent and the study was registered at clinicaltrials.gov (NCT03310034). 
All participants (4 females, 10 males) were Caucasian, non-smokers, and generally 
healthy as predetermined by a medical questionnaire and physical examination by a 




others: anti-hypertensives, statins, and proton pump inhibitors (summarized in Table 
1). Impaired physical function of the participants was defined as a walking distance 
of 465 meters or less as assessed during a six-minute walk test (6MWT). Thus, 
during a clocked 6-minute session, participants were instructed to walk as far as 
possible without running, over a 20-meter flat surface track. The cut-off used to 
define impaired physical function was based on the median 6MWT walking distance 
(personal communication with Prof. Dr. Ir. C.P.G.M. de Groot, Dept. Of 
Agrotechnology and Food Sciences, Human Nutrition & Health, Wageningen 
University and Research) of the pre-frail subgroup of the NU-AGE cohort  (26). 
Habitual physical activity was assessed and analyzed by Baecke’s Habitual Physical 
Activity Questionnaire (27). Exclusion from participation was primarily based on the 
following: excessive alcohol and/or drug abuse, physical activity > 1 hour/week, 
inability to complete the required measurements, type 2 diabetes, significant 
allergies or intolerances concerning the study products, and medication use known 
to hamper the participant’s safety during the study procedures. 
The study was conducted between November 2017 and February 2020. Conduction 
of the study protocol was hampered and curtailed prematurely during the SARS-
CoV-2 (COVID-19) virus outbreak in the Netherlands in accordance with the 
imposed governmental restrictions in early 2020. Ultimately, 13 participants 
completed the study protocol, with the fourteenth participant completing only the first 
research period and wash-out of the study protocol. 
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Table 1 Baseline participant characteristics at screening. 
Participant characteristics  
 Sex (female / male) 4 / 10 
 Age (years) 72.9 (4.0) 
 Height (cm) 170 (6) 
 Weight (kg) 72.9 (7.1) 
 Body Mass Index (kg/m2) 25.2 (2.3) 
 Systolic Blood Pressure (mmHg) 144 (12) 
 Diastolic Blood Pressure (mmHg) 84 (6) 
 Heart rate (beats per minute) 63 (10) 
 6-minute walking distance (m) 393 (53) 
 Maximal aerobic capacity (L/min) 2.31 (0.66) 
 Maximal cycling resistance (Watt) 176 (63) 
Blood parameters  
 Hemoglobin (mmol/L) 9.1 (0.6) 
 Creatinine (μmol/L) 88 (18) 
 eGFR CKD-EPI 71.6 (10.1) 
 Alkaline Phosphatase (U/L) 74 (22) 
 γGT (U/L) 23 (9) 
 AST (U/L) 23 (5) 
 ALT (U/L) 21 (5) 
 Bilirubin (μmol/L) 11.5 (5.0) 
 Cholesterol (mmol/L) 5.1 (0.7) 
 HDL-Cholesterol (mmol/L) 1.7 (0.5) 
 LDL-Cholesterol (mmol/L) 2.9 (0.6) 
 Triglycerides (mmol/L) 1.03 (0.32) 
 Free Fatty Acids (mmol/L) 0.47 (0.11) 
 Hb1Ac (%) 5.4 (0.3) 
 Glucose (mmol/L) 5.1 (0.6) 
Baecke Physical Activity Index 7.26 (1.34) 
 Work Index 1.62 (0.98) 
 Sport Index 2.25 (0.49) 
 Leisure Index 3.39 (0.41) 
Medication used (n)  
 Statin 1 
 Proton pump inhibitor 1 
 Thrombocyte aggregation inhibitor 1 
 Calcium and Vitamin D 2 
 Thyromimetic 1 
 Anti-hypertensive drugs 3 
 Alfa blocker 1 
 NSAID 1 
 Benzodiazepine 1 
Data is presented as mean (SD) for n = 14. Abbreviations: ALT, alanine transaminase; 
AST, aspartate transaminase; eGRF CKD-EPI, estimated glomerular filtration rate chronic 
kidney disease epidemiology collaboration; Hb1Ac, glycated hemoglobin; NSAID, 






We conducted a double-blind, randomized, controlled, cross-over trial in 13 
physically compromised, older adults. Primary outcome parameters were ex and in 
vivo mitochondrial function and resting and submaximal exercise energy 
expenditure. Secondary outcome parameters were glucose tolerance, ectopic fat 
content, acetylcarnitine levels and physical function. All other outcome measures 
were exploratory. Each study period consisted of 32 days of supplementation with 
either the intervention product (INT) or control (CON), separated by at least 5 weeks 
of wash-out. We chose this intervention duration, based on previous studies in our 
lab with other nutritional supplements, such as resveratrol, that showed effects on 
metabolic outcome parameters (28).  During the entire study, participants were 
instructed to maintain habitual physical activity levels and dietary choices and no 
dietary restrictions were imposed. An overview of the study design is presented in 
Figure 1. 
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Figure 1 (A) Study timeline and (B) study protocol depicting a CONSORT flow diagram of 
participant inclusion in the study. Abbreviations: B, baseline measurements preceding 
randomization; COVID-19, coronavirus disease 2019; M, end of study period measurements 





The intervention product (INT) was composed of a whey protein powder as a source 
of tryptophan, to which NA and NAM were added. In total, the equivalent of 207.5 
mg/day niacin equivalents (NE) of NAD+-precursors was supplemented through L-
Trp (210 mg/day at a 60:1 conversion rate (29, 30)), NA (4 mg/day), and NAM (200 
mg/day). The control product (CON) was composed of an amino acid powder 
mixture resembling whey protein, but lacking L-Trp, NA, and NAM. Participants 
received the dietary supplements in a single daily serving, to be ingested during 
breakfast after dissolving the powder in 200 mL of orange juice. Production and 
packaging of the supplements were done by Danone Research and approved by the 




At baseline, participants underwent a maximal cycling test determining maximal 
aerobic capacity (VO2max) and maximal power output (Wmax) on an electronically 
braked cycle ergometer (Lode Excalibur, Groningen, The Netherlands), as described 
previously (31). O2 consumption and CO2 production were measured using indirect 
calorimetry (Omnical, IDEE, Maastricht, the Netherlands), and the respiratory 
exchange ratio (RER) was monitored as a verification of the participant’s maximal 
effort.  
 
Day 1 – Start of supplementation 
Following the baseline cycling test, participants were randomly allocated to the 
intervention or control arm and supplementation was initiated. Participants then 
reported to our facility on Day 1 and 15 to measure blood pressure, to provide a 
venous blood sample, and to fill out the RAND-36 Health Survey 1.0 questionnaire 
(32, 33). The venous blood sample was analyzed for standard clinical lab values in 
the Maastricht Hospital. The participants were randomized in blocks of 4 using the 
website Randomizer.org for randomization by an independent researcher. 
Blood pressure was measured in sitting position on the non-dominant arm with an 
oscillometric cuff (Omron M6 Comfort, OMRON Healthcare Europe B.V., Hoofddorp, 
the Netherlands) in triplicate from which mean arterial pressure (MAP) was 
estimated from the systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
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mean values of the measurement and calculated as MAP = [(2/3 x DBP) + (1/3 x 
SBP)]. 
 
Day 29 – Hepatic lipid content 
On day 29, participants reported to our facility in the fasted state at 7 AM to undergo 
proton magnetic resonance spectroscopy (1H-MRS) for the quantification of hepatic 
lipid content (intrahepatic lipid, IHL) with a 3T whole-body MR system (Achieva 3Tx; 
Philips Healthcare, Best, the Netherlands), as described previously (34). To prevent 
motion artifacts, participants were asked to breathe in the rhythm of the 
spectroscopic measurement. Subsequently, the water signal dominating the proton 
spectra was suppressed using frequency-selective pre-pulses and the spectra was 
fitted to quantify the lipid peak. The lipid/water ratio was used as a parameter of 
intrahepatic lipid content, as previously reported (34). 
Next, a venous blood sample was acquired, the RAND-36 Health Survey 1.0 
questionnaire was repeated and the short physical performance battery (SPPB) (35) 
was performed to assess physical function of the lower extremities. Lastly, blood 
pressure was measured as described previously under Day 1. 
 
Day 31 – Muscle volume  
The participants underwent another MRI session at 5 PM on Day 31 to determine the 
muscle volume of the upper leg. Henceforth, the participant was positioned in the 3T 
MRI scanner (Achieva 3Tx; Philips Healthcare, Best, the Netherlands) in the supine 
position, feet first. T2 weighted MRI measurements were acquired covering the from 
the patella to the art. coxae, allowing muscle volume to be determined using 3D 
segmentation. 
 
Day 33 – Submaximal cycling test and skeletal muscle biopsy 
On the last day of the study period (Day 33), participants reported to the research 
facility in the fasted state (from 10 PM the evening before). Body composition was 
measured by means of air displacement plethysmography (BodPod®, COSMED, 
Rome, Italy). Subsequently, indirect calorimetry through a ventilated hood system 
was used to determine the basal metabolic rate (BMR) and respiratory exchange 




Next, a skeletal muscle biopsy was obtained from the m. vastus lateralis according to 
the Bergström method (36) with a side-cutting needle under local anesthesia using 
1.0% lidocaine (10 mg/mL) without epinephrine, from which a portion was kept in a 
preservation medium and freshly used to prepare permeabilized muscle fibers 
according to Hoeks et al. (37). Subsequently, ex vivo high-resolution respirometry 
was performed using a two-chamber Oxygraph (OROBOROS Instruments, 
Innsbruck, Austria) using a multiple substrate/inhibitor titration protocol to extensively 
characterize the mitochondrial capacity of skeletal muscle tissue, as previously 
reported (38). Measurements were performed in quadruplicate and the integrity of 
the outer mitochondrial membrane was assessed by the addition of cytochrome c 
(CytC) upon maximal coupled respiration (State 3) and deemed intact if the response 
to the CytC addition remained under 10%, hence 16 out of 100 individual 
measurements were excluded.  
Following the muscle biopsy, participants were submitted to a submaximal exercise 
session of one hour on an electrically braked cycling ergometer (Lode Excalibur, 
Groningen, The Netherlands) at 50% of their Wmax achieved in the maximal cycling 
test at baseline. indirect calorimetry was measured during the second and fourth 
quarter of the one-hour session. 
 
Calculations 
From the indirect calorimetry data, energy expenditure and substrate oxidation rates 
were calculated using Weir’s formula under the assumption of negligible protein 
oxidation (39). In addition, gross exercise efficiency (GEE) was calculated as [Wext / 
Etot] and net exercise efficiency (NEE) as [Wext / (Etot - Erest)] (40) from the 




Using EDTA plasma, glucose (Horiba, Montpellier, France), insulin (Crystal Chem, 
Elk Grove Village, Illinois, USA), total free fatty acids (FFA) (Wako, Neuss, 
Germany), and triglycerides (TG) (Sigma, Saint Louis, Missouri, USA) concentrations 
were determined in samples collected on Day 1 and 29 by means enzymatic 
quantification with the ABX Pentra C400 (Horiba, Montpellier, France). All time points 
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of one participant were measured in the same run with insulin and FFA levels 
measured in duplicates. 
 
Acylcarnitine analysis 
2-4 mg of freeze-dried muscle tissue was used to analyze skeletal muscle 
acylcarnitines, as previously described (41) . Quantitative determination of the 
propylated acylcarnitines in the medium was performed using tandem mass 
spectrometry in an Acquity UPLC System (Waters) coupled to a Quattro Premier XE 
Tandem Quadrupole Mass Spectrometer (Waters). The internal standards d3-0, d3-
3, d3-6, d3-8, d3-10 and d3-16 carnitine were purchased from Dr. Herman J. ten 
Brink (Vrije Universiteit Medical Hospital, Amsterdam, The Netherlands).  
 
Enzymatic cyclic assay for quantitative NAD determination 
1-5 mg of freeze-dried muscle tissue were homogenized in 250 µL of 2M HClO4 
using a TissueLyser II (Qiagen) bead mill for 5 minutes at 30 pulses per second. 
After centrifugation at 16000g, 100 µL of the acidic supernatant were neutralized by 
addition of 150 µL 2M/0.6M KOH/MOPS and centrifuged again to remove 
precipitated salts. NAD+ content was determined using an enzymatic 
spectrophotometric cycling assay based on the coupled reaction of malate and 
alcohol dehydrogenases, as previously described (42). Enzymes used for NAD+ 
determination (alcohol dehydrogenase from yeast, malate dehydrogenase from pig 




2-4 mg of freeze-dried muscle tissue was used for metabolomics analysis as 
previously described (20). Briefly, metabolite analysis was carried out in an Aquity 
UPLC system (Waters) coupled to an Impact IITM Ultra-High Resolution Qq-Time-Of-
Flight mass spectrometer (Bruker). Chromatographic separation of the compounds 
was achieved using a SeQuant ZIC-cHILIC column (PEEK 100 x 2.1 mm, 3 µm 
particle size, Merck, Darmstadt, Germany) at 30 °C. The LC method consisted in a 
gradient running at 0.25 mL/min from 100% mobile phase B (9:1 acetonitrile:water 
with 5 mM ammonium acetate pH 6.8) to 100% mobile phase A (1:9 




are-equilibration step at 100% B of 5 minutes. MS data were acquired both in 




The variation in the primary outcome mitochondrial state 3 respiration on a 
combination of malate, octanoyl-carnitine, glutamate and succinate (σ = ~8 pmol* mg 
wet tissue-1*min-1) was established previously during a pre- and post-intervention 
high-resolution respirometry (43). We have previously shown that the difference in 
mitochondrial function between healthy and insulin resistance volunteers is ~ 20%. 
To detect a difference of ~10% increase in mitochondrial function (μ = ~6.0 pmol* mg 
wet tissue-1*min-1), which we believe is physiologically relevant in this population and 
which is achievable with a short-term nutritional intervention as demonstrated 
previously (28), 14 participants must be included with a power (π) of 80% and a two-
sided significance level (α) of 0.05. 
Statistical analysis was performed in SPSS 26 for Mac OS (IBM® SPSS® Statistics, 
USA) and graphs were made in Prism 8.4.2 for Windows (GraphPad Software, Inc., 
USA). Descriptive statistics were reported for all data parameters as mean ± 
standard deviation (SD), unless otherwise stated. Normality of the data distributions 
were evaluated with the Kolmogorov-Smirnov normality test and deemed significant 
when p < 0.05. The paired Students t-test was used to compare the results of the 
intervention to the control, or the equivalent Wilcoxon signed-rank test was used if 
normality was not met. In the event of missing values, the values were not replaced 
and the participant in question did not contribute to the analysis of that outcome, 
hence all analyses encompass n = 13, unless stated otherwise. No carry-over or 
order effect was detected. In addition, Pearson correlation coefficients were 
computed. Bonferroni corrections were imposed to correct for multiple testing of 
single outcome measures. Moreover, due to multiplicity of the primary outcomes the 
type 1 error was corrected for using a Bonferroni correction as (alpha / n). Statistical 
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RESULTS 
NAD+-precursor supplementation increased methyl-nicotinamide but not NAD+ 
bioavailability in skeletal muscle 
Compliance to the supplement use was estimated by the fraction of sachets returned 
compared to the number of sachets provided to the participants. For the 
supplementation with precursors (INT), 100% (100%) of all sachets were consumed, 
compared to 99% (range, min-max: 97-100%) in the control condition (CON). 
Overall, the products were well tolerated, with only one participant reporting cold 
sores (herpes labialis), which resolved without intervention. Subject characteristics at 
the start of the study are summarized in Table 1. No carry-over or order effect was 
detected for any of the primary outcome parameters. 
In order to determine the efficacy of the NAD+-precursor supplementation, the 
concentration of NAD+ as well as several metabolites of the NAD+ synthesis 
pathways were measured in skeletal muscle tissue, obtained from the m. vastus 
lateralis. These analyses showed that NAD+ levels were similar between INT and 
CON (p = 0.123, Figure 2). 
From the de novo biosynthesis pathway, L-Trp, kynurenine, and quinolinic acid (QA) 
did not differ between INT and CON (p ≥ 0.05, n = 11, Figure 2). Synthesis of NAD+ 
from nicotinic acid (NA) through the Preiss-Handler pathway leads to synthesis of 
nicotinic acid adenine dinucleotide (NAAD), which was not different between NAD 
and CON (p = 0.262, n = 11, Figure 2). NAD+ can also be salvaged from NMN, NAM, 
and NR, but also in these precursors no differences between INT and CON were 
observed (p ≥ 0.05, n = 11, Figure 2). Consumption of NAD yields NAM and ADPr, 
with no differences observed in ADPr levels between INT and CON (p = 0.413, n = 
11, Figure 2). Conversely, the concentration of the primary breakdown product of 
NAM, methyl-NAM (MeNAM), which is also commonly described as a marker for 
increased NAD turnover (22), was measured and revealed significantly higher 
MeNAM concentrations in INT compared to CON (p = 0.001, Figure 2). Alternatively, 
NAD+ can be phosphorylated into nicotinamide dinucleotide phosphate (NADP+), in 
which we did not observe a difference between conditions (p = 0.833, n = 11, Figure 
2). The respective reduced forms, NADH and NADPH, also did not differ between 






Figure 2 NAD+ metabolome in skeletal muscle tissue obtained from older adults with 
compromised physical function administered supplemental niacin equivalents and placebo, 
each for 32 days. The y-axis defines the AUC (AUC* IS AUC–1) per mg of dry tissue used in 
the MS analysis. Data are displayed as means ± SDs, n = 11. *P < 0.01. Abbreviations: 
ADPr, adenosine diphosphate riboside; AUC, area under curve; CON, control; INT, NAD 
intervention; IS, internal standard; MeNAM, methyl-nicotinamide; NA, nicotinic acid; NAAD, 
nicotinic acid adenine dinucleotide; NAM, nicotinamide; NMN, nicotinamide mononucleotide; 
NR, nicotinamide riboside. 
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Skeletal muscle acylcarnitine levels were unaffected by NAD+-precursor 
supplementation 
We previously showed that NR supplementation in humans altered acylcarnitine 
levels in skeletal muscle (20). Therefore, acylcarnitine levels were determined in the 
skeletal muscle tissue and species were categorized in subgroups, being free (C0), 
independent (C2), short-chain (C3-C5), medium-chain (C6-C12), and long-chain 
(C13-C20) acylcarnitines. Ultimately, no differences were observed in the 
concentrations of acylcarnitine subgroups between INT and CON (p ≥ 0.05, Figure 
3ABCD, n = 11). 
 
Figure 3 Skeletal muscle acylcarnitine levels in older adults with compromised physical 
function administered supplemental niacin equivalents and placebo. (A) Acylcarnitine levels 
in skeletal muscle for free (C0) and independent species (C2). Acylcarnitine levels for (B) 
short chain, (C) medium chain, and (D) long chain species (LC). Data are displayed as 




Body composition was not affected by NAD+-precursor supplementation 
Body weight did not differ between INT (73.0 kg (68.6, 77.5) and CON (72.9 kg 
(68.6, 77.2), p = 0.812). Also, body composition was unaffected by NAD+-precursor 
supplementation as fat percentage was not different for INT and CON (34.2% (29.3, 
39.2) and 33.3% ( 27.6, 38.9) respectively, p = 0.121). 
 
NAD+-precursor supplementation did not improve overall ex vivo 
mitochondrial respiration capacity 
To determine skeletal muscle mitochondrial capacity, we performed ex vivo high-
resolution respirometry on permeabilized muscle fibers obtained from skeletal 
muscle biopsies. In the presence of substrates alone (State 2, Figure 4A), oxygen 
flux was similar in INT and CON, although a slight but significant difference was 
observed upon malate + glutamate (MG, p = 0.010) between INT and CON. Also, the 
assessment of ADP-stimulated (State 3) respiration fueled by complex I-linked 
substrates (MO: Figure 4B, p = 0.882) did not reveal any differences between INT 
and CON. If anything, state 3 respiration upon malate + glutamate tended to be 
lower in INT vs. CON (MG: p = 0.054, Figure 4C). State 3 respiration upon parallel 
electron input into complex I and II showed no differences between INT and CON 
with the substrate combinations malate + octanoyl-carnitine + glutamate (MOG, p = 
0.753), malate + octanoyl-carnitine + glutamate + succinate (MOGS, p = 0.716), or 
malate + glutamate + succinate (MGS, p = 0.388, Figure 4D). Maximal uncoupled 
respiration (State 3U), a reflection of the maximal capacity of the electron transport 
chain, did not differ between INT and CON (p = 0.495, Figure 4E). Lastly, 
mitochondrial proton leak (State 4o) was assessed through the addition of 
oligomycin and did not differ between INT and CON (p = 0.888, Figure 4F). CytC 
responses were on average 1.32% for INT and 0.73% for CON and did not differ 
between conditions (p = 0.368). 
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Figure 4 States of mitochondrial respiration of skeletal muscle tissue obtained from older 
adults with compromised physical function administered supplemental niacin equivalents 
and placebo, each for 32 days. (A) State 2 respiration. (B) State 3 respiration under ADP 
stimulation with lipid substrates. (C) State 3 respiration with substrates focusing on Complex 
I. (D) State 3 respiration with parallel substrates focus on Complex I and II. (E) Uncoupled 
respiration under FCCP addition. (F) State 4o respiration uncoupled from ATP synthase. 
Values are represented as means ± SDs, n = 13. *P < 0.05. Abbreviations: FCCP, 
carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone; G, glutamate; M, malate; O, 




NAD+-precursor supplementation did not affect plasma substrate 
concentrations 
Plasma samples obtained on Day 29 of each research period were analyzed for the 
concentrations of glucose, insulin, FFA, and TG. Glucose concentrations did not 
differ for INT (5.87 mmol/L (5.57, 6.16) and CON (5.76 mmol/L (5.52, 6.01), p = 
0.223). Correspondingly, insulin levels were not different between INT (9.41 mU/L 
(4.18, 14.7) and CON (9.12 mU/L (5.40, 12.8), p = 0.807). Concentrations of FFA 
showed no differences between INT (496 μmol/L (397, 595) and CON (512 μmol/L 
(416, 609), p = 0.812). Lastly, plasma TG levels were not different between INT 
(0.830 mmol/L (IQR 0.675, 1.03) and CON (0.990 mmol/L (IQR 0.610, 1.43), p = 
0.266). 
 
Basal metabolic rate and exercise efficiency were not altered by NAD+-
precursor supplementation 
Basal metabolic rate and fasting RER were similar in INT and CON (p = 0.824 and p 
= 0.297, respectively, Figure 5A and B). As a result, neither carbohydrate nor lipid 
oxidation in the fasted state was different between INT and CON (p = 0.588, Figure 
5C and p = 0.787, Figure 5D, respectively). 
Besides assessment in resting conditions, substrate utilization was also determined 
during a submaximal cycling test. All participants completed the first 30 minutes of 
the cycling test, however, 6 out of 14 participants could not proceed with the cycling 
test at the set resistance and either decided to cease testing (n = 2) or required the 
resistance to be reduced (n = 4) in order to complete the remaining 30 minutes of the 
test. Therefore, we only report parameters measured in the first half-hour of the 
cycling test.  
Besides substrate utilization, also gross (GEE) and net (NEE) exercise efficiency 
were also evaluated during the submaximal cycling test. Total energy expenditure 
during cycling did not differ between INT and CON (p = 0.103, Figure 6E), nor did 
cycling RER, carbohydrate oxidation, or lipid oxidation rates differ between INT and 
CON (p = 0.366, p = 0.186, p = 0.466 respectively, Figure 6F-H). GEE did not differ 
between conditions (p = 0.419, Figure 6I). NEE (i.e. GEE corrected for the BMR,) 
was also not different between conditions (p = 0.636, Figure 6J). 
 
 
NAD+-Precursor Supplementation in Older Adults 
159 
Figure 5 Whole-body indirect calorimetry of older adults with compromised physical function 
administered supplemental niacin equivalents and placebo. (A) Basal metabolic rate and (B) 
respiratory exchange ratio, with corresponding (C) carbohydrate oxidation rate and (D) lipid 
oxidation rate. (E) Submaximal exercise energy expenditure with corresponding (F) 
respiratory exchange ratio with corresponding (G) carbohydrate and (H) lipid oxidation rates. 
(I) Gross and (J) net exercise efficiency from submaximal cycling test. Data are represented 
as means ± SDs, n = 13. Abbreviations: CO, control; INT, NAD intervention. 
 
Intrahepatic lipid content and muscle volume were not affected by NAD+-
precursor supplementation 
Intrahepatic lipid content was measured non-invasively by 1H-MRS and did not differ 
between INT (2.8% (0.8, 4.8) and CON (2.7% (1.1, 4.3), p = 0.624). Muscle volume 
of the m. vastus lateralis, assessed by MRI, was not different for INT (1700 cm3 
(1440, 1960) compared to CON (1710 cm3 (1450, 1980), n = 11, p = 0.450). 
 
NAD+-precursor supplementation did not affect blood pressure 
SBP and DBP were measured throughout each study period to evaluate the effect of 
NAD+-precursor supplementation on this parameter. Summary of the data is 
presented in Table 2. No differences were observed between INT and CON in SBP 
on Day 1 (p = 0.821), Day 15 (p = 0.741), and Day 29 (n = 12, p = 0.877). DBP did 
not differ between conditions on Day 1 (p = 0.551), Day 15 (p = 0.733), and Day 29 
(n =12, p = 0.433). Lastly, MAP was estimated from the acquired SBP and DBP 
values and was not different for INT and CON on Day 1 (p = 0.653), Day 15 (p = 




Table 2 Blood pressure in older adults with compromised physical function 
administered supplemental niacin equivalents and placebo, each for 32 days. 
 Intervention Control P-value 
SBP 
(mmHg) 
   





















   





















   



















Values are presented as means (95% CIs), n = 13 or 12 (Day 29). 
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SPPB performance did not improve under NAD+-precursor supplementation 
The SPPB was used as a clinical measure of physical functioning. Scores for the 
balance test, the walking speed, and the chair-rise test were similar in INT and CON 
(p > 0.999, p = 0.500, and p = 0.489, respectively). The overall score on the SPPB 
was also not different between INT (11.0 (IQR 10.00, 11.5) and CON (11.0 (IQR 
9.50, 12.0), p > 0.999). 
 
Perceived physical functioning was positively influenced by NAD+-precursor 
supplementation 
The RAND-36 Health Survey 1.0 questionnaire was used as a measure of perceived 
health status. Although measured physical functioning was unaffected by NAD+-
precursor supplementation, significantly higher scores were observed for the 
perceived physical functioning domain in INT (92.0 (IQR 90.0, 100) as compared to 
CON (90.0 (IQR 86.3, 93.8), n = 12, p = 0.031, Figure 6). However, the other 8 out of 
9 domains of the RAND-36 did not show any differences between INT and CON on 
Day 29 (p ≥ 0.05, Figure 6).  
  
 
Figure 6 RAND-36 Health Survey 1.0 questionnaire of older adults with compromised 
physical function administered supplemental niacin equivalents and placebo over 8 domains 
on Day 29. All domains can be scored between 0 and 100, with higher scores being better. 





Mitochondrial dysfunction is an established hallmark of aging and together with 
declining NAD+ levels, these factors are thought to drive the age-dependent decline 
in skeletal muscle physical function. Here, we hypothesized that supplementation 
with the NAD+-precursors L-Trp, NA, and NAM, in a dose that could be achieved 
through increased dietary intake, would improve mitochondrial oxidative capacity in 
community-dwelling, older adults with impaired physical function. We tested this 
hypothesis by conducting a double-blind, randomized, controlled, cross-over trial 
with detailed metabolic phenotyping. We show that supplementing with L-Trp, NA, 
and NAM does elevate MeNAM concentrations in skeletal muscle tissue, but in 
discordance with our hypothesis, we found no improvement in mitochondrial 
respiration capacity in older adults with an impaired physical function. 
 
In the current study, we did not observe an improvement in mitochondrial respiratory 
capacity in skeletal muscle under NAD+-precursor supplementation compared to the 
control condition. We have previously shown that the NAD+-precursor acipimox was 
able to improve mitochondrial function in type 2 diabetes patients (44). However, the 
lack of effect of NAD+-precursor supplementation in the current study is in 
accordance with similar recent observations with NR supplementation in obese 
individuals (45, 46) and in older adults (22), and extends this observation to 
physically compromised older adults. Along the same lines, SPPB performance, 
energy expenditure, substrate utilization, and exercise efficiency were all unaffected 
by NAD+-precursor supplementation. These findings are in agreement with Martens 
et al. (19), who investigated the effect of NR supplementation in healthy, lean, 
middle-aged to older adults on parameters of physical function such as resting 
energy expenditure, maximum aerobic capacity, and body composition, and found 
no differences between NR and placebo. In accordance, Elhassan et al. (22) showed 
that three weeks of NR supplementation does not increase handgrip strength in older 
adults. In contrast to our previous finding that NR supplementation resulted in a 
minor but significant reduction in fat mass in middle-aged obese humans (45), we did 
not find any effect on body composition upon NAD+-precursor supplementation in the 
current study. Also, muscle volume was similar in both conditions. Interestingly, 
although no improvements in physical function were detected upon NAD+-precursor 
supplementation, perceived physical function was improved upon NAD+. Possibly, 
NAD+-Precursor Supplementation in Older Adults 
163 
subtle changes in physical function did occur, which were not detected by our 
outcome parameters. However, given the small number of volunteers in our study 
and the fact that this conclusion was based on one out of 9 domains of the RAND-36 
survey, one should be cautious in interpreting this result. Future studies should 
determine both perceived versus actual physical function in (NAD+) supplementation 
studies.    
 
Blood pressure has also been reported to be susceptible to NAD+-precursor 
supplementation in humans (19). However, we did not observe a change in SBP, 
DBP, or MAP under NAD+-precursor supplementation. This is in agreement with our 
previous NR supplementation study in healthy obese humans, which revealed no 
improvements in SBP, DBP, or MAP by performing 36-hour blood pressure 
measurements (45). These data, however, conflict with previous findings from 
Martens et al. (19) showing improvements in SBP and DBP in healthy middle-aged 
to older adults following 6 weeks of NR supplementation, which may be explained by 
discrepancies in the methodologies used to measure blood pressure, such as the 
higher dose used and duration of the supplementation. 
Several studies have demonstrated the ability of NAD+-precursor supplementation to 
reduce IHL content in mice (47-49). Moreover, Dollerup et al. (21) have reported the 
tendency for IHL content to decline in obese humans following 12 weeks of NR 
supplementation. Although this observation did not reach statistical significance, the 
majority of the NR supplemented group (13 out of 20 participants) had an IHL 
content greater than 5% prior to supplementation, and 9 out of these 13 individuals 
had reduced IHL content after supplementation. Here, we did not observe a 
beneficial effect of NAD+-precursor supplementation on IHL content. This is possibly 
due to the already low IHL content in our cohort, with only two participants displaying 
IHL contents greater than 5%, which is representative of non-alcoholic fatty liver 
disease (NAFLD) (50), thereby limiting the potential for a reduction in IHL content.  
 
It was previously shown that aging is associated with reduced intracellular NAD+ 
levels in skeletal muscle in humans (14, 15). It is now generally accepted that NAD+ 
metabolism is a main pathway in the regulation of mitochondrial function in skeletal 
muscle and would be a target for intervention to stimulate mitochondrial function and 




et al. have shown that a titration protocol of 250 mg/day to 1000/day mg of niacin 
over 4 weeks is able to rescue mitochondrial respiration in adult-onset mitochondrial 
myopathy patients (51), demonstrating the potential and efficacy of NAD+-precursor 
supplementation in humans with pre-existent conditions. Notably, the window of 
opportunity for NAD+-precursor supplementation in this population with niacin 
deficiency by far exceeds the possibilities in populations who are not niacin deficient. 
Here, we studied a group of community-dwelling, older adults with an impaired 
physical function and, in measuring the NAD+ levels in skeletal muscle tissue, we 
found that NAD+ concentrations in skeletal muscle remained unaffected upon 
supplementation. We supplemented with three separate NAD+-precursors, being L-
Trp, NA, and NAM, aiming to take advantage of their respective pathways to 
contribute to the overall NAD+ pool, as illustrated in Figure 2. It has previously been 
shown that NAM supplementation to cells and mice leads to extended lifespan and 
healthspan, respectively (52, 53). Furthermore, NAM supplementation has been 
shown to improve glucose metabolism in a rodent model of obesity and type 2 
diabetes (54). Recently, de novo biosynthesis of NAD+ from L-Trp has received more 
attention as a viable dietary source of NAD+ (25). Katsyuba et al. demonstrated that 
upon the inhibition of the α-amino-β-carboxymuconate-ε-semialdehyde 
decarboxylase (ACMSD) enzyme in liver and kidney, the conversion of L-Trp to 
NAD+ has the potential to induce SIRT1 activation and, thereby, improve 
mitochondrial function (25). Here, we did not observe an increase in metabolites 
belonging to the kynurenine pathway from L-Trp to QA and subsequently to NAAD, a 
suggested sensitive biomarker of NAD+-precursor supplementation efficacy (55). It is 
possible that the majority of the L-Trp ingested was consumed by the ACSMD 
enzyme instead of allowing for spontaneous cyclisation of ACSM into QA and further 
enzymatic conversion to NAAD and ultimately NAD+. However, this remains 
speculative, as this can only be investigated by acquiring liver tissue, which we have 
not done in this study. Therefore, more human studies are needed to examine the 
effects of L-Trp and NAM, given at higher doses, on metabolic health outcomes. 
 
Moreover, we opted to use a low dose of 4 mg of NA daily in order to limit the 
occurrence of flushing due to its vasoactive properties (56). NAAD is the point of 
convergence for L-Trp and NA metabolism towards NAD+ synthesis. However, 
NAAD concentrations did not increase in skeletal muscle, suggesting either an 
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insufficient dose or the preference of skeletal muscle tissue for another NAD+-
precursor. Additionally, Liu et al. have shown through isotope-tracer methodology 
that L-Trp, NA, and NAM are the predominant physiological circulatory NAD+-
precursors (57). Labeling of L-Trp and NA showed that these precursors are 
converted to NAD+ in the liver and subsequently excreted into the circulation as 
NAM, and that NAM exchange from the circulation to skeletal muscle tissue is slow, 
in addition to skeletal muscle tissue exhibiting a low turnover rate of NAD+ (57). This 
may possibly explain why we did not observe an increase in NAM in skeletal muscle 
tissue in this study, or any other metabolite of the NAD+-precursors used in our 
supplementation protocol. Herein, our results contrast with observations of 
increasing NAAD in skeletal muscle made by us and others previously when 
supplementing with high doses of NR in obese (45) and aged individuals (22), 
suggesting that NAAD may be a sensitive, yet specific biomarker for NR 
supplementation efficacy. 
The concentrations of NAD+ in skeletal muscle tissue observed in both conditions of 
the current study appear to be comparable to concentrations found previously by us 
in a group of healthy, middle-aged, obese individuals supplemented with 1000 
mg/day of NR, and demonstrating unresponsive NAD+ levels to NR supplementation 
compared to placebo (20). This raises the question whether NAD+ levels per se are 
determinants of efficacy of NAD+-precursor supplementation, or that fluxes of NAD+ 
are more reliable measures of efficacy. We found that the NAD+ concentrations in 
skeletal muscle tissue were unresponsive to supplementation under differing 
supplementation strategies in two different populations (the present study and (20)) 
and observed increased levels of MeNAM in both studies. This observation is also in 
line with the observations of Elhassan et al. (22) in NR supplemented older adults 
showing increased MeNAM levels in skeletal muscle, admit unchanged NAD+ 
concentrations. From the above, one could speculate that the concentration of NAD+ 
in skeletal muscle tissue is likely to be near the homeostatic maximum in humans in 
the absence of disease or niacin deficiency, as illustrated by the study of Pirinen et 
al. (51). This has also been proposed in the ‘second hit’ theory by Elhassan et al. 
(22), in which NAD+ levels may only decline if chronological age is struck by a 
second trigger leading to metabolic stress, such as physical inactivity or (chronic) 
disease. In accordance with this reasoning, we previously showed that 




mitochondrial respiration capacity in individuals with T2DM, who are characterized 
by a relatively low mitochondrial capacity compared to BMI-matched healthy controls 
(44).  From the above, it could be concluded that there is potential little room for 
improvement in skeletal muscle NAD+ levels in healthy individuals through 
supplementation with NAD+-precursors, with as a consequence, little or no effect on 
downstream targets such as mitochondrial function, such as observed in the current 
study. 
 
We acknowledge that this study is susceptible to limitations. The participants may 
represent the ‘cream of the crop’ in terms of older adults with an impaired physical 
function. As per the 6MWT distances recorded during the screening, the average 
walking speed in this cohort is 1.09 m/s, fitting of a healthy older (58) and prefrail 
population (59). Although individual 6MWT performance met our inclusion criterium, 
performance on the maximal cycling test yielded a larger variation in overall 
maximum cycling performance leading to a more heterogeneous cohort than 
expected. Walking performance is a good predictor of physical function and frailty, 
co-morbidity, and death (58), but it is hard to distinguish whether walking 
performance is limited by muscle function or may be limited by other health 
problems; i.e. a decreased walking performance does not necessarily have to 
translate to a reduced cycling performance, as joint issues could be the limiting 
factor and may be less prominent during cycling compared to walking. Secondly, the 
selected dose of 207.5 mg/day NE (niacin equivalents), although being 12-15 times 
the RDA for vitamin B-3, may be insufficient to elevate NAD+ levels in humans. The 
recommended daily allowance (RDA) of niacin for adult humans is set at 16 mg NE  
for males and 14 mg for females (17). However, no guidelines exist for older adults 
specifically. To date, only a small number of studies have looked into the NAD+ 
boosting ability of lower doses of NAD+-precursors in humans (23, 24), and found 
that doses of 100 mg/day, 250 mg/day, and 300 mg/day NE are able to increase 
plasma NAD+ metabolite levels over baseline, such as NAM and MeNAM. However, 
these studies did not investigate intracellular levels in target tissues such as skeletal 
muscle. Here, we have supplemented older adults with 207.5 mg NE per day, a level 
of supplementation emulating increased dietary intake, and show that this is 
insufficient to increase levels of NAD+ and its metabolites in skeletal muscle tissue 
but does increase skeletal muscle MeNAM levels, suggesting an increase in skeletal 
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muscle NAD+ metabolism. Further, the duration of the intervention was set at 32 
days, which may be relatively short for health benefits to surface. However, we have 
shown that 30 days of resveratrol supplementation in obese individuals improves 
mitochondrial respiration capacity (28), supporting the notion that short-term 
interventions can positively affect human metabolism. Lastly, we cannot exclude that 
the sample size of the study was too small, although we have previously shown with 
a similar cross-over design and the methodology used that differences upon 
nutritional supplementation can be observed with similar sample size. Also, the 
chance of making a type I error due to testing of multiple study outcomes cannot be 
excluded. 
 
In summary, we investigated the efficacy of NAD+-precursor supplementation on 
mitochondrial function aiming to combat the age-dependent decline in skeletal 
muscle function. We show in community-dwelling, older adults with impaired physical 
function that of L-Trp, NA, and NAM did increase MeNAM levels in skeletal muscle 
tissue but did not improve mitochondrial function and skeletal muscle function. 
Notwithstanding, further research is merited to elucidate the full potential of NAD+-
precursor supplementation in specific groups with more prominent metabolic 
dysfunction, such as (morbidly) obese and T2DM individuals. Future studies must 
also tailor their interventions towards the tissues targeted, optimizing delivery, and 





This work was supported by the Top Institute Food and Nutrition (TIFN) research 
program Mitochondrial Health under grant number 16NH01. 
 
Duality of interest 




N.J.C., L.G., J.d.V., R.H., J.G., B.H., J.H., and P.S. designed research; N.J.C., L.G., 
C.E.F., and Y.M.H.B. performed research; N.J.C., E.K.M., Y.M.H.B., V.B.S.H., B.H., 
R.Z.P., R.H.H., J.H., and P.S. analyzed samples and data. N.J.C., J.H., and P.S. 
wrote the manuscript and all authors critically reviewed the manuscript. P.S. is the 
guarantor of this work and, as such, had full access to all the data in the study and 
takes responsibility for the integrity of the data and the accuracy of the data analysis. 
P.S. is the corresponding author of this work. All authors approved the version to be 
published. 
NAD+-Precursor Supplementation in Older Adults 
169 
 REFERENCES 
1. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of 
aging. Cell 2013;153(6):1194-217. doi: 10.1016/j.cell.2013.05.039. 
2. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr 2000;54 
Suppl 3:S40-7. 
3. Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S. Skeletal muscle 
mitochondrial energetic efficiency and aging. Int J Mol Sci 2015;16(5):10674-85. doi: 
10.3390/ijms160510674. 
4. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, 
Teodoro JS, Wrann CD, Hubbard BP, et al. Declining NAD(+) induces a 
pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. 
Cell 2013;155(7):1624-38. doi: 10.1016/j.cell.2013.11.037. 
5. Conley KE, Jubrias SA, Esselman PC. Oxidative capacity and ageing in human 
muscle. J Physiol 2000;526 Pt 1:203-10. doi: 10.1111/j.1469-7793.2000.t01-1-
00203.x. 
6. Kim Y, Triolo M, Hood DA. Impact of Aging and Exercise on Mitochondrial Quality 
Control in Skeletal Muscle. Oxid Med Cell Longev 2017;2017:3165396. doi: 
10.1155/2017/3165396. 
7. Andreux PA, Houtkooper RH, Auwerx J. Pharmacological approaches to restore 
mitochondrial function. Nat Rev Drug Discov 2013;12(6):465-83. doi: 
10.1038/nrd4023. 
8. Camacho-Pereira J, Tarrago MG, Chini CCS, Nin V, Escande C, Warner GM, 
Puranik AS, Schoon RA, Reid JM, Galina A, et al. CD38 Dictates Age-Related NAD 
Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. 
Cell Metab 2016;23(6):1127-39. doi: 10.1016/j.cmet.2016.05.006. 
9. Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. In vivo NAD assay reveals the 
intracellular NAD contents and redox state in healthy human brain and their age 
dependences. Proceedings of the National Academy of Sciences of the United 
States of America 2015;112(9):2876-81. doi: 10.1073/pnas.1417921112. 
10. Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) 
intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. 
Cell Metab 2011;14(4):528-36. doi: 10.1016/j.cmet.2011.08.014. 
11. Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud 
ME, Apte RS, Uchida K, et al. Long-Term Administration of Nicotinamide 
Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab 
2016;24(6):795-806. doi: 10.1016/j.cmet.2016.09.013. 
12. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and 
healthspan. Nat Rev Mol Cell Biol 2012;13(4):225-38. doi: 10.1038/nrm3293. 
13. Canto C, Auwerx J. Targeting sirtuin 1 to improve metabolism: all you need is 
NAD(+)? Pharmacol Rev 2012;64(1):166-87. doi: 10.1124/pr.110.003905. 
14. de Guia RM, Agerholm M, Nielsen TS, Consitt LA, Sogaard D, Helge JW, Larsen S, 
Brandauer J, Houmard JA, Treebak JT. Aerobic and resistance exercise training 
reverses age-dependent decline in NAD(+) salvage capacity in human skeletal 
muscle. Physiol Rep 2019;7(12):e14139. doi: 10.14814/phy2.14139. 
15. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated 
changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One 
2012;7(7):e42357. doi: 10.1371/journal.pone.0042357. 
Chapter 5 
170  
16. Mouchiroud L, Houtkooper RH, Auwerx J. NAD(+) metabolism: a therapeutic target 
for age-related metabolic disease. Crit Rev Biochem Mol Biol 2013;48(4):397-408. 
doi: 10.3109/10409238.2013.789479. 
17. Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a 
molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 
2008;28:115-30. doi: 10.1146/annurev.nutr.28.061807.155443. 
18. Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, D'Amico D, Ropelle ER, Lutolf 
MP, Aebersold R, et al. NAD(+) repletion improves mitochondrial and stem cell 
function and enhances life span in mice. Science 2016;352(6292):1436-43. doi: 
10.1126/science.aaf2693. 
19. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, 
Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-
tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat Commun 
2018;9(1):1286. doi: 10.1038/s41467-018-03421-7. 
20. Remie CME, Roumans KHM, Moonen MPB, Connell NJ, Havekes B, Mevenkamp J, 
Lindeboom L, de Wit VHW, van de Weijer T, Aarts S, et al. Nicotinamide riboside 
supplementation alters body composition and skeletal muscle acetylcarnitine 
concentrations in healthy obese humans. Am J Clin Nutr 2020. doi: 
10.1093/ajcn/nqaa072. 
21. Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, Stodkilde-
Jorgensen H, Moller N, Brenner C, Treebak JT, et al. A randomized placebo-
controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-
sensitivity, and lipid-mobilizing effects. Am J Clin Nutr 2018;108(2):343-53. doi: 
10.1093/ajcn/nqy132. 
22. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright 
DM, Oakey L, Burley CV, Jenkinson N, et al. Nicotinamide Riboside Augments the 
Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and 
Anti-inflammatory Signatures. Cell Rep 2019;28(7):1717-28 e6. doi: 
10.1016/j.celrep.2019.07.043. 
23. Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, 
Shigaki S, Ono T, Yukioka H, et al. Effect of oral administration of nicotinamide 
mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy 
Japanese men. Endocr J 2020;67(2):153-60. doi: 10.1507/endocrj.EJ19-0313. 
24. Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration 
of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, 
Placebo-controlled Clinical Trial of Healthy Overweight Adults. Sci Rep 
2019;9(1):9772. doi: 10.1038/s41598-019-46120-z. 
25. Katsyuba E, Mottis A, Zietak M, De Franco F, van der Velpen V, Gariani K, Ryu D, 
Cialabrini L, Matilainen O, Liscio P, et al. De novo NAD(+) synthesis enhances 
mitochondrial function and improves health. Nature 2018;563(7731):354-9. doi: 
10.1038/s41586-018-0645-6. 
26. Grootswagers P, Mensink M, Berendsen AAM, Deen CPJ, Kema IP, Bakker SJL, 
Santoro A, Franceschi C, Meunier N, Malpuech-Brugere C, et al. Vitamin B-6 intake 
is related to physical performance in European older adults: results of the New 
Dietary Strategies Addressing the Specific Needs of the Elderly Population for 
Healthy Aging in Europe (NU-AGE) study. Am J Clin Nutr 2021. doi: 
10.1093/ajcn/nqaa368. 
NAD+-Precursor Supplementation in Older Adults 
171 
27. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of 
habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36(5):936-
42. doi: 10.1093/ajcn/36.5.936. 
28. de Ligt M, Bruls YMH, Hansen J, Habets MF, Havekes B, Nascimento EBM, 
Moonen-Kornips E, Schaart G, Schrauwen-Hinderling VB, van Marken Lichtenbelt W, 
et al. Resveratrol improves ex vivo mitochondrial function but does not affect insulin 
sensitivity or brown adipose tissue in first degree relatives of patients with type 2 
diabetes. Mol Metab 2018;12:39-47. doi: 10.1016/j.molmet.2018.04.004. 
29. Edtion ed. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, 
Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington (DC), 1998. 
30. Fukuwatari T, Shibata K. Nutritional aspect of tryptophan metabolism. Int J 
Tryptophan Res 2013;6(Suppl 1):3-8. doi: 10.4137/IJTR.S11588. 
31. Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G. Variability of 
aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 
1985;6(4):197-201. doi: 10.1055/s-2008-1025839. 
32. VanderZee KI, Sanderman R, Heyink JW, de Haes H. Psychometric qualities of the 
RAND 36-Item Health Survey 1.0: a multidimensional measure of general health 
status. Int J Behav Med 1996;3(2):104-22. doi: 10.1207/s15327558ijbm0302_2. 
33. VanderZee KI, Sanderman R. Het meten van de algemene gezondheidstoestand met 
de RAND-36, een handleiding. UMGC / Rijksuniversiteit Groningen, Research 
Institute SHARE 2012;Tweede herziene druk. 
34. Lindeboom L, Nabuurs CI, Hesselink MK, Wildberger JE, Schrauwen P, Schrauwen-
Hinderling VB. Proton magnetic resonance spectroscopy reveals increased hepatic 
lipid content after a single high-fat meal with no additional modulation by added 
protein. Am J Clin Nutr 2015;101(1):65-71. doi: 10.3945/ajcn.114.094730. 
35. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr 
PA, Wallace RB. A short physical performance battery assessing lower extremity 
function: association with self-reported disability and prediction of mortality and 
nursing home admission. Journal of gerontology 1994;49(2):M85-94. 
36. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and 
clinical research. Scand J Clin Lab Invest 1975;35(7):609-16. 
37. Hoeks J, van Herpen NA, Mensink M, Moonen-Kornips E, van Beurden D, Hesselink 
MK, Schrauwen P. Prolonged fasting identifies skeletal muscle mitochondrial 
dysfunction as consequence rather than cause of human insulin resistance. Diabetes 
2010;59(9):2117-25. doi: 10.2337/db10-0519. 
38. Phielix E, Meex R, Ouwens DM, Sparks L, Hoeks J, Schaart G, Moonen-Kornips E, 
Hesselink MK, Schrauwen P. High oxidative capacity due to chronic exercise training 
attenuates lipid-induced insulin resistance. Diabetes 2012;61(10):2472-8. doi: 
10.2337/db11-1832. 
39. Weir JB. New methods for calculating metabolic rate with special reference to protein 
metabolism. J Physiol 1949;109(1-2):1-9. 
40. Matomaki P, Linnamo V, Kyrolainen H. A Comparison of Methodological Approaches 
to Measuring Cycling Mechanical Efficiency. Sports Med Open 2019;5(1):23. doi: 
10.1186/s40798-019-0196-x. 
41. van Vlies N, Tian L, Overmars H, Bootsma AH, Kulik W, Wanders RJ, Wood PA, Vaz 
FM. Characterization of carnitine and fatty acid metabolism in the long-chain acyl-




42. Kato T, Berger SJ, Carter JA, Lowry OH. An enzymatic cycling method for 
nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases. Anal 
Biochem 1973;53(1):86-97. doi: 10.1016/0003-2697(73)90409-0. 
43. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, 
Hoeks J, van der Krieken S, Ryu D, Kersten S, et al. Calorie restriction-like effects of 
30 days of resveratrol supplementation on energy metabolism and metabolic profile 
in obese humans. Cell Metab 2011;14:612-22. 
44. van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, 
Livingstone R, Nowotny P, Sparks LM, Paglialunga S, et al. Evidence for a direct 
effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. 
Diabetes 2015;64(4):1193-201. doi: 10.2337/db14-0667. 
45. Remie CM, Roumans KH, Moonen MP, Connell NJ, Havekes B, Mevenkamp J, 
Lindeboom L, de Wit VH, van de Weijer T, Aarts SA. Nicotinamide riboside 
supplementation alters body composition and skeletal muscle acetylcarnitine 
concentrations in healthy obese humans. The American Journal of Clinical Nutrition 
2020. 
46. Dollerup OL, Chubanava S, Agerholm M, Sondergard SD, Altintas A, Moller AB, 
Hoyer KF, Ringgaard S, Stodkilde-Jorgensen H, Lavery GG, et al. Nicotinamide 
riboside does not alter mitochondrial respiration, content or morphology in skeletal 
muscle from obese and insulin-resistant men. J Physiol 2020;598(4):731-54. doi: 
10.1113/JP278752. 
47. Zhou CC, Yang X, Hua X, Liu J, Fan MB, Li GQ, Song J, Xu TY, Li ZY, Guan YF, et 
al. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver 
disease in ageing. Br J Pharmacol 2016;173(15):2352-68. doi: 10.1111/bph.13513. 
48. Gariani K, Menzies KJ, Ryu D, Wegner CJ, Wang X, Ropelle ER, Moullan N, Zhang 
H, Perino A, Lemos V, et al. Eliciting the mitochondrial unfolded protein response by 
nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. 
Hepatology 2016;63(4):1190-204. doi: 10.1002/hep.28245. 
49. Trammell SA, Weidemann BJ, Chadda A, Yorek MS, Holmes A, Coppey LJ, Obrosov 
A, Kardon RH, Yorek MA, Brenner C. Nicotinamide Riboside Opposes Type 2 
Diabetes and Neuropathy in Mice. Sci Rep 2016;6:26933. doi: 10.1038/srep26933. 
50. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-
alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, 
dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013;5(5):1544-
60. doi: 10.3390/nu5051544. 
51. Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, Hakkarainen A, 
Kuula J, Heinonen U, Schmidt MS, et al. Niacin Cures Systemic NAD(+) Deficiency 
and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell 
Metab 2020;31(6):1078-90 e5. doi: 10.1016/j.cmet.2020.04.008. 
52. Lim CS, Potts M, Helm RF. Nicotinamide extends the replicative life span of primary 
human cells. Mech Ageing Dev 2006;127(6):511-4. doi: 10.1016/j.mad.2006.02.001. 
53. Mitchell SJ, Bernier M, Aon MA, Cortassa S, Kim EY, Fang EF, Palacios HH, Ali A, 
Navas-Enamorado I, Di Francesco A, et al. Nicotinamide Improves Aspects of 
Healthspan, but Not Lifespan, in Mice. Cell Metab 2018;27(3):667-76 e4. doi: 
10.1016/j.cmet.2018.02.001. 
54. Yang SJ, Choi JM, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. 
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin 
NAD+-Precursor Supplementation in Older Adults 
173 
pathway in a rodent model of obesity and type 2 diabetes. J Nutr Biochem 
2014;25(1):66-72. doi: 10.1016/j.jnutbio.2013.09.004. 
55. Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li 
Z, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally 
bioavailable in mice and humans. Nat Commun 2016;7:12948. doi: 
10.1038/ncomms12948. 
56. Benyo Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced 
flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol 
2006;70(6):1844-9. doi: 10.1124/mol.106.030833. 
57. Liu L, Su X, Quinn WJ, 3rd, Hui S, Krukenberg K, Frederick DW, Redpath P, Zhan L, 
Chellappa K, White E, et al. Quantitative Analysis of NAD Synthesis-Breakdown 
Fluxes. Cell Metab 2018;27(5):1067-80 e5. doi: 10.1016/j.cmet.2018.03.018. 
58. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari 
M, Donini LM, Gillette Guyonnet S, Inzitari M, et al. Gait speed at usual pace as a 
predictor of adverse outcomes in community-dwelling older people an International 
Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 
2009;13(10):881-9. doi: 10.1007/s12603-009-0246-z. 
59. Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman 
AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, et al. Allogeneic Mesenchymal 
Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-





Type II muscle fi bre properties are not associated with balance 
recovery following large perturbations during walking
 in young and older adults
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Falls among older adults are often attributed to declining muscle strength with 
ageing. Associations between muscle strength and balance control have been 
reported, but the evidence for, and key mechanisms of resistance exercise in fall 
prevention are unclear. No studies have directly examined the relationship between 
muscle fibre characteristics and reactive balance control. Here, we address whether 
or not Type II muscle fibre characteristics associate with reactive balance during 
walking in young and older adults with varying muscle fibre type composition. We 
analyse muscle biopsy-derived fibre characteristics and stability during a treadmill-
based walking perturbation (trip-like) task of healthy young adults, healthy, normally 
active older adults, trained older adults and physically impaired older adults. We find 
no significant associations between Type II muscle fibre properties and reactive 
balance during walking, indicating that practitioners and researchers should consider 
more than just the muscle tissue properties when assessing and intervening on fall 
risk. 
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INTRODUCTION 
Loss of muscle mass in humans after the age of 50 years is largely attributable to 
declines in lower body muscle mass [1], which has implications for mobility in older 
age. Specifically, the leg extensor muscle-tendon groups critical for gait [2-4] show 
reduced muscle strength and altered tendon mechanical properties in older, 
compared to younger adults [5-8]. Lower limb muscle strength [9-12], power 
[11,13,14] and quality [15,16] have been associated with daily life falls incidence in 
older adults, although findings are not unequivocal [12,13,17]. The majority of falls in 
community-dwelling older adults occur following large balance disturbances (like 
trips and slips) during walking [18-25]. Small to moderate associations have been 
reported between lower limb muscle strength and balance recovery performance 
following laboratory-based lean-and-release [26-30], trip [31-34] and slip [35,36] 
perturbations simulating common causes of falls. Regarding interventions, there is 
weak or mixed evidence that general strength training alone can improve balance 
[37-39] and reduce falls [40], and whether a direct cause-effect relationship between 
muscle strength and balance performance exists has been questioned [41]. 
The loss in muscle strength and function with increasing age may occur due to 
muscle fibre atrophy and muscle fibre loss [42-45]. Age-related decline in muscle 
mass seems to be primarily attributable to an atrophy of specifically Type II muscle 
fibres [46-51]. Older age is also associated with a change in the expression of 
myosin heavy chain isoforms (MHC) in favor of slow MHC I, reflecting the shift 
towards a slower fibre type profile (Type I) and the selective atrophy of Type II fibres 
[51-53]. One study on older female participants with and without hip fractures 
reported that age and hip fracture history had significant individual and accumulating 
effects on Type II muscle fibre size (decreasing with age and fall-related hip fracture) 
[46]. Encouragingly, physical activity may prevent or slow this age-related atrophy of 
Type II fibres [49] and it has been reported that increases in muscle mass as a result 
of resistance exercise in old age is attributable to hypertrophy of Type II fibres 
specifically (and almost exclusively)[48]. In contrast, in endurance-trained older 
adults, greater proportions of Type I fibres have been observed when compared to 




Together, these data suggest that muscle fibre characteristics are an important 
factor in balance performance and falls. Despite this, there are no studies, to our 
knowledge, directly examining the relationship between muscle fibre characteristics 
and reactive balance control in the literature. In this study, we address for the first 
time whether or not Type II muscle fibre characteristics associate with reactive 
balance during walking in young and older adults with varying muscle fibre type 
composition. To do this, we analyse muscle biopsy-derived fibre characteristics and 
stability during a treadmill-based gait perturbation task of healthy young adults, 
healthy, normally active older adults, trained older adults and physically impaired 
older adults. Based on previous studies, we hypothesised that there would be a 
small to moderate relationship between Type II muscle fibre characteristics (size and 
proportion) and stability recovery following large perturbations during walking 
(number of recovery steps needed following a novel perturbation). We additionally 
explored these relationships after repeated perturbations to examine the potential 





The data and analyses in the current secondary analysis were part of a larger study 
(n=59; chapter 3), which was approved by the institutional Medical Ethical 
Committee, conducted in accordance with the declaration of Helsinki and registered 
at clinicaltrials.gov (NCT03666013). All participants provided their written informed 
consent. Some data have been reported in our previous publication addressing 
different research questions (chapter 3). For the current secondary analysis, the 
data of all participants who underwent muscle biopsies and completed the walking 
perturbation experiment in the larger study were included. This resulted in a sample 
of 52 participants including 14 young (7 male and 7 female) and 38 older (22 male 
and 16 female) individuals. Due to this being a secondary analysis, no formal power 
calculation was conducted to determine the sample size. However, sample sizes of 
46 and 47 will achieve approximately 80% power with a significance level of 0.05 to 
detect Pearson and Spearman Correlation Coefficients of 0.4, which we consider 
reasonable for the purpose of the current analysis. 
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Prior to inclusion, all participants underwent a medical screening that included a 
medical questionnaire, a physical examination by a physician, and an assessment of 
physical function by means of a Short Physical Performance Battery [57]. After 
screening, participants were assigned to the following groups: Young individuals with 
normal physical activity (Y, 20 – 30 years), older adults with normal physical activity 
(O, 65 – 80 years), trained older adults (TO, 65 – 80 years) and older adults with 
impaired physical function (IO, 65 – 80 years). Participants were considered normally 
physically active if they completed no more than one structured exercise session per 
week, whereas participants were considered trained if they engaged in at least 3 
structured exercise sessions of at least 1 hour each per week for an uninterrupted 
period of at least one year. Participants were classified as older adults with impaired 
physical function (IO) in case of an SPPB score of ≤ 9.  
 
Body Composition and Muscle Volume 
Body composition (fat and fat-free mass) was determined at 8 AM after an overnight 
fast from 10 PM the previous evening using air displacement plethysmography 
(BodPod®, COSMED, Inc., Rome, Italy) [58]. To measure muscle volume, a 3T 
whole body MRI scanner was used (Achieva 3T-X; Philips Healthcare, Best, The 
Netherlands). Participants were positioned in the supine position in the MR scanner 
(feet first) to determine muscle volume of the upper leg using the body coil. 
Subsequently, a series of T1-weighted images were acquired of the upper leg (slice 
thickness of 10mm, no gap between slices, in‐plane resolution of 0.78 x 0.78mm). A 
custom-written MATLAB script was used to automatically segment adipose and 
muscle tissue. Thereby each image was normalised, and a histogram calculated. 
Histogram peaks corresponding to muscle tissue grey values were summed up, 
resulting in the count of muscle pixels. Muscle volume was calculated by voxel size 
times the number of muscle pixels: Vol_muscle =Vox_size*N_muscle pixels. Every 
slice was reviewed individually and in case of a clear notable deviation, a manual 
threshold correction for muscle grey values was performed. The muscle 
segmentation was performed in the consecutive slices between the starting point 




Habitual physical activity 
Habitual physical activity was estimated using an ActivPAL activity monitor (PAL 
Technologies, Glasgow, Scotland) for five consecutive days, including two weekend 
days. The total amount of steps per day was measured, as well as the total stepping 
time in proportion to waking time, determined according to van der Berg et al. [59]. 
Stepping time (i. e., physical activity) was then further classified into high-intensity 
physical activity (HPA; minutes with a step frequency >110 steps/min in proportion to 
waking time) [60].  
 
Muscle Strength  
Maximum voluntary knee extension and flexion torque was measured using the 
Biodex System 3 Pro dynamometer (Biodex® Medical Systems, Inc., Shirley, NY, 
USA). Participants were stabilized with shoulder, leg, and abdominal straps to 
prevent compensatory movement and the test was performed with the left leg in all 
participants. Participants performed three 5s maximal extensions and flexions with a 
30s rest period in between trials. The knee position was fixed at a 70° angle. 
Maximal voluntary isometric knee-extensor and knee-flexor torque was defined as 
the average of the highest two out of three peak torques.   
Participants also performed 30 consecutive extension and flexion movements (range 
of motion 120 degrees/s). The peak torque of each extension and flexion was 
recorded and the maxima were defined as the highest peak. For both protocols, 
maximal torque was recorded in Newton-meters and corrected for bodyweight 
(Nm/kg). 
 
Muscle Biopsy and Fibre Typing 
A biopsy specimen was taken from the vastus lateralis muscle under local 
anesthesia (1.0% lidocaine without epinephrine), according to the Bergström method 
[61]. Muscle tissue was immediately frozen in melting isopentane cooled with liquid 
nitrogen for immunohistochemistry and stored at -80°C degrees until analysis. Fresh 
5µm-thick cryosections were treated for five minutes with 0.25% Triton X-100 in 
phosphate-buffered saline and incubated for 45 minutes at room temperature with a 
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mouse monoclonal MHC1-antibody (A.4840; Developmental Studies Hybridoma 
Bank, Iowa City, IO) and with the basal membrane marker laminin (L9393; Sigma, 
Zwijndrecht, The Netherlands). Thereafter, sections were incubated for 45 minutes 
with the appropriate secondary antibodies goat anti-mouse IgM 
AlexaFluor488 (A21042; Invitrogen Thermo Fisher, Breda, The Netherlands) and 
goat anti-rabbit IgG AlexaFluor555 (A21428; Invitrogen Thermo Fisher) and mounted 
with Mowiol. All sections were captured using a Nikon E800 fluorescence 
microscope (Nikon Instruments, Amsterdam, The Netherlands [62]) and images were 
analyzed in ImageJ [63]. Cell membranes were background corrected and threshold 
was set manually to create a binary image. Subsequently, the original cell membrane 
image (laminin staining) was added to the binary image of the cell membranes to 
check whether all cell membranes in the binary image were closed. If not, cell 
membranes were closed manually. Fibre size was determined by measuring the 
cross-sectional area (CSA) and fibre type distribution was expressed as a 
percentage with respect to the number of fibres and as a percentage of CSA (% fibre 
type I/II area relative to total CSA).  
 
Stability during Perturbed Walking 
The walking measurements were conducted using the Computer Assisted 
Rehabilitation Environment Extended (CAREN; Motekforce Link, Amsterdam). The 
system includes a dual-belt force plate-instrumented treadmill (1000Hz), a 12 
camera Vicon Nexus motion capture system (100Hz; Vicon Motion Systems, Oxford, 
UK) and a 180° virtual environment providing optic flow. A safety harness connected 
to an overhead frame was worn by participants at all times. Six retroflective markers 
were attached to anatomical landmarks (C7, sacrum, left and right trochanter and left 
and right hallux). 
Participants were already accustomed to the CAREN setup, as they had previously 
completed an instrumented six-minute walk test as part of the larger study. To further 
ensure participants were comfortable and familiarised to the measurement setup and 
conditions, the perturbation measurement session began with unrecorded fixed-
speed walking trials of two minutes at speeds of 0.4m/s up to 1.8m/s in 0.2m/s 
increments. Following a break, the same fixed-speed walking trials were repeated 
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and recorded. During another break, the data from these trials were used to 
calculate a stability-normalised walking speed for each participant individually for use 
in the subsequent walking perturbation trial, which was set for a margin of stability 
(MoS; see below; [64]) of 0.05m as described previously [65], ensuring a comparable 
baseline walking stability for all groups [66,67]. Next, participants completed the 
perturbation trial which started with three to four minutes of unperturbed walking at 
the stability-normalised walking speed, followed by 10 unannounced unilateral 
treadmill belt acceleration perturbations (every 30 to 90 seconds). The first and tenth 
accelerations were applied to the right leg, while the second to ninth accelerations 
were applied to the left leg as described previously [66,67]. Participants were told 
that they would complete a walking balance challenge and to try to continue walking 
as normally as possible. The participants were unaware of the specifics of the 
perturbations and no warnings or cues were given during the trial. For the current 
study, the first perturbations to each limb were analysed (Pert1R and Pert2L), 
representing novel disturbances, as well as the ninth perturbation (final left leg 
perturbation; Pert9L) to indicate adaptation in gait following eight repeated 
perturbations.  
Data processing was conducted in MATLAB (2016a, The MathWorks, Inc., Natick). 
The three-dimensional coordinates of the markers were filtered using a low pass 
second order Butterworth filter (zero-phase) with a 12Hz cut-off frequency. Foot 
touchdown and toe-off were detected using a combined method of force plate data 
(50 N threshold) and foot marker data [68], as described in detail previously [69]. The 
anteroposterior MoS at foot touchdown were calculated as the anteroposterior 
distance between the anterior boundary of the base of support (BoS) and the 
extrapolated centre of mass (XCoM) [64], adapted for our validated reduced kinematic 
model [70] and treadmill walking [71], in the same manner as our previous studies 
[65-67]. The MoS was calculated for the following steps: the mean MoS of the 
eleventh to second last step before each perturbation (Base); the final step before 
each perturbation (Pre); and the first eight recovery steps following each perturbation 
(Post1-8). In order to determine the number of steps to recover to baseline stability 
(up to the eighth recovery step), two methods were used. The first, as used in our 
previous study [67], used a 0.05m threshold – if the recovery step MoS value was 
within 0.05m of the Base MoS, this was heuristically considered not meaningfully 
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different to unperturbed baseline walking. The second method, rather than using a 
standard value for all participants, used an individual threshold of three standard 
deviations of the 10 pre-perturbation steps used to calculate Base. This accounted 
for those individuals with either much lower or higher variability in their unperturbed 
walking for whom the 0.05m threshold might have been inappropriate. As there is no 
accepted standard for establishing the number of recovery steps, we have included 
and analysed both outcomes.  
 
Statistics 
Normality for all data was checked with Shapiro-Wilk tests, which determined 
whether parametric or non-parametric analyses would be used. Group differences in 
the parameters were assessed using either one-way ANOVAs with Tukey’s multiple 
comparisons tests or Kruskal-Wallis tests with Dunn's multiple comparisons tests. All 
analyses involving the number of recovery steps included analyses using the 
standard 0.05m threshold (Standard Threshold) and the individualised, three 
standard deviation threshold (Individual Threshold). Spearman correlations were 
conducted to assess the relationships between the recovery steps required by 
participants during Pert1R, Pert2L and Pert9L and the muscle fibre properties 
(percentage of Type II fibres, mean Type II fibre CSA and the percentage of CSA 
taken up by Type II fibres). Spearman correlations were also conducted for the 
recovery steps required and the muscle volume and strength measures. Correlations 
with Pert1R and Pert2L were used to determine associations with balance recovery 
following a novel perturbation (similar unexpected and unfamiliar situation to how 
falls occur in daily life) whereas associations with Pert9L were used to determine 
associations with adaptability of the stability recovery responses. α was set at 0.05. 
Correlation coefficients were interpreted as follows: 0-0.1: Negligible; 0.1-0.3: Small; 
0.3-0.5: Moderate; 0.5 and above: Large [72], although these may be overestimates 
in comparison to the field of gerontology, where there is evidence that Pearson’s r = 
0.12, 0.20, and .032 may better represent small medium and large effects [73]. 
Statistical analyses were conducted, and figures were prepared using GraphPad 






Of the 52 participants who were included in this study, one participant was excluded 
due to problems in both walking motion capture (noise and marker gaps) and muscle 
biopsy (not enough tissue), and a further three participants were excluded due to 
issues with the muscle biopsy (not enough useable tissue was collected). The 
remaining 48 participants’ data were included in the analyses and their 
characteristics, arranged per group, are displayed in Table 1. Note that we did not 
specifically aim to have groups of a specific size, as the groups themselves were not 
related to our primary aims. Rather we wanted to achieve a sample that included a 
wide range of muscle fibre type characteristics and stability recovery performance 
that could provide insight into the associations between these parameters. Due to 
technical issues, walking data from Pert1R for one participant of group O, walking 
data from Pert2L for one participant of group TO and MRI-derived muscle volume 
data for one participant of group TO were excluded.   
Groups O and Y possessed similar physical activity levels (~10K steps/day and 
similar active time in high-intensity activities; Table 1). Group TO, in comparison 
were more active (~13K steps/day and 4.9% active time was at high intensity; Table 
1) and were mainly involved in endurance sports and training, whereas Group IO 
were less active (~7.5K steps/day and 1.6% active time at high intensity; Table 1). 
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N 12 16 3 17 
Male 7 8 2 11 
Age [years] 23.9 (2.2) 70.6 (3) 69.7 (4.2) 67.8 (2.4) 
BMI [kg/m2] 22.4 (3.3) 25.8 (3.4) 28.4 (1.8) 23.8 (1.8) 
Height [cm] 176 (7.4) 169 (11.3) 171 (4.4) 171.2 (7.2) 
Weight [kg] 69.3 (11.5) 74.0 (12.3) 82.9 (2.4) 70 (7.5) 
Fat mass [%] 22.6 (8.4) 33.3 (9.5) 37 (10.7) 25.9 (8.1) 
SPPB 4m walk 1.1 (0.2) 1.2 (0.2) 1.0 (0.3) 1.3 (0.2) 
SPPB chair test 9.2 (2.7) 10.2 (1.4) 13.7 (7.1) 8.9 (2.1) 
Steps/day 10487 (3134) 10007 (2885)ǂ 7594 (1851)  13604 (6218) 
HPA time/wake 
time (%) 
2.6 (1.7)* 2.1 (1.2)ǂ 1.6 (0.1) 4.9 (3.9) 
BMI: body mass index. SPPB: short physical performance battery.HPA: high intensity 
physical activity. *: One participant excluded due to data processing issues. ǂ: Two 
participants excluded due to data collection and analysis issues. 
 
Type I and II Muscle Fibre Characteristics 
In order to evaluate the muscle fibre type characteristics of the muscle biopsy 
samples, a mean (SD) of 454(260) muscle fibres were analysed per participant. 
Representative fluorescence microscope images used for fibre type analyses are 
displayed in Fig. 1. In order to explore the range in the characteristic, one-way 
ANOVAs were applied and did not reveal a significant group effect on Type I or II 
muscle fibre percentage (F(3, 44)=2.8, P=0.051), Type I fibre CSA (F(3, 44)=0.8, 
P=0.5) or Type II fibre CSA (F(3, 44)=1.9, P=0.14), although group TO tended to 
have lower Type II fibre percentage (Fig. 1). A one-way ANOVA did reveal a 
significant effect of group on the percentage of total CSA taken up by Type I and II 
fibres (F(3, 44)=4.5, P=0.007), with Tukey’s multiple comparisons tests revealing 
significantly lower values for group TO vs. Y (adjusted P=0.008) and O (adjusted 
P=0.036), as indicated in Fig. 1. While group comparisons were not always 
significant, these data confirm a range of muscle fibre type characteristics were 
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present in our analysed participants, that there were no significant differences 
between groups Y and O and that group TO have an altered fibre type composition 
favouring Type I fibres. As can be seen in Fig. 1, Type II fibre mean CSA appeared 
to be lower in all older adult groups compared to group Y, despite a non-significant 
one-way ANOVA. Post hoc Mann Whitney tests comparing group Y (n=12, 
Median=5477µm2) with all older participants collapsed into one group (n=36, 
Median=3509µm2) and with Group O (n=16, Median=3500 µm2) revealed significant 
differences in Type II fibre mean CSA (U=114, P=0.014 and U=49, P=0.029, 
respectively).  
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Figure 1: Top Panel: Representative fluorescence microscope images used for fibre type 
analyses from young adults (Y), older adults with normal physical activity (O), trained older 
adults (TO) and physically impaired older adults (IO). Basal membrane (laminin; red); type 1 
fibres (MHC1; green) and type 2 fibres (no stain / black). Each participant shown has the 
median value of average fibre CSA within their group. Bottom Panel: Group median and 
individual Type I and II muscle fibre characteristics. *: P=0.036 **: P=0.008
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Muscle Volume, Strength Characteristics and Perturbation Recovery Steps 
A one-way ANOVA did not reveal a significant effect of group on upper leg muscle 
volume (F(3, 43)=0.74, P=0.35). A significant group effect on peak isometric knee 
extension torque was found (F(3, 44)=3.06, P=0.038) with significantly lower values 
for group O vs. Y (adjusted P=0.0287). Kruskal-Wallis tests did not reveal a 
significant group effect on peak isometric knee flexion torque (H(3)=4.68, P=0.197) 
but did reveal significant group effects on peak isokinetic knee extension 
(H(3)=25.96, P<0.0001) and flexion (H(3)=25.98, P<0.0001) torque, with significantly 
greater peak isokinetic knee extension torque in group Y vs. O (adjusted P<0.0001), 
vs. IO (adjusted P=0.0024) and vs. TO (adjusted P=0.0178) and significantly greater 
peak isokinetic knee flexion torque in group Y vs. O (adjusted P<0.0001) and vs. IO 
(adjusted P=0.0022). Similar to the muscle fibre type characteristics, these data 
confirm a range of muscle strength values in our analysed participants. The muscle 
volume and strength data are displayed in the supplemental figures 1 and 2. 
Kruskal-Wallis tests did not reveal a significant group effect on the number of 
recovery steps for any perturbation or recovery step threshold (Fig. 2; Standard 
Threshold: H(3)=2.35, P=0.5, H(3)=1.2, P=0.75 and H(3)=2.66, P=0.45 for Pert1R, 
Pert2L and Pert9L, respectively; Individual Threshold: H(3)=4.6, P=0.2, H(3)=2.68, 
P=0.44 and H(3)=0.36, P=0.95 for Pert1R, Pert2L and Pert9L, respectively). However, 
as can be seen in Figure 2, a large range of numbers of recovery steps was 
observed across the participants.  
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Figure 2: Group median and individual values for the number of recovery steps determined 
by the standard and individual thresholds for all the first perturbation to each leg (Pert1R and 
Pert2L) and the final left leg perturbation (Pert9L) for young adults (Y), older adults with 
normal physical activity (O), trained older adults (TO) and physically impaired older adults 
(IO). 
 
No Associations between Type II Fibre Characteristics and Balance Recovery  
To test our hypothesis of a relationship between Type II muscle fibre characteristics 
(size and proportion) and stability recovery (number of recovery steps needed 
following a novel perturbation), Spearman correlations were conducted between 
these outcomes. These revealed no significant associations between the number of 
recovery steps following Pert1R and Pert2L and the three Type II fibre characteristics: 
Type II fibre percentage, Type II fibre CSA and the percentage of total CSA taken up 
by Type II fibres (Table 2).  
To provide further context for the muscle fibre characteristic associations, 
associations between the number of recovery steps and upper leg muscle volume 
and torque were also analysed. These Spearman correlations revealed no significant 
between upper leg muscle volume and the number of recovery steps following 
Pert1R and Pert2L (Supplement Table 1). They revealed no significant associations 
between peak isometric and isokinetic knee extension and flexion torque and the 
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number of recovery steps following Pert1R and one (of 8) moderate, significant 
association for Pert2L (significant for Peak Isometric Knee Flexion Torque; 
Supplement Table 1). Note that to provide further insight into these relationships, we 
also ran post hoc Spearman correlations between the fibre type characteristics and 
the muscle volume and torque outcomes, which revealed significant correlations 
between all pairs of muscle volume and torque outcomes, four (out of five) significant 
correlations between Type II fibre CSA and the muscle volume and torque outcomes 
but no significant correlations between Type II muscle fibre content or percentage of 
CSA from Type II fibres and the muscle volume and torque outcomes 
(Supplementary Table 2).  
 
No Associations between Type II Fibre Characteristics and Adapted Balance 
Recovery  
To explore the potential role of Type II muscle fibre characteristics in adaptability of 
stability recovery responses, associations between the recovery steps after eight 
repeated perturbations to the left leg (Pert9L) and the Type II muscle fibre 
characteristics were conducted. Spearman correlations revealed no significant 
associations between the number of recovery steps following Pert9L and the three 
Type II fibre characteristics: Type II fibre percentage, Type II fibre CSA and the 
percentage of total CSA taken up by Type II fibres (Table 2).  
Again, to provide additional information, associations between the Pert9L recovery 
steps and muscle volume and torque were also conducted. In general agreement 
with the fibre type correlations, Spearman correlations revealed no significant 
associations between upper leg muscle volume and the number of recovery steps 
following Pert9L, and only one (of 8) moderate, significant associations between 
peak isometric and isokinetic knee extension and flexion torque and the number of 
recovery steps following Pert9L (Significant for Peak Isometric Knee Flexion Torque; 
Supplement Table 1).  
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Table 2: Spearman Correlation Results for Recovery Steps and Type II Fibre Characteristics 
 






















































P 0.861 0.856 0.490 0.710 0.144 0.745 
CSA % 
from Type II 
Fibres 


















In this study, we aimed to provide the first data on whether or not Type II muscle 
fibre characteristics associate with reactive balance during walking in young and 
older adults with varying muscle fibre type composition. We hypothesised that there 
would be a small to moderate relationship between Type II muscle fibre 
characteristics (size and proportion) and stability recovery (number of recovery steps 
needed following a novel perturbation). We conducted correlation analyses on our 
data from 48 young and older participants, with varying physical activity levels, 
muscle fibre type characteristics, muscle volume and strength, as well as stability 
recovery performance, and were not able to confirm this hypothesis, as we did not 
observe such correlations. The results of our secondary, exploratory correlations 
with muscle volume and strength generally aligned with the fibre type characteristic 
results, since associations between these parameters and stability recovery were 
also virtually absent.  
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The current study found no significant differences in muscle fibre size in older adults 
compared to younger adults. Thus, we found no age-related differences between 
young and older participants who were not engaged in structured physical exercise 
but possessed comparable physical activity levels (~10K steps/day) well above the 
general recommendation [60]. These results appear in contrast to previous studies 
reporting a substantial decrease in muscle fibre size, especially in Type II fibres, with 
age [47,48,50]. However, most of these studies did not measure and control for an 
age-related decrease in physical activity [47,48,50], which could explain muscle fibre 
atrophy [56]. In line with our data, St‐Jean‐Pelletier et al. [49] observed an age-
related decrease in muscle Type II fibre size in sedentary middle-aged and older 
adults (~7K vs. ~6.3K  steps/day on average) but not in physically active middle-
aged and older adults (~12.9K vs. ~12.6K steps/day). These results further support 
the hypothesis that muscle fibre atrophy is not simply a function of ageing per se but 
might also be driven by age-related physical inactivity and immobilization. However, 
it should be kept in mind that while the ANOVA was not significant, our post hoc 
analyses comparing the young adults with all older adults and with group O each 
found a significant effect of age on Type II fibre CSA (Hedges g=0.82 and g=0.84, 
respectively). 
In the present study, the relative proportion of Type I muscle fibres was larger in 
endurance-trained older adults when compared to older adults with normal physical 
activity levels and young individuals. Although individual studies have shown 
conflicting findings regarding muscle fibre type distribution between young and older 
endurance-trained individuals [74,75], our results are in line with evidence indicating 
greater proportions of Type I fibres in endurance-trained older adults when 
compared to untrained older adults and untrained young individuals [54-56]. While 
evidence suggests long-term strength training provides a strong stimulus for the 
preservation of the structural and mechanical characteristics of skeletal muscle 
during ageing [51,76], it remains unclear to what extent aerobic training alone can 
counteract these age-related changes [74,77,78]. However, endurance athletes may 
benefit from other adaptations that play a role in stability. One previous study 
reported that in a mixed group of older and younger adults, those who were 
recreational runners performed better on a forward falling task than the non-active 
participants, despite similar muscle strength values [28]. The authors suggested that 
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runners frequently manage the stability of their body position during running and may 
therefore be better able to perform such destabilising tasks [28]. In our study, of the 
17 participants in group TO, eight participated in regular running and a further two 
participated in badminton and tennis, which also involve multidirectional stepping 
and change of direction, and these individuals may have compensated their 
reduction in Type II fibre size and number with relatively more refined stability 
control.  
The literature is currently mixed regarding the role of muscle strength in balance and 
falls [9-13,17,37-40]. Despite this, small to moderate associations between lower 
limb muscle strength and balance recovery performance following laboratory-based 
perturbations [26-36] led us to our hypothesis of a small to moderate relationship 
between Type II muscle fibre properties and balance recovery performance from a 
sudden walking perturbation. Our results suggest that the muscle fibre properties 
themselves are not critical factors for reactive balance recovery during walking, due 
to the lack of correlations, the inconsistent direction of the (non-significant) 
correlations, as well as the fact that the trained older group did not require a 
significantly different number of recovery steps, despite a significantly different 
proportion of the muscle fibre CSA coming from Type II fibres. In order to check if the 
younger adults’ data were unduly influencing these results, we repeated the 
Spearmen correlation analyses post hoc with only the older participants included and 
these demonstrated similar results, with only one of the 18 associations being 
significant (Supplementary Table 3). Our collective muscle volume and strength 
correlation results were also mostly not statistically significant. These results may, to 
some extent, explain some of the mixed findings in the literature. Strength testing or 
training that primarily targets the muscle tissue properties and neglects other factors 
(such as motor coordination, response/movement speed, functionally relevant 
movements, among others; see Tieland et al. [44] and Hunter et al. [79] for reviews) 
may not capture critical elements of muscle function relevant for reactive balance 
control. That being said, the success of the recovery actions may not critically 
depend on maximal muscle strength at all. For example, one biomechanical 
modelling study found that, for backward balance loss, there is quite some overlap in 
the feasible regions for balance recovery during simulations with strength 
characteristics of young and older adults and recovery was only limited by strength 
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during very short or very long recovery steps [80]. This is also supported by other 
studies demonstrating that older adults can improve their balance recovery 
responses to a level similar to young adults when repeatedly exposed to 
perturbations (acutely and over longer time periods), without changes in muscle 
strength [34,81]. As falls among community-dwelling older adults usually occur 
during dynamic movement [18-25], specificity of both strength and balance 
assessment and training should be key considerations in fall prevention. 
 
Study Limitations 
Some limitations of the current study should be considered. Regarding the walking 
perturbation protocol, our participants were informed that they would complete a 
walking balance challenge but were unaware of the specifics of the perturbations 
and no warnings or cues were given during the trial. However, beneficial effects of 
increased awareness of perturbations on stability recovery performance following 
trips have been shown [82,83], even when the specifics are unknown. This may have 
resulted in better balance recovery performance than might be expected in natural 
settings. Regarding our outcome measure, the number of recovery steps, this is not 
a standard measure of balance recovery following perturbations to walking. 
However, no gold-standard outcome measure exists for this purpose. Other 
possibilities would be to use specific biomechanical variables such as the margin of 
stability or trunk lean at a specific time point. However, due to the heterogeneity in 
the balance recovery responses to such perturbations, using such specific measures 
at specific time points has limitations when trying to capture “overall” balance 
recovery during walking. We feel that the current measure gives a more general 
overall indicator that is more robust to individual differences in response behaviour. It 
should also be kept in mind that our muscle biopsies came from the vastus lateralis 
muscle which is not necessarily the most critical muscle for gait [2-4] (although it 
likely plays an important role in leg extension and energy absorption during the initial 
recovery steps) nor entirely representative of the fibre type properties from other 
lower limb muscles [84-86]. Finally, one potential limitation is the exploratory nature 
of some of the correlations and the lack of a priori correction for multiple 
comparisons. In general, despite the relatively high number of correlations 
performed, the lack of significance and the inconsistency in the direction of the 
Balance and Muscle Fibre properties in Older Adults 
195 
correlations leads us to believe that our conclusions are justified and not dependent 
on spurious correlations (significant or not). 
 
Conclusions 
The current results indicate that Type II muscle fibre properties (proportion and 
dimensions) are not significantly associated with reactive balance recovery following 
perturbations to walking in young and older adults. Upper leg muscle volume and 
knee flexion and extension torque also failed to show a significant relationship with 
reactive balance recovery. These results have implications for muscle strength 
testing and training in fall prevention, as it appears that the muscle tissue properties 
are not key factors for balance recovery.  
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SUPPLEMENTARY MATERIAL FOR CHAPTER 6
 
Supplement Fig. 1: Group median and 
individual upper leg muscle volume for 
young adults (Y), older adults with 
normal physical activity (O), trained 
older adults (TO) and physically 
impaired older adults (IO). 
 
 
Supplement Figure 2: Group median and individual values 
for peak isometric and isokinetic knee extension and flexion 
torque for young adults (Y), older adults with normal physical 
activity (O), trained older adults (TO) and physically impaired 





Supplement Table 1: Spearman correlation results for upper leg muscle volume, peak isometric and 
isokinetic knee extension and flexion torque and Pert1R, Pert2L and Pert9L 
 













Upper Leg Muscle 
Volume 
Spearman r -0.1226 -0.01128 -0.01661 -0.1461 -0.1766 -0.1825 











P 0.417 0.9407 0.9127 0.3327 0.235 0.2195 
Peak Isometric Knee 
Extension Torque 
Spearman r 0.1023 0.09993 -0.06967 -0.2268 -0.03795 -0.1397 











P 0.4939 0.5039 0.6417 0.1252 0.7979 0.3437 
Peak Isometric Knee 
Flexion Torque 
Spearman r -0.01427 0.002994 -0.2043 -0.3262 -0.2399 -0.3902 











P 0.9242 0.9841 0.1683 0.0252 0.1006 0.0061 
Peak Isokinetic Knee 
Extension Torque 
Spearman r -0.1622 -0.2081 -0.2041 -0.06516 -0.1998 -0.1164 











P 0.276 0.1604 0.1688 0.6635 0.1734 0.4308 
Peak Isokinetic Knee 
Flexion Torque 
Spearman r -0.08 -0.1216 -0.2476 -0.07478 -0.1597 -0.07469 











P 0.593 0.4155 0.0933 0.6174 0.2781 0.6139 
 
 
Supplement Table 2: Spearman correlation matrix for upper leg muscle volume, peak isometric and isokinetic knee extension and flexion torque, Type II fibre 


















Type II Fibre 
Content [%] 
Type II Fibre 
Mean CSA [µm2] 




Spearman r         
95% CI         




Spearman r 0.405412        
95% CI 0.1252 to 0.6257        




Spearman r 0.533534 0.646       
95% CI 0.2829 to 0.7159 0.4361 to 0.7891       




Spearman r 0.631707 0.608 0.528      
95% CI 0.4137 to 0.7812 0.3839 to 0.7642 0.2790 to 0.7105      




Spearman r 0.490634 0.670 0.538 0.877     
95% CI 0.2286 to 0.6864 0.4697 to 0.8045 0.2914 to 0.7171 0.7858 to 0.9305     
P 0.0005 <0.0001 0.0001 <0.0001     
Type II Fibre 
Content [%] 
Spearman r -0.04845 0.043 0.175 0.045 -0.118    
95% CI -0.3388 to 0.2503 -0.2523 to 0.3308 -0.1234 to 0.4443 -0.2508 to 0.3322 -0.3961 to 0.1806    
P 0.7464 0.7723 0.2342 0.7639 0.4257    
Type II Fibre 
Mean CSA 
[µm2] 
Spearman r 0.570421 0.282 0.297 0.564 0.405 -0.018   
95% CI 0.3310 to 0.7408 -0.01117 to 0.5302 0.005062 to 0.5418 0.3256 to 0.7350 0.1284 to 0.6235 -0.2946 to 0.2610  
 
P <0.0001 0.0523 0.0406 <0.0001 0.0043 0.8970   
CSA % from 
Type II Fibres 
Spearman r 0.066374 0.187 0.297 0.185 0.048 0.855 0.331  
95% CI -0.2334 to 0.3546 -0.1114 to 0.4540 0.005538 to 0.5421 -0.1132 to 0.4526 -0.2473 to 0.3355 0.7566 to 0.9153 0.05832 to 0.5575  
P 0.6576 0.2038 0.0403 0.2082 0.7449 <0.0001 0.0155  
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Supplementary Table 3: Spearman Correlation Results for Recovery Steps and Type II 
Fibre Characteristics in the Older Participants. 
 













Type II Fibre 
Content [%] 
Spearman r 0.2188 0.3559 0.1725 -0.1154 -0.08924 -0.2365 











P 0.2066 0.0359 0.3217 0.5090 0.6048 0.1650 
Type II Fibre 
Mean CSA 
[µm2] 
Spearman r 0.008247 0.001569 0.06739 -0.009371 -0.2108 -0.08795 











P 0.9625 0.9929 0.7005 0.9574 0.2172 0.6100 
CSA % from 
Type II Fibres 
Spearman r 0.2514 0.3135 0.1707 -0.2258 -0.1783 -0.3070 











P 0.1452 0.0667 0.3269 0.1922 0.2980 0.0686 
 
Balance and Muscle Fibre properties in Older Adults 
201 
REFERENCES 
1. Janssen I, Heymsfield SB, Wang Z, Ross R (2000) Skeletal muscle mass and distribution 
in 468 men and women aged 18–88 yr. J Appl Physiol 89 (1):81-88. 
doi:10.1152/jappl.2000.89.1.81 
2. Kulmala JP, Korhonen MT, Ruggiero L, Kuitunen S, Suominen H, Heinonen A, Mikkola A, 
Avela J (2016) Walking and Running Require Greater Effort from Ankle than Knee Extensor 
Muscles. Med Sci Sports Exerc. doi:10.1249/mss.0000000000001020 
3. Kulmala JP, Korhonen MT, Kuitunen S, Suominen H, Heinonen A, Mikkola A, Avela J 
(2014) Which muscles compromise human locomotor performance with age? Journal of the 
Royal Society, Interface / the Royal Society 11 (100):20140858. doi:10.1098/rsif.2014.0858 
4. Pandy MG, Andriacchi TP (2010) Muscle and joint function in human locomotion. Annu 
Rev Biomed Eng 12:401-433. doi:10.1146/annurev-bioeng-070909-105259 
5. McCrum C, Leow P, Epro G, Konig M, Meijer K, Karamanidis K (2018) Alterations in Leg 
Extensor Muscle-Tendon Unit Biomechanical Properties With Ageing and Mechanical 
Loading. Front Physiol 9 (150):150. doi:10.3389/fphys.2018.00150 
6. Stenroth L, Peltonen J, Cronin NJ, Sipila S, Finni T (2012) Age-related differences in 
Achilles tendon properties and triceps surae muscle architecture in vivo. Journal of applied 
physiology (Bethesda, Md : 1985) 113 (10):1537-1544. doi:10.1152/japplphysiol.00782.2012 
7. Onambele GL, Narici MV, Maganaris CN (2006) Calf muscle-tendon properties and 
postural balance in old age. Journal of applied physiology (Bethesda, Md : 1985) 100 
(6):2048-2056. doi:10.1152/japplphysiol.01442.2005 
8. Mademli L, Arampatzis A, Karamanidis K (2008) Dynamic stability control in forward falls: 
postural corrections after muscle fatigue in young and older adults. Eur J Appl Physiol 103 
(3):295-306. doi:10.1007/s00421-008-0704-z 
9. De Rekeneire N, Visser M, Peila R, Nevitt MC, Cauley JA, Tylavsky FA, Simonsick EM, 
Harris TB (2003) Is a Fall Just a Fall: Correlates of Falling in Healthy Older Persons. The 
Health, Aging and Body Composition Study. J Am Geriatr Soc 51 (6):841-846. 
doi:10.1046/j.1365-2389.2003.51267.x 
10. Cattagni T, Scaglioni G, Laroche D, Van Hoecke J, Gremeaux V, Martin A (2014) Ankle 
muscle strength discriminates fallers from non-fallers. Front Aging Neurosci 6:336. 
doi:10.3389/fnagi.2014.00336 
11. Perry MC, Carville SF, Smith ICH, Rutherford OM, Newham DJ (2007) Strength, power 
output and symmetry of leg muscles: effect of age and history of falling. Eur J Appl Physiol 
100 (5):553-561. doi:10.1007/s00421-006-0247-0 
12. LaRoche DP, Cremin KA, Greenleaf B, Croce RV (2010) Rapid torque development in 
older female fallers and nonfallers: A comparison across lower-extremity muscles. J 
Electromyogr Kinesiol 20 (3):482-488. doi:10.1016/j.jelekin.2009.08.004 
13. Kamo T, Asahi R, Azami M, Ogihara H, Ikeda T, Suzuki K, Nishida Y (2019) Rate of 
torque development and the risk of falls among community dwelling older adults in Japan. 
Gait Posture 72:28-33. doi:10.1016/j.gaitpost.2019.05.019 
14. Skelton DA, Kennedy J, Rutherford OM (2002) Explosive power and asymmetry in leg 
muscle function in frequent fallers and non-fallers aged over 65. Age Ageing 31 (2):119-125. 
doi:10.1093/ageing/31.2.119 
15. Gadelha AB, Neri SGR, Nobrega OT, Pereira JC, Bottaro M, Fonseca A, Lima RM 
(2018) Muscle quality is associated with dynamic balance, fear of falling, and falls in older 
women. Exp Gerontol 104:1-6. doi:10.1016/j.exger.2018.01.003 
Chapter 6 
202 
16. Gadelha AB, Neri SGR, Bottaro M, Lima RM (2018) The relationship between muscle 
quality and incidence of falls in older community-dwelling women: An 18-month follow-up 
study. Exp Gerontol 110:241-246. doi:10.1016/j.exger.2018.06.018 
17. Melzer I, Benjuya N, Kaplanski J (2004) Postural stability in the elderly: a comparison 
between fallers and non-fallers. Age Ageing 33 (6):602-607. doi:10.1093/ageing/afh218 
18. Berg WP, Alessio HM, Mills EM, Tong C (1997) Circumstances and consequences of 
falls in independent community-dwelling older adults. Age Ageing 26 (4):261-268. 
doi:10.1093/ageing/26.4.261 
19. Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons 
living in the community. N Engl J Med 319 (26):1701-1707. 
doi:10.1056/NEJM198812293192604 
20. Sheldon JH (1960) On the Natural History of Falls in Old Age. Br Med J 2 (5214):1685-
1690. doi:10.1136/bmj.2.5214.1685 
21. Lord SR, Ward JA, Williams P, Anstey KJ (1993) An epidemiological study of falls in 
older community-dwelling women: the Randwick falls and fractures study. Aust J Public 
Health 17 (3):240-245 
22. Niino N, Tsuzuku S, Ando F, Shimokata H (2000) Frequencies and circumstances of falls 
in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J 
Epidemiol 10 (1 Suppl):S90-94. doi:10.2188/jea.10.1sup_90 
23. Talbot LA, Musiol RJ, Witham EK, Metter EJ (2005) Falls in young, middle-aged and 
older community dwelling adults: perceived cause, environmental factors and injury. BMC 
Public Health 5:86. doi:10.1186/1471-2458-5-86 
24. Crenshaw JR, Bernhardt KA, Achenbach SJ, Atkinson EJ, Khosla S, Kaufman KR, Amin 
S (2017) The circumstances, orientations, and impact locations of falls in community-
dwelling older women. Arch Gerontol Geriatr 73:240-247. doi:10.1016/j.archger.2017.07.011 
25. McCrum C (2019) A Trip to Remember: Assessing and Improving Walking Stability in 
Older Adults. Maastricht University, Gildeprint Drukkerijen 
26. Grabiner MD, Owings TM, Pavol MJ (2005) Lower extremity strength plays only a small 
role in determining the maximum recoverable lean angle in older adults. J Gerontol A Biol 
Sci Med Sci 60 (11):1447-1450. doi:10.1093/gerona/60.11.1447 
27. Karamanidis K, Arampatzis A, Mademli L (2008) Age-related deficit in dynamic stability 
control after forward falls is affected by muscle strength and tendon stiffness. J Electromyogr 
Kinesiol 18 (6):980-989. doi:10.1016/j.jelekin.2007.04.003 
28. Karamanidis K, Arampatzis A (2007) Age-related degeneration in leg-extensor muscle-
tendon units decreases recovery performance after a forward fall: compensation with 
running experience. Eur J Appl Physiol 99 (1):73-85. doi:10.1007/s00421-006-0318-2 
29. Carty CP, Barrett RS, Cronin NJ, Lichtwark GA, Mills PM (2012) Lower limb muscle 
weakness predicts use of a multiple- versus single-step strategy to recover from forward loss 
of balance in older adults. J Gerontol A Biol Sci Med Sci 67 (11):1246-1252. 
doi:10.1093/gerona/gls149 
30. Carty CP, Cronin NJ, Lichtwark GA, Mills PM, Barrett RS (2012) Lower limb muscle 
moments and power during recovery from forward loss of balance in male and female single 
and multiple steppers. Clin Biomech (Bristol, Avon) 27 (10):1031-1037. 
doi:10.1016/j.clinbiomech.2012.07.009 
31. Pavol MJ, Owings TM, Foley KT, Grabiner MD (2002) Influence of lower extremity 
strength of healthy older adults on the outcome of an induced trip. J Am Geriatr Soc 50 
(2):256-262 
Balance and Muscle Fibre properties in Older Adults 
203 
32. Pijnappels M, van der Burg PJ, Reeves ND, van Dieen JH (2008) Identification of elderly
fallers by muscle strength measures. Eur J Appl Physiol 102 (5):585-592. 
doi:10.1007/s00421-007-0613-6 
33. Pijnappels M, Bobbert MF, van Dieen JH (2005) Push-off reactions in recovery after
tripping discriminate young subjects, older non-fallers and older fallers. Gait Posture 21 
(4):388-394. doi:10.1016/j.gaitpost.2004.04.009 
34. Epro G, McCrum C, Mierau A, Leyendecker M, Brüggemann GP, Karamanidis K (2018)
Effects of triceps surae muscle strength and tendon stiffness on the reactive dynamic 
stability and adaptability of older female adults during perturbed walking. Journal of applied 
physiology (Bethesda, Md : 1985) 124 (6):1541-1549. doi:10.1152/japplphysiol.00545.2017 
35. Ding L, Yang F (2016) Muscle weakness is related to slip-initiated falls among
community-dwelling older adults. J Biomech 49 (2):238-243. 
doi:10.1016/j.jbiomech.2015.12.009 
36. Han L, Yang F (2015) Strength or power, which is more important to prevent slip-related
falls? Hum Mov Sci 44:192-200. doi:10.1016/j.humov.2015.09.001 
37. Orr R, Raymond J, Fiatarone Singh M (2008) Efficacy of progressive resistance training
on balance performance in older adults : a systematic review of randomized controlled trials. 
Sports Med 38 (4):317-343. doi:10.2165/00007256-200838040-00004 
38. Howe TE, Rochester L, Neil F, Skelton DA, Ballinger C (2011) Exercise for improving
balance in older people. Cochrane Database Syst Rev (11):Cd004963. 
doi:10.1002/14651858.CD004963.pub3 
39. Horlings CG, van Engelen BG, Allum JH, Bloem BR (2008) A weak balance: the
contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol 4 
(9):504-515. doi:10.1038/ncpneuro0886 
40. Sherrington C, Fairhall NJ, Wallbank GK, Tiedemann A, Michaleff ZA, Howard K,
Clemson L, Hopewell S, Lamb SE (2019) Exercise for preventing falls in older people living 
in the community. Cochrane Database Syst Rev 1:CD012424. 
doi:10.1002/14651858.CD012424.pub2 
41. Orr R (2010) Contribution of muscle weakness to postural instability in the elderly. A
systematic review. Eur J Phys Rehabil Med 46 (2):183-220 
42. Wilkinson DJ, Piasecki M, Atherton PJ (2018) The age-related loss of skeletal muscle
mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre 
loss in humans. Ageing research reviews 47:123-132. doi:10.1016/j.arr.2018.07.005 
43. Deschenes MR (2004) Effects of Aging on Muscle Fibre Type and Size. Sports Med 34
(12):809-824. doi:10.2165/00007256-200434120-00002 
44. Tieland M, Trouwborst I, Clark BC (2018) Skeletal muscle performance and ageing.
Journal of cachexia, sarcopenia and muscle 9 (1):3-19. doi:10.1002/jcsm.12238 
45. Mitchell WK, Atherton PJ, Williams J, Larvin M, Lund JN, Narici M (2012) Sarcopenia,
Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; 
a Quantitative Review. Front Physiol 3. doi:10.3389/fphys.2012.00260 
46. Kramer IF, Snijders T, Smeets JSJ, Leenders M, van Kranenburg J, den Hoed M, Verdijk
LB, Poeze M, van Loon LJC (2017) Extensive Type II Muscle Fiber Atrophy in Elderly 
Female Hip Fracture Patients. The Journals of Gerontology: Series A 72 (10):1369-1375. 
doi:10.1093/gerona/glw253 
47. McPhee JS, Cameron J, Maden-Wilkinson T, Piasecki M, Yap MH, Jones DA, Degens H
(2018) The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary 




48. Nilwik R, Snijders T, Leenders M, Groen BBL, van Kranenburg J, Verdijk LB, van Loon 
LJC (2013) The decline in skeletal muscle mass with aging is mainly attributed to a reduction 
in type II muscle fiber size. Exp Gerontol 48 (5):492-498. doi:10.1016/j.exger.2013.02.012 
49. St‐Jean‐Pelletier F, Pion CH, Leduc‐Gaudet J-P, Sgarioto N, Zovilé I, Barbat‐Artigas S, 
Reynaud O, Alkaterji F, Lemieux FC, Grenon A, Gaudreau P, Hepple RT, Chevalier S, 
Belanger M, Morais JA, Aubertin‐Leheudre M, Gouspillou G (2017) The impact of ageing, 
physical activity, and pre-frailty on skeletal muscle phenotype, mitochondrial content, and 
intramyocellular lipids in men. Journal of cachexia, sarcopenia and muscle 8 (2):213-228. 
doi:10.1002/jcsm.12139 
50. Lee W-S, Cheung W-H, Qin L, Tang N, Leung K-S (2006) Age-associated Decrease of 
Type IIA/B Human Skeletal Muscle Fibers. Clinical Orthopaedics and Related Research® 
450:231–237. doi:10.1097/01.blo.0000218757.97063.21 
51. Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, Schnohr P, 
Saltin B (1990) Function, morphology and protein expression of ageing skeletal muscle: a 
cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 
140 (1):41-54. doi:10.1111/j.1748-1716.1990.tb08974.x 
52. Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD (2003) Expression of IGF-
I splice variants in young and old human skeletal muscle after high resistance exercise. J 
Physiol 547 (Pt 1):247-254. doi:10.1113/jphysiol.2002.032136 
53. Short KR, Vittone JL, Bigelow ML, Proctor DN, Coenen-Schimke JM, Rys P, Nair KS 
(2005) Changes in myosin heavy chain mRNA and protein expression in human skeletal 
muscle with age and endurance exercise training. Journal of applied physiology (Bethesda, 
Md : 1985) 99 (1):95-102. doi:10.1152/japplphysiol.00129.2005 
54. Aagaard P, Magnusson PS, Larsson B, Kjaer M, Krustrup P (2007) Mechanical muscle 
function, morphology, and fiber type in lifelong trained elderly. Med Sci Sports Exerc 39 
(11):1989-1996. doi:10.1249/mss.0b013e31814fb402 
55. Mackey AL, Karlsen A, Couppé C, Mikkelsen UR, Nielsen RH, Magnusson SP, Kjaer M 
(2014) Differential satellite cell density of type I and II fibres with lifelong endurance running 
in old men. Acta Physiol (Oxf) 210 (3):612-627. doi:10.1111/apha.12195 
56. Mosole S, Carraro U, Kern H, Loefler S, Fruhmann H, Vogelauer M, Burggraf S, Mayr W, 
Krenn M, Paternostro-Sluga T, Hamar D, Cvecka J, Sedliak M, Tirpakova V, Sarabon N, 
Musarò A, Sandri M, Protasi F, Nori A, Pond A, Zampieri S (2014) Long-term high-level 
exercise promotes muscle reinnervation with age. J Neuropathol Exp Neurol 73 (4):284-294. 
doi:10.1097/nen.0000000000000032 
57. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, 
Wallace RB (1994) A short physical performance battery assessing lower extremity function: 
association with self-reported disability and prediction of mortality and nursing home 
admission. J Gerontol 49 (2):M85-94. doi:10.1093/geronj/49.2.m85 
58. Dempster P, Aitkens S (1995) A new air displacement method for the determination of 
human body composition. Med Sci Sports Exerc 27 (12):1692-1697 
59. van der Berg JD, Willems PJB, van der Velde JHPM, Savelberg HHCM, Schaper NC, 
Schram MT, Sep SJS, Dagnelie PC, Bosma H, Stehouwer CDA, Koster A (2016) Identifying 
waking time in 24-h accelerometry data in adults using an automated algorithm. J Sports Sci 
34 (19):1867-1873. doi:10.1080/02640414.2016.1140908 
60. Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Cocker K, Giles-Corti B, Hatano Y, 
Inoue S, Matsudo SM, Mutrie N, Oppert JM, Rowe DA, Schmidt MD, Schofield GM, Spence 
JC, Teixeira PJ, Tully MA, Blair SN (2011) How many steps/day are enough? For adults. Int 
J Behav Nutr Phys Act 8 (1):79. doi:10.1186/1479-5868-8-79 
Balance and Muscle Fibre properties in Older Adults 
205 
61. Bergström J, Hermansen L, Hultman E, Saltin B (1967) Diet, Muscle Glycogen and 
Physical Performance. Acta Physiol Scand 71 (2-3):140-150. doi:10.1111/j.1748-
1716.1967.tb03720.x 
62. Koopman R, Schaart G, Hesselink MK (2001) Optimisation of oil red O staining permits 
combination with immunofluorescence and automated quantification of lipids. Histochem Cell 
Biol 116 (1):63-68. doi:10.1007/s004180100297 
63. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of 
image analysis. Nat Methods 9 (7):671-675. doi:10.1038/nmeth.2089 
64. Hof AL, Gazendam MG, Sinke WE (2005) The condition for dynamic stability. J Biomech 
38 (1):1-8. doi:10.1016/j.jbiomech.2004.03.025 
65. McCrum C, Willems P, Karamanidis K, Meijer K (2019) Stability-normalised walking 
speed: A new approach for human gait perturbation research. J Biomech 87:48-53. 
doi:10.1016/j.jbiomech.2019.02.016 
66. McCrum C, Karamanidis K, Grevendonk L, Zijlstra W, Meijer K (2020) Older adults 
demonstrate interlimb transfer of reactive gait adaptations to repeated unpredictable gait 
perturbations. Geroscience 42 (1):39-49. doi:10.1007/s11357-019-00130-x 
67. McCrum C, Karamanidis K, Willems P, Zijlstra W, Meijer K (2018) Retention, savings 
and interlimb transfer of reactive gait adaptations in humans following unexpected 
perturbations. Commun Biol 1 (1):230. doi:10.1038/s42003-018-0238-9 
68. Zeni JA, Jr., Richards JG, Higginson JS (2008) Two simple methods for determining gait 
events during treadmill and overground walking using kinematic data. Gait Posture 27 
(4):710-714. doi:10.1016/j.gaitpost.2007.07.007 
69. McCrum C, Lucieer F, van de Berg R, Willems P, Perez Fornos A, Guinand N, 
Karamanidis K, Kingma H, Meijer K (2019) The walking speed-dependency of gait variability 
in bilateral vestibulopathy and its association with clinical tests of vestibular function. Sci Rep 
9 (1):18392. doi:10.1038/s41598-019-54605-0 
70. Süptitz F, Moreno Catala M, Brüggemann GP, Karamanidis K (2013) Dynamic stability 
control during perturbed walking can be assessed by a reduced kinematic model across the 
adult female lifespan. Hum Mov Sci 32 (6):1404-1414. doi:10.1016/j.humov.2013.07.008 
71. Suptitz F, Karamanidis K, Moreno Catala M, Bruggemann GP (2012) Symmetry and 
reproducibility of the components of dynamic stability in young adults at different walking 
velocities on the treadmill. J Electromyogr Kinesiol 22 (2):301-307. 
doi:10.1016/j.jelekin.2011.12.007 
72. Cohen J (1992) A power primer. Psychol Bull 112 (1):155-159. doi:10.1037//0033-
2909.112.1.155 
73. Brydges CR (2019) Effect Size Guidelines, Sample Size Calculations, and Statistical 
Power in Gerontology. Innov Aging 3 (4):igz036. doi:10.1093/geroni/igz036 
74. McKendry J, Breen L, Shad BJ, Greig CA (2018) Muscle morphology and performance in 
master athletes: A systematic review and meta-analyses. Ageing research reviews 45:62-82. 
doi:10.1016/j.arr.2018.04.007 
75. Zampieri S, Pietrangelo L, Loefler S, Fruhmann H, Vogelauer M, Burggraf S, Pond A, 
Grim-Stieger M, Cvecka J, Sedliak M, Tirpáková V, Mayr W, Sarabon N, Rossini K, Barberi 
L, De Rossi M, Romanello V, Boncompagni S, Musarò A, Sandri M, Protasi F, Carraro U, 
Kern H (2015) Lifelong physical exercise delays age-associated skeletal muscle decline. J 
Gerontol A Biol Sci Med Sci 70 (2):163-173. doi:10.1093/gerona/glu006 
76. Pearson SJ, Young A, Macaluso A, Devito G, Nimmo MA, Cobbold M, Harridge SD 




77. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM, Holloszy JO (1992) 
Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. 
Journal of applied physiology (Bethesda, Md : 1985) 72 (5):1780-1786. 
doi:10.1152/jappl.1992.72.5.1780 
78. Cadore EL, Pinto RS, Bottaro M, Izquierdo M (2014) Strength and endurance training 
prescription in healthy and frail elderly. Aging Dis 5 (3):183-195. 
doi:10.14336/ad.2014.0500183 
79. Hunter SK, Pereira HM, Keenan KG (2016) The aging neuromuscular system and motor 
performance. Journal of applied physiology (Bethesda, Md : 1985) 121 (4):982-995. 
doi:10.1152/japplphysiol.00475.2016 
80. Kadono N, Pavol MJ (2013) Effects of aging-related losses in strength on the ability to 
recover from a backward balance loss. J Biomech 46 (1):13-18. 
doi:10.1016/j.jbiomech.2012.08.046 
81. Epro G, Mierau A, McCrum C, Leyendecker M, Bruggemann GP, Karamanidis K (2018) 
Retention of gait stability improvements over 1.5 years in older adults: effects of perturbation 
exposure and triceps surae neuromuscular exercise. J Neurophysiol 119 (6):2229-2240. 
doi:10.1152/jn.00513.2017 
82. Oludare SO, Pater ML, Rosenblatt NJ, Grabiner MD (2018) Trip-specific training 
enhances recovery after large postural disturbances for which there is NO expectation. Gait 
Posture 61:382-386. doi:10.1016/j.gaitpost.2018.02.001 
83. Pater ML, Rosenblatt NJ, Grabiner MD (2015) Expectation of an upcoming large postural 
perturbation influences the recovery stepping response and outcome. Gait Posture 41 
(1):335-337. doi:10.1016/j.gaitpost.2014.10.026 
84. Luden N, Minchev K, Hayes E, Louis E, Trappe T, Trappe S (2008) Human vastus 
lateralis and soleus muscles display divergent cellular contractile properties. American 
journal of physiology Regulatory, integrative and comparative physiology 295 (5):R1593-
R1598. doi:10.1152/ajpregu.90564.2008 
85. Gollnick PD, Sjödin B, Karlsson J, Jansson E, Saltin B (1974) Human soleus muscle: a 
comparison of fiber composition and enzyme activities with other leg muscles. Pflugers Arch 
348 (3):247-255. doi:10.1007/bf00587415 
86. Edgerton VR, Smith JL, Simpson DR (1975) Muscle fibre type populations of human leg 





Although advanced chronological age is one of the most critical risk factors for many 
chronic diseases, the rate at which physiological functions and overall health status 
decline with age - defined as biological age - is highly variable among individuals (1). 
In contrast to the quantitative measure of chronological age, biological aging is more 
qualitative and can be influenced by factors including genetic background, lifestyle, 
nutrition, socio-economic status, and environmental influences such as access to 
health care (2,3). The biological processes involved in aging are complex and are 
predominantly driven by damage acquired by cells and tissues over time (4), thereby 
defining aging as the progressive decline of function through the loss of physiological 
integrity (5).  
Frailty is a late-life syndrome resulting from cumulative decline across various 
physiological reserves. An older adult with frailty has an increased vulnerability to 
stressors and consequently develops adverse health-related outcomes such as 
disability, increased dependency, comorbidities, and mortality (6–8). Deterioration of 
the musculoskeletal system is the main component of frailty, but also other physical 
domains, including cognitive, psychological, and social domains, can be affected (8). 
Physical frailty often involves sarcopenia, which is defined as decreased muscle 
mass and function, including muscle strength and physical performance (9). 
Sarcopenia has implications on mobility, the risk of falls, and the onset of insulin 
resistance, type 2 diabetes and obesity (5,10). In turn, the development of frailty and 
sarcopenia can be accelerated under the influence of metabolic disturbances, 
nutritional deficiencies, lack of physical activity, and comorbidities (9), together 
leading to a vicious cycle. Skeletal muscle mass starts to decline with age from 
around the age of 40 years (11), and even more prominent is the age-related decline 
in muscle strength, which is two to five times faster than the decline in muscle mass 
and is a more consistent risk for disability (12). To better understand the aging 
process, the present thesis aimed to investigate the age-related changes in the 
skeletal muscle and its consequences on physical performance and metabolic 
health. In chapter 3, irrespective of lean mass, muscle strength was remarkably 
lower in older adults than in young individuals. The age-related decline in muscle 
mass seems to be attributable to muscle fiber atrophy and muscle fiber loss of 
especially type II fibers, contributing to muscle weakness (13–15). Nevertheless, 
despite changes in muscle strength, we did not observe age-related differences in 
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muscle fiber characteristics between young and older participants who, important to 
mention, had comparable levels of physical activity (chapter 3). The discrepancy 
could be explained by the fact that previous studies did not measure and control for 
an age-related decrease in physical activity (13–15), which could explain muscle 
fiber atrophy (16). These results suggest that muscle fiber atrophy is not simply a 
function of aging per se but might also be driven by age-related physical inactivity 
and immobilization.  
One of the most critical consequences of age-related disability is the increased risk 
of falls leading to further functional decline and physical impairments (17). As such, 
numerous exercise training programs in older adults aim to prevent the loss of gait 
stability and improve physical independence. It is commonly assumed that muscle 
strength and power are essential factors for coping with large balance disturbances. 
Nevertheless, muscle strength training programs usually only moderately improve 
balance and fall management (18–20). In addition, in chapter 6, no correlations 
were observed between muscle fiber characteristics, muscle volume and strength, 
and stability recovery performance in young and older participants with varying 
physical activity levels. These results suggest that muscle tissue properties per se 
are not key factors for balance recovery and a multi-domain intervention might be 
demanded to mitigate physical aging. 
 
Mitochondrial dysfunction and aging 
Because mitochondria are essential regulators of processes such as ATP provision, 
oxidative stress, proteostasis, apoptosis, inflammation, and Ca2+ handling (21–24), 
impairments in mitochondrial function potentially impact the progression of 
sarcopenia and accelerate aging. Indeed, mitochondrial function is widely studied in 
relation to aging, as exemplified by numerous studies covering various aspects of 
mitochondrial capacity and function in human skeletal muscle.  
First of all, studies have focused on the effect of age on (markers of) mitochondrial 
density. Thus, using citrate synthase (CS) activity as a marker of cellular oxidative 
capacity and mitochondrial density (25), several studies reported reductions in 
mitochondrial density with age (26,27). In contrast to these findings, we did not show 
a significant difference in mitochondrial density in older adults compared to young 
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individuals, based on OXPHOS protein levels (chapter 3). Also, other studies 
reported no age-related differences in mitochondrial content based on CS activity 
and OXPHOS protein expression (28,29). However, despite a comparable 
mitochondrial density, we observed that mitochondrial respiratory capacity was lower 
in older adults than young individuals (chapter 3), supporting the idea that 
mitochondrial function can change with age in the absence of perceptible changes in 
mitochondrial volume (30). Although the observed age-related decline in 
mitochondrial respiratory capacity in older adults is in line with previous clinical work 
(31–33), other studies observed no chronological age effect on mitochondrial 
respiration (28,34,35). Factors like age-related changes in physical activity may 
explain these differences between studies. 
Besides mitochondrial content and (intrinsic) respiratory capacity, recent studies 
(36–40) have highlighted the importance of mitochondrial morphology and turnover 
for proper mitochondrial function (reviewed in chapter 2). Mitochondrial integrity 
relies on the efficiency of quality control processes, and their mitochondrial network 
is regulated by continuous fusion, fission, and mitophagy (41–43). While the 
activation of the mitochondrial biogenesis pathway leads to an increase in 
mitochondrial content, e.g. as a result of exercise training, it is also vital to eliminate 
any mitochondrial segments that have outlived their usefulness via mitophagy in 
order to maintain or improve the quality of the mitochondrial pool (44–46). Limited 
animal and human studies have examined mitochondrial quality control processes in 
muscle aging, with inconsistent results, and therefore warrant further investigation. 
Thus, some studies described increased fission in muscle tissue of older rats, 
indicated by smaller mitochondria and increased expression of fission proteins FIS1 
and DRP1 (47), whereas other studies indicated an increased fusion, illustrated by a 
larger mitochondrial reticulum size, along with concomitant increases in the fusion 
proteins OPA1 and MFN2 increased fusion in aged mice (48). Furthermore, other 
studies reported no differences in mRNA levels for mitochondrial fission protein Fis1 
and fusion protein Mitofusin 1 (Mfn1) between young and old sedentary individuals 
(49,50). The muscle tissue available from the young and older adults studied in 
chapter 3 may help to understand age-related changes through assessment of 
fission, fusion, and mitophagy proteins and their relationship with muscle health and 
physical function. Moreover, combining the measurement of these regulatory 
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proteins with confocal microscopy could shed further light on age-related alterations 
in the regulation of the finely tuned mitochondrial network. Nonetheless, it should be 
stressed that these experiments would only provide a snapshot of mitochondrial 
connectivity, whereas we know from previous studies that the network is highly 
dynamic and already displays changes over the course of a day (51)  
Potential confounders of the relationship between aging and mitochondrial 
capacity 
Some of the contradictory associations between aging and skeletal muscle 
mitochondrial capacity and integrity, particularly in humans, could relate to 
heterogeneous participant characteristics such as physical activity, body fat 
content/distribution, and insulin sensitivity (28,52). In other words, the isolated impact 
of aging on skeletal muscle mitochondrial function is difficult to unravel from the 
many other factors that change concurrently with aging (53). 
Aging has been associated with an increased abdominal white adipose tissue mass 
(54,55). In chapter 3 we also observed that body fat content was different between 
young and older adults and may therefore contribute to the reduction in 
mitochondrial function and physical capacity. Aging-related adiposity is also linked 
with increased fat deposition in skeletal muscle (56). Thus, in the m. vastus lateralis 
of older adults, intramyocellular lipid (IMCL) accumulation has been observed by 
proton magnetic resonance spectroscopy (1H-MRS) (57) as well as by histological 
analysis of muscle biopsies (58,59). Moreover, larger IMCL droplets have been 
linked to decreased mitochondrial content in muscle fibers from older adults, and 
lipid droplet morphology likely contributes to age-related reductions in mitochondrial 
function and lipid metabolism (52). Also, reduction in peroxisome proliferator-
activated receptor gamma coactivator 1α (PGC-1α) expression and disruption of 
mitochondrial dynamics and autophagy have been linked to lipid accumulation in 
muscle fibers during aging (60). Nevertheless, it remains to be established to which 
extent IMCL per se mediates the decline in mitochondrial function and if changes in 
mitochondrial capacity are a cause or consequence of increased adiposity.  
In addition to changes in body composition, aging is generally associated with 
decreased physical activity levels, and previous studies suggested that mitochondrial 
function is not affected by chronological aging per se but rather by the age-related 
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decrease in physical activity (34,61,62). Sedentary, older individuals exhibit impaired 
mitochondrial function, possible loss of membrane potential, and increased oxidative 
stress (63,64). These deleterious changes promote the loss of muscle endurance 
and strength associated with age and impair life quality (64–66). Interestingly though, 
our findings described in chapter 3 indicate that even when maintaining an adequate 
daily physical activity level, reflected by    ~10 000 steps per day, a decline in 
mitochondrial function and muscle health at older age is inevitable. However, it 
should be stressed that this does not exclude moderate physical activity as an 
important factor in preventing more severe deterioration of skeletal muscle 
mitochondrial capacity and muscle function at older age. Older adults with low(er) 
physical activity levels and impaired physical function were underrepresented in our 
cohort and, likely, this group still benefits from increases in moderate physical 
activity. Indeed, in larger cohorts of older adults, the number of steps per day 
correlated with the prevention of falls (67) and all-cause mortality (68). Nonetheless, 
only participants with an even higher physical activity level, achieved through regular 
physical exercise training, were able to negate the effects of aging on skeletal 
muscle mitochondrial capacity and muscle function in our study (chapter 3). In line 
with these results, modest aerobic activity, reported as ~3.5 h/week of leisure-time 
activity, fails to prevent the age-related decrease in mitochondrial respiration and 
insulin sensitivity. Simultaneously, rigorous exercise programs such as high-intensity 
interval training can normalize mitochondrial respiration in older adults (69,70), 
underscoring the importance of intensity of exercise as a determinant of ensuring 
healthy aging. 
 
Can physical exercise training prevent biological aging? 
While physical activity is defined as any bodily movement produced by skeletal 
muscles resulting in energy expenditure, physical exercise specifically refers to 
planned, structured, repetitive, and purposive activity to improve or maintain physical 
fitness (71). Given its whole-body, health-promoting nature, physical exercise is one 
of the most powerful tools to prevent functional decline and the onset of numerous 
age-related chronic diseases (72,73). As regular exercise training promotes 
independence in older adults, it is a key component of successful aging (74). 
General Discussion 
215 
Moreover, the 2018 Physical Activity Guidelines emphasize the importance of 
regular exercise as a medical therapy in older individuals (75). Benefits of exercise 
training in older adults have been demonstrated in multiple diseases and disorders, 
including cancer, type 2 diabetes, peripheral artery disease, hypertension, 
osteoporosis, dyslipidemia, obesity, cognitive impairment, depression, anxiety, and 
sleep disorders (75). An important goal of exercise interventions in older adults is to 
preserve skeletal muscle function to prevent physical disability (76). For example, 
resistance training in aged individuals increases muscle mass and strength, 
preventing sarcopenia and age-related muscle weakness (77). Furthermore, 
endurance training improves aerobic capacity and physical function, supporting 
independence in daily living activities (78). Moreover, exercise can also prevent age-
associated intermuscular adipose tissue infiltration and the associated development 
of insulin resistance and poor muscle function (79).  
As mentioned above, we found (chapter 3) that older adults who regularly perform 
exercise training display an improved skeletal muscle mitochondrial capacity and 
muscle function compared to non-exercising older individuals. This was 
accompanied by an increased insulin sensitivity and more favorable body 
composition, with a lower percentage of overweight observed amongst the trained 
older adults compared to the normally active and inactive older adults included in this 
study. Physical exercise is well known to increase mitochondrial content and 
function, largely through stimulation of PGC-1α activity (80,81). Furthermore, 
exercise can improve the efficiency of mitochondria through remodeling of the 
mitochondrial network resulting from an improved balance between mitochondrial 
biogenesis, fusion, fission and mitophagy (82–85). Moreover, in response to 
repeated bouts of endurance exercise, several studies have presented increases in 
autophagy and mitophagy markers within the muscle (45), essential in maintaining a 
healthy mitochondrial pool.  
Despite the extensively recognized benefits of exercise training in maintaining 
physical function during aging, only 23.5% of the aging population succeeds in 
meeting the WHO recommended physical exercise levels of at least 150 minutes of 
moderate-intensity aerobic physical exercise per week (86). Furthermore, highly 
structured exercise regimes may not be realistic for all older individuals, especially 
when they are affected by comorbidities and have a poor physical function. Even 
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when older adults engage in carefully controlled exercise training regimens, the 
training response is heterogeneous (87,88). In older exercise responders, a large 
interindividual variability was observed in the improvement of functional performance 
assessed by either maximal oxygen uptake (VO2max) and walking speed after 
endurance training or by knee extensor strength after resistance training (88). 
Moreover, a fraction of older participants does not respond or even declines in 
function following exercise training and shows apparent adverse effects on 
cardiometabolic parameters such as resting systolic blood pressure, triglycerides, 
and insulin levels (87,88). Although specific mechanisms have been proposed to 
explain the decreased response to exercise in older adults, including the age-related 
decline in the bone-derived hormone osteocalcin (89), there are likely multiple 
factors at play, which deserve more investigation. 
 
Exercise responsiveness and NAD+ 
The variability in exercise training responsiveness might relate to the downregulation 
of nicotinamide adenine dinucleotide (NAD+) and the NAD+ metabolome at older 
age. NAD+ is a pyridine nucleotide that serves as an essential cofactor and substrate 
for many critical cellular processes involved in DNA repair, oxidative phosphorylation 
and ATP production, epigenetically modulated gene expression, immunological 
functions and intracellular calcium signaling (90). NAD+ content in skeletal muscle in 
the resting state is positively correlated with the oxidative capacity of skeletal muscle 
fibers (90). Exercise requires a higher NAD+ recycling rate to cope with the increased 
energetic demand, and hence changes in NAD+ levels may provide a logical 
connection between exercise-induced metabolic stress and muscle adaptation (91). 
More specifically, exercise induces local energy deprivation and increases NAD+ 
levels, activating the NAD+-dependent deacetylase SIRT1 and other sirtuins that 
control the physiological responses to exercise. SIRT1, in turn, activates PGC-1α to 
induce mitochondrial biogenesis and fatty acid oxidation (92). Decreased NAD+ 
levels in aged mice have been linked to reduced activity of SIRT1 and mitochondrial 
activity (93–95), suggesting that inadequate exercise responses could be related to 
the observed decline in NAD+ upon aging.  
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Both underproduction and overconsumption of NAD+ may contribute to NAD+ 
depletion in aging. The rate-limiting enzyme in NAD+ biosynthesis is nicotinamide 
phosphoribosyl transferase (NAMPT) (96,97) and NAMPT was shown to be 
negatively correlated with age in human skeletal muscle, indicating a possible age-
related decline in NAD+ synthesis (98). NAD+ overconsumption results from an 
overactive response to DNA damage by poly (ADP ribose) polymerases (PARPs) 
and an age-related increase in CD38, as shown in murine and human muscle tissue 
(95,96,99). Numerous animal studies have indicated NAD+ depletion as the primary 
cause of disease and disability during aging (100). Nevertheless, very few studies 
have established that NAD+ also declines with aging in human tissues (101). In 
chapter 4, we therefore performed a metabolomic analysis in skeletal muscle 
biopsies. We identified NAD+ as one of the top 3 metabolites decreasing with age in 
skeletal muscle tissue in older adults compared to young adults with similar and 
adequate physical activity levels. Moreover, NAD+ was more severely depleted in 
physically impaired older adults, whereas exercise-trained older adults were nearly 
fully protected against this age-related loss of NAD+. Interestingly, we also found 
strong correlations between muscle NAD+ content and the subjects’ daily step count, 
mitochondrial capacity, and muscle function. Our results affirm the relation of NAD+ 
with muscle health in aging human individuals and highlight the NAD+-pathway as a 
promising target to promote healthy aging, possibly in combination with exercise 
training.  
Indeed, based on a large number of preclinical studies in invertebrate lab models 
and mice, NAD+-based therapeutics have been proposed as one of the most 
promising strategies to counteract physiological aging (96,100–102). More 
specifically, supplementation of the NAD+ precursor nicotinamide mononucleotide 
(NMN) in aging mice attenuated age-related decline of muscle strength, mitigated 
the age-associated decline in energy metabolism, insulin sensitivity and lipid 
metabolism, and increased lifespan and healthspan (102). In addition, treatment with 
the NAD+ precursor nicotinamide riboside (NR) in aged mice prevented muscle stem 
cell senescence, improved mitochondrial function and increased lifespan (103). 
Another strategy to increase NAD+ bioavailability is by inhibiting the NAD+ 
consuming enzymes CD38 en PPAR, reducing enzymatic competition, and 
enhancing SIRT1 activity. Long-term inhibition of the NAD+ consuming enzyme 
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PARP in mice enhanced SIRT1 activity, which was accompanied by improved 
mitochondrial function and enhanced energy expenditure and endurance 
performance (104). Nevertheless, evidence on the efficacy of NAD+ supplementation 
in improving physical function in humans is limited. NAD+ can be derived from 
various dietary sources as it can be synthesized (1) de novo from the essential 
amino acid L-tryptophan, (2) through the Preiss-Handler pathway from vitamin B3 
compounds such as nicotinic acid (NA, niacin), or (3) through the salvage pathway 
from nicotinamide, NMN, and NR (105). Chapter 5 investigated the efficacy of 
NAD+-precursor supplementation with L-tryptophan, nicotinic acid, and nicotinamide 
in older adults with an impaired physical function. However, NAD+ precursor 
supplementation did neither affect skeletal muscle mitochondrial respiratory capacity 
nor physical function. These findings are in line with data from Elhassan et al. (106), 
who supplemented healthy, older adults with a high dose of NR and also did not 
observe any alterations in mitochondrial respiration capacity and muscle strength. In 
fact, several other studies, performed in obese individuals (107,108), middle-aged 
participants (109), and older men (110), failed to establish beneficial effects of NR 
supplementation on mitochondrial capacity and metabolic health. 
Based on these mixed findings in animals vs. humans, NAD+ precursor 
supplementation alone might not be sufficient to improve in physical performance. 
Considering that the positive effects of regular exercise training may be limited in 
older adults by the dysregulated NAD+ metabolome, it is conceivable that the 
combination of exercise training with NAD+ precursor supplementation could 
potentiate exercise therapy in older adults. Preclinical studies on the combination of 
NR (48,49) or NMN (113) with exercise training have reported mixed results. These 
studies were conducted mainly on young animals and used different exercise 
protocols. Nevertheless, NR has a good safety profile and showed beneficial effects 
in individuals with impaired baseline health status, as shown in patients with 
myopathies (114). Additional well-designed preclinical studies and RCTs in humans 
are warranted to test the combination of NAD+ precursor supplementation and 
exercise in improving the homeostasis of the NAD+ metabolome, mitochondrial 
function and exercise tolerance in older adults with moderate physical function. 
Taken together, physical exercise training is a powerful tool to prevent the decline in 
physical integrity with age but might not be feasible and equally effective for all older 
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individuals. Nutritional supplementation of NAD+ precursors might facilitate and 
optimize the adaptive process to exercise training in older adults, and as such, may 
boost the efficacy of exercise therapy for healthy aging.  
 
Concluding remarks  
This thesis aimed to study skeletal muscle mitochondria’s role in the age-related loss 
of physical function. Based on the results, we conclude that, despite maintaining 
recommended daily physical activity levels, aging is associated with a decline in 
mitochondrial capacity, NAD+ levels, muscle health, and physical function. Higher 
levels of physical activity, achieved through high-intensity regular exercise training, 
partially prevent the effects of aging on NAD+ abundance, mitochondrial function, 
and muscle health. The observed correlations between mitochondrial capacity and 
exercise efficiency and insulin sensitivity highlight the role of mitochondrial 
dysfunction in accelerated aging and deterioration of skeletal muscle health. 
Moreover, NAD+ metabolism strongly correlates with skeletal muscle health during 
aging as assessed through mitochondrial and physical functioning, affirming the 
relation of NAD+ with overall health status, especially in older adults, and 
emphasizing the NAD-pathway as a promising target to promote healthy aging in 
humans. Nevertheless, NAD+ supplementation with NAD+-precursors alone did not 
improve mitochondrial function and muscle health. Moreover, we conclude that 
despite differences in fiber type distribution across the different age groups, muscle 
tissue properties per se are not key factors for balance recovery, highlighting that fall 
prevention training should include the multiple aspects of physical decline with aging. 
   
Taken together, mitochondria represent a significant target in the strategy to extend 
healthspan. To this point, exercise remains the most effective behavioral medicine 
for improving mitochondrial health, not only in muscle but also in other tissues. 
Further elucidation of mitochondrial turnover mechanisms and NAD+ metabolism in 
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Spiergezondheid en veroudering: een focus op mitochondriën, metabolisme 
en fysieke functie. 
Mensen leven langer dan ooit tevoren en ondanks de voortdurend verbeterende 
levensverwachting en gezondheidszorg, is het behoud van een goede 
levenskwaliteit gedurende deze extra jaren niet vanzelfsprekend. Eén van de meest 
opvallende processen bij het ouder worden is de progressieve afname van 
spiermassa en spierkracht. Dit verlies van spierkwaliteit is gaat gepaard met 
functionele beperkingen en het verlies van onafhankelijkheid in dagelijkse 
activiteiten, maar ook met metabole stoornissen en een groter risico op chronische 
ziekten. Eén van de veronderstelde oorzaken van het verlies van spiergezondheid 
tijdens veroudering is de afname van de mitochondriële capaciteit. Dit proefschrift 
beoogt een beter inzicht te krijgen in de rol van het mitochondriële metabolisme in de 
afname van de spiergezondheid tijdens veroudering. Daarbij is tevens aandacht voor 
verschillende andere factoren die tijdens het verouderingsproces vaak gelijktijdig 
veranderen, zoals een afname van fysieke activiteit en veranderingen in 
lichaamssamenstelling. Inzichten in het proces van spierveroudering op fysiologisch 
en moleculair niveau kunnen bijdragen aan de verdere ontwikkeling van optimale 
strategieën om ook op oudere leeftijd een goede (spier)gezondheid en 
levenskwaliteit te behouden. 
Mitochondriën zijn geen op zichzelf staande organellen, maar vormen strak 
gereguleerde, dynamische netwerken. Om te kunnen voldoen aan de fluctuerende 
energiebehoeftes van de cel worden deze netwerken voortdurend opgebouwd, 
afgebroken en onderworpen aan strenge kwaliteitscontroles. Om de gepaste 
morfologie en functie te behouden, kunnen slecht functionerende delen van 
mitochondriële netwerken worden afgesplitst en afgebroken via een proces dat 
mitofagie wordt genoemd. Daarnaast kunnen nieuwgevormde mitochondriën fuseren 
met andere mitochondriën om zo het mitochondriële netwerk aan te passen aan de 
fysiologische benodigdheden van de cel. Een goede dynamiek van het netwerk is 
essentieel voor het behoud van een optimale mitochondriële functie. Hoofdstuk 2 
bestudeert de beschikbare literatuur over verstoringen in de regulatie van 
mitochondriële netwerken bij veroudering. Deze literatuurstudie laat zien dat een 
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afwijkende mitochondriële dynamiek en verminderde kwaliteitscontrole gerelateerd 
zijn aan de gezondheid van skeletspieren bij veroudering. De conclusie is ook dat er 
meer humane studies nodig zijn om de onderliggende mechanismen te begrijpen en 
nieuwe therapieën te ontwikkelen om de verstoorde mitochondriële dynamiek bij 
ziekte en veroudering aan te pakken. 
 
Of de afname van de mitochondriële functie tijdens het ouder worden verklaard 
wordt door de toenemende (chronologische) leeftijd of meer door een 
leeftijdsgebonden afname in fysieke activiteit is nog onduidelijk. In hoofdstuk 3 werd 
daarom het effect van leeftijd op mitochondriële functie en spiergezondheid 
onderzocht aan de hand van een gedetailleerde fenotypische karakterisering van 
jongere en oudere personen met vergelijkbare niveaus van fysieke activiteit. 
Daarnaast werd de invloed van fysieke activiteit op het verouderingsproces 
onderzocht door een vergelijking te maken in spierfunctie en spiergezondheid tussen 
getrainde ouderen, ouderen met een normaal niveau van fysieke activiteit en 
ouderen met een verminderde fysieke functie. Het vergelijken van deze groepen laat 
zien dat veroudering geassocieerd is met een afname van de mitochondriële functie, 
inspanningsvermogen, inspanningsefficiëntie, loopstabiliteit, spierfunctie en 
insulinegevoeligheid. Opvallend genoeg zien we deze afname in ouderen ondanks 
dat het fysiek activiteitsniveau vergelijkbaar is met dat van jongeren. Tevens voldoen 
beide groepen qua activiteit aan de algemene aanbevelingen, namelijk een 
gemiddelde van 10000 stappen per dag. Enkel een forse verhoging van de fysieke 
activiteit, door middel van regelmatig en intensief te trainen, blijkt de effecten van 
veroudering op de mitochondriële functie en spierfunctie tegen te kunnen gaan. 
Daarnaast onderschrijven de waargenomen correlaties tussen mitochondriële 
capaciteit en inspanningsefficiëntie en insulinegevoeligheid, de rol van mitochondria 
bij de afname van de spiergezondheid tijdens veroudering. Deze resultaten 
identificeren de mitochondria als een potentieel therapeutisch doelwit om 
spierveroudering tegen te gaan en om de fysieke functie te kunnen behouden. 
Om beter te begrijpen waarom de mitochondriële functie afneemt met de leeftijd, 
werden in hoofdstuk 4 de metabole verschillen in het spierweefsel van de 
proefpersonen uit hoofdstuk 3 verder onderzocht. Het niveau van 137 metabolieten 
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(metabole signaalstoffen) werd gedetecteerd en vergeleken in jongeren, ouderen 
met een normale fysieke functie, getrainde ouderen en ouderen met een 
verminderde fysieke functie en 65 metabolieten bleken te veranderen met 
veroudering. Van de metabolieten die verlaagd waren in ouderen ten opzichte van 
jongeren, was de afname van nicotinamide adenine dinucleotide (NAD+) het meest 
prominent. NAD+ is een essentieel metaboliet dat onder andere nodig is voor 
verschillende cellulaire processen die betrokken zijn bij oxidatieve fosforylering en 
energieproductie in de mitochondriën. Interessant is dat hoofdstuk 4 ook aantoont 
dat deze afname in NAD+ sterker aanwezig is bij ouderen met een verminderde 
fysieke functie en dat het NAD+ niveau bij fysiek getrainde ouderen bijna volledig 
vergelijkbaar is met dat van de jongeren. NAD+ en andere belangrijke metabolieten 
van het NAD+ metabolisme blijken ook sterk te correleren met de mitochondriële 
functie, het gemiddeld aantal stappen per dag en de spiergezondheid. Deze 
resultaten tonen de potentie aan van inspanningstraining om gezond ouder te 
worden en suggereren een cruciale rol van NAD+ hierin.  
Een mogelijke manier om het aan veroudering gerelateerde verlies in NAD+ tegen te 
gaan is door middel van de suppletie van NAD+- precursoren via de voeding. In 
hoofdstuk 5 werd het effect onderzocht van een 32 dagen durende suppletie met 
NAD+-precursoren (bestaande uit L-tryptofaan, nicotinezuur en nicotinamide) op de 
mitochondriële functie en spiergezondheid in ouderen met een lagere fysieke functie. 
In de controle arm namen alle deelnemers gedurende 32 dagen tevens een 
controlemiddel, zonder NAD+ precursoren. Hierbij was niet bekend in welke volgorde 
zij de NAD+ supplementen en het controlemiddel ontvingen. De studieresultaten 
tonen aan dat de NAD+ concentraties in de skeletspier niet significant verschillen in 
vergelijking met de controleconditie. Echter is de concentratie van het 
afbraakproduct methyl-nicotinamide significant hoger na suppletie met NAD+-
precursoren wat lijkt te wijzen op een verhoging van het NAD+ metabolisme. De 
mitochondriële respiratie capaciteit blijkt niet te verbeteren door suppletie met NAD+-
precursoren en de inspanningsefficiëntie en spierfunctie blijven onveranderd. Deze 
resultaten zijn vergelijkbaar met andere studieresultaten over de werkzaamheid van 
NAD+-precursoren via de voeding in mensen. Kortom, de inname van extra NAD+-
precursoren bestaande uit L-tryptofaan, nicotinezuur en nicotinamide verhoogt de 
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methylnicotinamide niveaus in de spieren, maar verbetert de mitochondriële 
capaciteit en spiergezondheid niet in ouderen met een verminderde fysieke functie. 
Eén van de meest kritieke complicaties van veroudering is het verlies van 
evenwichtscontrole en stabiliteit, wat leidt tot een verhoogd risico op vallen en val-
gerelateerde gevolgen zoals breuken, verdere functionele achteruitgang en 
immobiliteit. Over het algemeen wordt aangenomen dat spiermassa en kracht 
essentiële factoren zijn om met grote evenwichtsverstoringen om te gaan. Echter 
blijkt spierkrachttraining slechts een matig effect te hebben op de 
evenwichtscontrole. De leeftijdsgebonden afname van spiermassa wordt 
voornamelijk toegeschreven aan atrofie van type II spiervezels wat leidt tot een 
afname van de spierkracht. In hoofdstuk 6 onderzochten we of de karakteristieken 
van de type II spiervezels al dan niet geassocieerd zijn met de evenwichtscontrole 
van jonge en oudere personen. Om dit te doen werd de dynamische stabiliteit 
gemeten tijdens een evenwichtsverstoring op een loopband en werden de 
spiervezels gekarakteriseerd in spierbiopsies van de jongvolwassenen, normaal 
actieve ouderen, getrainde ouderen en ouderen met een verminderde spierfunctie. 
Ondanks de grote variatie in spiervezelverdeling, spiermassa en spierkracht over de 
verschillende groepen, blijken deze spiereigenschappen niet te correleren met de 
stabiliteit tijdens deze evenwichtsverstoringen. Dit geeft aan dat valpreventie 
interventies niet enkel zouden moeten focussen op het verbeteren van de kwaliteit 
van het spierweefsel, maar dat mogelijk ook de andere verouderingsprocessen 
moeten worden aangepakt om functionele achteruitgang in ouderen te voorkomen. 
Op basis van dit proefschrift kunnen we concluderen dat ondanks het handhaven 
van de aanbevolen hoeveelheid dagelijkse lichaamsbeweging, veroudering gepaard 
gaat met een afname van de mitochondriële capaciteit, NAD+ metabolisme, 
spiergezondheid, loopstabiliteit en fysieke functie. Enkel hogere niveaus van fysieke 
activiteit, bereikt door regelmatig en intensief te trainen, kunnen de effecten tegen 
gaan van veroudering op het NAD+ metabolisme, mitochondriële functie en 
spiergezondheid. Een beter begrip van de regulatie van mitochondriële functie en de 
rol van NAD+ metabolisme in de spier bieden mogelijk therapeutische 
aanknopingspunten om de achteruitgang in fysieke functie tegen te gaan en op een 




Skeletal muscle health in aging: A focus on mitochondria, metabolism, and 
physical performance 
People are living longer than ever before and despite continuously improving life 
expectancy and healthcare, maintaining a good quality of life during these extra 
years is not a matter of course. One of the most striking processes of aging is the 
progressive decline in muscle mass and strength. This loss of muscle quality is 
associated with functional limitations and loss of independence in daily activities, as 
well as metabolic disorders and a greater risk of chronic disease. One of the 
hypothesized causes of the loss of muscle health during aging is the decrease in 
mitochondrial capacity. This thesis aims to gain a better understanding of the role of 
mitochondrial metabolism in the decline of muscle health during aging. Attention is 
also paid to several other factors that often change simultaneously during the aging 
process, such as a decrease in physical activity and changes in body composition. 
Insights into the process of muscle aging on a physiological and molecular level can 
contribute to the further development of to maintain good (muscle) health and quality 
of life in old age. 
Mitochondria form tightly regulated, dynamic networks. To meet the fluctuating 
energy needs of the cell, these networks are continuously built, broken down, and 
subjected to strict quality controls. To maintain appropriate morphology and function, 
malfunctioning portions of mitochondrial networks can be cleaved off and broken 
down through a process called mitophagy. In addition, newly formed mitochondria 
can fuse with other mitochondria to adapt the mitochondrial network to the 
physiological needs of the cell. Good network dynamics are essential for maintaining 
optimal mitochondrial function. Chapter 2 examines the available literature on 
disturbances in the regulation of mitochondrial networks in aging. This literature 
review shows that aberrant mitochondrial dynamics and impaired quality control are 
related to skeletal muscle health in aging. It also concludes that more human studies 
are needed to understand the underlying mechanisms and develop new therapies to 
address the disrupted mitochondrial dynamics in disease and aging. 
Whether the decrease in mitochondrial function during aging is explained by 
increasing (chronological) age or by an age-related reduction in physical activity is 
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still unclear. Therefore, in chapter 3 the effect of age on mitochondrial function and 
muscle health was investigated by detailed phenotypic characterization of younger 
and older individuals with comparable levels of physical activity. In addition, the 
influence of physical activity on the aging process was investigated by comparing 
muscle function and muscle health between trained older adults, older adults with 
normal levels of physical activity, and older adults with reduced physical function. 
Comparing these groups shows that aging is associated with a decrease in 
mitochondrial function, exercise capacity, exercise efficiency, gait stability, muscle 
function, and insulin sensitivity. Remarkably, we see this decrease in older adults 
despite the fact that the physical activity level is comparable to that of young people. 
Both groups also meet the general recommendations in terms of activity, namely an 
average of 10,000 steps per day. Only a substantial increase in physical activity, 
through regular and intensive training, appears to counteract the effects of aging on 
mitochondrial and muscle function. In addition, the observed correlations between 
mitochondrial capacity and exercise efficiency, and insulin sensitivity support the role 
of mitochondria in the decline in muscle health during aging. These results identify 
the mitochondria as a potential therapeutic target to counteract muscle aging and 
maintain physical function. 
To better understand why mitochondrial function declines with age, in chapter 4 the 
metabolic differences in the muscle tissue of the subjects from chapter 3 were further 
investigated. The level of 137 metabolites (metabolic signaling substances) was 
detected and compared in young people, the older adults with normal physical 
function, trained older adults, and older adults with impaired physical function, and 
65 metabolites were found to change with aging. Of the metabolites decreased in the 
older adults compared to the young, the decrease in nicotinamide adenine 
dinucleotide (NAD+) was most prominent. NAD+ is an essential metabolite required 
for various cellular processes involved in oxidative phosphorylation and energy 
production in the mitochondria. Interestingly, chapter 4 also shows that this 
decrease in NAD+ is more pronounced in older adults with impaired physical function 
and that NAD+ levels in physically trained older adults are almost completely 
comparable to that of the young. NAD+ and other metabolites of NAD+ metabolism 
have also been found to correlate strongly with mitochondrial function, average steps 
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per day, and muscle health. These results demonstrate the potential of exercise 
training for healthy aging and suggest a crucial role of NAD+ in this. 
A possible way to counteract the aging-related loss in NAD+ is through dietary 
supplementation of NAD+ precursors. In chapter 5, the effect of a 32-day 
supplementation with NAD+ precursors (consisting of L-tryptophan, nicotinic acid, 
and nicotinamide) on mitochondrial function and muscle health in older adults with 
lower physical function was investigated. In the control arm, all participants also took 
a control product, without NAD+ precursors, for 32 days. It was not known in which 
order they received the NAD+ supplements and the control. The study results show 
that the NAD+ concentrations in skeletal muscle do not differ significantly compared 
to the control condition. However, the concentration of the degradation product 
methyl-nicotinamide is significantly higher after supplementation with NAD+ 
precursors, which seems to indicate an increase in NAD+ metabolism. The 
mitochondrial respiratory capacity does not appear to be improved by 
supplementation with NAD+ precursors and the exercise efficiency and muscle 
function remain unchanged. These results are comparable to other study results on 
the efficacy of dietary NAD+ precursors in humans. In short, the intake of additional 
NAD+ precursors consisting of L-tryptophan, nicotinic acid, and nicotinamide 
increases methylnicotinamide levels in muscles but does not improve mitochondrial 
capacity and muscle health in older adults with a reduced physical function. 
One of the most critical complications of aging is loss of balance control and stability, 
leading to an increased risk of falls and fall-related consequences such as fractures, 
further functional decline, and immobility. It is generally believed that muscle mass 
and strength are essential factors for dealing with significant imbalances. However, 
muscle strength training appears to have only a moderate effect on balance control. 
The age-related decrease in muscle mass is mainly attributed to the atrophy of type 
II muscle fibers leading to a decrease in muscle strength. In chapter 6 we 
investigated whether or not the characteristics of the type II muscle fibers are 
associated with balance control in young and older participants. Dynamic stability 
was measured during a balance disturbance on a treadmill, and muscle fibers were 
characterized in muscle biopsies from the young adults, normally active older adults, 
trained older adults, and older adults with impaired muscle function. Despite the 
large variation in muscle fiber distribution, muscle mass, and muscle strength across 
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the different groups, these muscle properties do not appear to correlate with stability 
during these imbalances. This indicates that fall prevention interventions should not 
only focus on improving muscle tissue quality but may also need to address other 
aging processes to prevent functional decline in older adults. 
Based on this thesis, we can conclude that despite maintaining the recommended 
amount of daily physical activity, aging is associated with a decrease in 
mitochondrial capacity, NAD+ metabolism, muscle health, gait stability, and physical 
function. Only higher levels of physical activity, achieved through regular and intense 
exercise, can counteract the effects of aging on NAD+ metabolism, mitochondrial 
function, and muscle health. A better understanding of the regulation of 
mitochondrial function and the role of NAD+ metabolism in muscle may provide 





Salute dei muscoli scheletrici nell'invecchiamento: un focus su mitocondri, 
metabolismo e prestazioni fisiche  
Le persone vivono più a lungo che mai e, nonostante il continuo miglioramento 
dell'aspettativa di vita e dell'assistenza sanitaria, mantenere una buona qualità della 
vita durante tutti questi anni non è scontato. Uno dei processi più eclatanti 
dell'invecchiamento, è il progressivo declino della massa muscolare e della forza. 
Questa perdita di qualità muscolare, è associata a limitazioni funzionali e perdita di 
indipendenza nelle attività quotidiane, nonché a disturbi metabolici e ad un maggior 
rischio di malattie croniche. Una delle cause ipotizzate della perdita di salute 
muscolare durante l'invecchiamento, è la diminuzione della capacità mitocondriale. 
Questa tesi, mira ad ottenere una migliore comprensione del ruolo del metabolismo 
mitocondriale nel declino della salute muscolare durante l'invecchiamento. Viene 
prestata attenzione anche a diversi altri fattori, che spesso cambiano 
contemporaneamente durante il processo di invecchiamento, come la diminuzione 
dell'attività fisica e le variazioni della composizione corporea. Approfondimenti sul 
processo di invecchiamento muscolare a livello fisiologico e molecolare, possono 
contribuire all'ulteriore sviluppo di strategie ottimali per mantenere una buona salute 
(muscolare) e una buona qualità di vita in età avanzata. 
I mitocondri, sono reti dinamiche strettamente regolate. Per soddisfare le fluttuazioni 
del fabbisogno energetico della cellula, queste reti vengono continuamente costruite, 
scomposte e sottoposte a severi controlli di qualità. Per mantenere una morfologia e 
una funzione appropriate, le parti malfunzionanti delle reti mitocondriali possono 
essere scisse e scomposte attraverso un processo chiamato mitofagia. Inoltre, i 
mitocondri di nuova formazione, possono fondersi con altri mitocondri per adattare la 
rete mitocondriale ai bisogni fisiologici della cellula. Una buona dinamica della rete è 
essenziale per mantenere una funzione mitocondriale ottimale. Il capitolo 2, esamina 
la letteratura disponibile sui disturbi nella regolazione delle reti mitocondriali 
nell'invecchiamento. Questa revisione della letteratura, mostra che le dinamiche 
mitocondriali aberranti e il controllo di qualità alterato, sono correlati alla salute del 
muscolo scheletrico nell'invecchiamento. Si afferma inoltre, che sono necessari 
ulteriori studi sull'uomo per comprendere i meccanismi sottostanti e sviluppare nuove 
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terapie per affrontare le dinamiche mitocondriali interrotte nella malattia e 
nell'invecchiamento. 
Non è ancora chiaro se la diminuzione della funzione mitocondriale durante 
l'invecchiamento sia spiegata dall'aumento dell'età (cronologica) o, piuttosto, da una 
diminuzione dell'attività fisica correlata all'età. Pertanto, nel capitolo 3, è stato 
studiato l'effetto dell'età sulla funzione mitocondriale e sulla salute muscolare, 
mediante una dettagliata caratterizzazione fenotipica di individui più giovani e più 
anziani con comparabili livelli di attività fisica. Inoltre, è stata studiata l'influenza 
dell'attività fisica sul processo di invecchiamento, confrontando la funzione 
muscolare e la salute muscolare tra anziani che fanno spesso sport, anziani con 
normali livelli di attività fisica e anziani con funzione fisica ridotta. Il confronto di 
questi gruppi, mostra che l'invecchiamento è associato a una diminuzione della 
funzione mitocondriale, della capacità di esercizio, dell'efficienza dell'esercizio, della 
stabilità dell'andatura, della funzione muscolare e della sensibilità all'insulina. 
Sorprendentemente, vediamo questa diminuzione negli anziani, nonostante il fatto 
che il livello di attività fisica sia paragonabile a quello dei giovani. Entrambi i gruppi, 
soddisfano anche le raccomandazioni generali in termini di attività, ovvero una 
media di 10.000 passi al giorno. Solo un sostanziale aumento dell'attività fisica, 
attraverso un allenamento regolare e intensivo, sembra contrastare gli effetti 
dell'invecchiamento sulla funzione mitocondriale e muscolare. Inoltre, le correlazioni 
osservate tra capacità mitocondriale, efficienza dell'esercizio e sensibilità all'insulina, 
supportano il ruolo dei mitocondri nel declino della salute muscolare durante 
l'invecchiamento. Questi risultati, identificano i mitocondri come un potenziale 
bersaglio terapeutico, per contrastare l'invecchiamento muscolare e mantenere la 
funzione fisica. 
Per capire meglio perché la funzione mitocondriale diminuisce con l'età, nel capitolo 
4 sono state ulteriormente studiate le differenze metaboliche nel tessuto muscolare 
dei soggetti del capitolo 3. Il livello di 137 metaboliti (sostanze di segnalazione 
metabolica), è stato rilevato e confrontato nei giovani, negli anziani con funzione 
fisica normale, negli anziani allenati e negli anziani con funzione fisica compromessa 
e, 65 metaboliti, sono stati trovati a cambiare con l'invecchiamento. Dei metaboliti 
diminuiti negli anziani rispetto ai giovani, la diminuzione della nicotinamide adenina 
dinucleotide (NAD+) è stata la più notevole. NAD+, è un metabolita essenziale 
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richiesto per vari processi cellulari coinvolti nella fosforilazione ossidativa e nella 
produzione di energia nei mitocondri. È interessante notare, che il capitolo 4 mostra 
anche che questa diminuzione di NAD+ è più pronunciata negli anziani con funzione 
fisica compromessa e che i livelli di NAD+ negli anziani allenati fisicamente, sono 
quasi completamente paragonabili a quelli dei giovani. È stato anche scoperto che il 
NAD+ e altri metaboliti del metabolismo del NAD+ sono fortemente correlati con la 
funzione mitocondriale, i passi medi al giorno e la salute muscolare. Questi risultati 
dimostrano il potenziale dell'esercizio fisico, per un invecchiamento sano e 
suggeriscono un ruolo cruciale del NAD+ in questo. 
Un modo possibile per contrastare la perdita di NAD+ correlata all'invecchiamento, è 
attraverso l'integrazione alimentare di precursori di NAD+. Nel capitolo 5, è stato 
studiato l'effetto di un'integrazione di 32 giorni con precursori NAD+ (costituiti da L-
triptofano, acido nicotinico e nicotinamide), sulla funzione mitocondriale e sulla 
salute muscolare negli anziani con funzione fisica inferiore. In una delle fasi, tutti i 
partecipanti hanno anche assunto un prodotto di controllo, senza precursori NAD+ 
per 32 giorni. Non era noto in quale ordine ricevessero gli integratori NAD+ e i 
prodotti di controllo. I risultati dello studio, mostrano che le concentrazioni di NAD+ 
nel muscolo scheletrico, non differiscono significativamente rispetto alla condizione 
di controllo. Tuttavia, la concentrazione del prodotto di degradazione 
metilnicotinammide è significativamente più alta dopo l'integrazione con precursori di 
NAD+, il che sembra indicare un aumento del metabolismo del NAD+. La capacità 
respiratoria mitocondriale, non sembra essere migliorata dall'integrazione con 
precursori NAD+ inoltre, l'efficienza dell'esercizio e la funzione muscolare rimangono 
invariate. Questi risultati sono paragonabili ai risultati di altri studi sull'efficacia dei 
precursori NAD+ nella dieta nell'uomo. In breve, l'assunzione di precursori NAD+ 
aggiuntivi costituiti da L-triptofano, acido nicotinico e nicotinamide aumenta i livelli di 
metilnicotinamide nei muscoli, ma non migliora la capacità mitocondriale e la salute 
muscolare negli anziani con una funzione fisica ridotta. 
Una delle complicanze più critiche dell'invecchiamento, è la perdita del controllo 
dell'equilibrio e della stabilità, che porta ad un aumento del rischio di cadute e delle 
conseguenze ad esse correlate, come fratture, ulteriore declino funzionale e, 
qualche volta, immobilità. Si ritiene generalmente, che la massa muscolare e la forza 
siano fattori essenziali per affrontare squilibri significativi. Tuttavia, l'allenamento 
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della forza muscolare sembra avere solo un effetto moderato sul controllo 
dell'equilibrio. La diminuzione della massa muscolare legata all'età, è principalmente 
attribuita all'atrofia delle fibre muscolari di tipo II che porta ad una diminuzione della 
forza muscolare. Nel capitolo 6, abbiamo studiato se le caratteristiche delle fibre 
muscolari di tipo II, sono associate o meno al controllo dell'equilibrio in soggetti 
giovani e anziani. La stabilità dinamica, è stata misurata durante un disturbo 
dell'equilibrio su un tapis roulant e le fibre muscolari sono state caratterizzate in 
biopsie muscolari di giovani adulti, anziani normalmente attivi, anziani allenati e 
anziani con funzione muscolare compromessa. Nonostante la grande variazione 
nella distribuzione delle fibre muscolari, nella massa muscolare e nella forza 
muscolare tra i diversi gruppi, queste proprietà muscolari non sembrano essere 
correlate alla stabilità durante questi squilibri. Ciò indica che gli interventi di 
prevenzione delle cadute, non dovrebbero concentrarsi solo sul miglioramento della 
qualità del tessuto muscolare, ma potrebbero anche dover affrontare altri processi di 
invecchiamento per prevenire il declino funzionale negli anziani. 
Sulla base di questa tesi, possiamo concludere che, nonostante il mantenimento 
della quantità raccomandata di attività fisica quotidiana, l'invecchiamento è associato 
a una diminuzione della capacità mitocondriale, del metabolismo NAD+, della salute 
muscolare, della stabilità dell'andatura e della funzione fisica. Solo livelli più elevati di 
attività fisica, raggiunti attraverso un esercizio fisico intenso e regolare, possono 
contrastare gli effetti dell'invecchiamento sul metabolismo NAD+, sulla funzione 
mitocondriale e sulla salute muscolare. Una migliore comprensione della regolazione 
della funzione mitocondriale e del ruolo del metabolismo NAD+ nel muscolo, può 
fornire indicazioni terapeutiche per contrastare il declino della funzione fisica e 




What is the main objective of the thesis, and what are the most important 
results and conclusions? 
Between 1990 and 2019, the number of people older than 80 has tripled, and this 
number is expected to triple again by 2050 (1). This enormous accomplishment of 
increasing life expectancy illustrates the remarkable advances achieved in 
biomedicine and healthcare but comes at a cost though, since many diseases such 
as type 2 diabetes and cardiovascular diseases are more prevalent at an older age 
(2). Moreover, in proportion, there are increasingly more older adults in the 
population than young individuals, an imbalance known as the 'silver tsunami,' which 
implicates increased healthcare costs and significant social challenges. If we 
consider the aging human body, skeletal muscle is prominently affected. Age-
induced loss of lean muscle mass and function is known as sarcopenia and leads to 
disabilities and increased dependency and care needs. A better understanding of the 
aging process itself, rather than focusing on age-associated disease, can help to 
develop strategies to target the aging process and maintain people's health during 
those extra years of life.  
In the cells of the human body, the mitochondria are organelles that maintain cellular 
energy levels necessary for all vital processes. As a result, mitochondria are also 
known as the cell's powerhouses. In muscle cells, healthy mitochondria regulate 
various metabolic processes and provide energy for muscle contractions. It is well 
documented that with aging, muscle mitochondrial function declines, which is 
paralleled by a loss in muscle strength and mass. Importantly, this reduction in 
muscle health translates into a loss of physical independence and an increased risk 
for metabolic disease. If and how age-related alterations in mitochondrial function 
and muscle health (causally) relate to each other is however not well established in 
humans. This thesis aimed to better understand the aging process in skeletal muscle 
by investigating the role of mitochondrial metabolism in the age-related loss of 
physical performance. 
It has become increasingly clear that mitochondria do not operate as individual 
organelles but physically and functionally connect into dynamic networks. These 
networks are constantly built, restored, and subjected to quality control mechanisms 
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to assure efficient mitochondrial function. Growing evidence indicates that altered 
mitochondrial dynamics and impaired quality control influence skeletal muscle health 
in aging and metabolic disease. In chapter 2 this evidence was reviewed in a 
literature study on the role of abnormal mitochondrial network dynamics in the age-
related loss of muscle health. However, more - especially human - studies are 
needed to understand the implications and underlying mechanisms in order to 
develop new therapeutics to target mitochondrial dynamics in human disease. An 
important first step in this context is to develop suitable techniques to study these 
dynamic processes properly. 
To better understand the relationship between skeletal muscle mitochondrial 
metabolism and muscle health, we, in chapter 3, extensively measured 
mitochondrial capacity and muscle function in young and older adults. We found that 
aging is associated with a decline in mitochondrial capacity, muscle health, and 
physical function. Interestingly, this decline was observed in older adults despite the 
fact that they performed more than 10000 steps-per-day, which is above the general 
physical activity recommendations. Since we also studied trained older adults in this 
study, we could also show that only a further increase in physical activity levels, 
achieved through regular high-intensity exercise training, was able to prevent the 
effects of aging on muscle health. Furthermore, we found a correlation between 
mitochondrial function and muscle health, indicating that maintaining mitochondrial 
function at older age is important to promote healthy aging. 
To further understand why mitochondrial function declines when we age, we next 
studied the muscle tissue of the young and older participants and compared their 
metabolic profiles, using untargeted metabolomics (chapter 4).  The most prominent 
change we observed was an age-related decline in NAD+, an essential metabolite 
that is needed in the mitochondria to generate energy. Interestingly, this decline in 
NAD+ was exacerbated in older individuals with a lower physical function and was 
nearly entirely prevented in the exercise-trained older adults. NAD+ also strongly 
correlated to the average steps-per-day and mitochondrial and muscle functioning, 
demonstrating the importance of exercise to age healthier and suggesting a crucial 
role of NAD+ therein.  
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A strategy to potentially alleviate the age-related depletion of NAD+ in the 
mitochondria is by stimulating NAD+ synthesis through nutritional supplementation of 
NAD+ precursors. In this context, chapter 5 explored the effectiveness of NAD+ 
precursors supplementation (consisting of tryptophan, vitamin B3, and nicotinamide) 
on NAD+ levels, mitochondrial function, and muscle health in older adults with 
reduced physical function. Nevertheless, the extra intake of these NAD+ precursors 
appeared not to be sufficient to boost mitochondrial function and failed to improve 
physical function. 
One of the most critical consequences of age-related decrease in physical function is 
the loss of balance control leading to an increased risk of falls and fall-related effects 
such as fractures, further functional decline, immobility, and causal mortality. 
Therefore, fall prevention therapy is essential to promote healthy aging. The 
reduction in muscle strength and mass is assumed to be the main reason for the 
age-related loss in the ability to cope with balance disturbances. Nevertheless, in 
chapter 6, no strong correlations were observed in young and older adults between 
muscle characteristics and balance control. These results indicate that fall prevention 
therapy in older individuals should not only focus on improving muscle quality, but a 
multi-domain intervention might be necessary.  
Taken together, results from this dissertation indicate the importance of 
mitochondrial function and NAD+ metabolism in muscle aging and suggest that 
physical exercise training remains the most powerful tool to improve mitochondrial 
function and to age in a healthy way. A better understanding of the role of NAD+ in 
muscle metabolism and the mitochondrial quality control mechanism can reveal 
promising therapeutic targets to promote healthy aging. 
 
What is the contribution of the research results to science and society? 
The studies described in this thesis add to the existing knowledge on changes that 
occur in skeletal muscle while human age. With this new knowledge, we add some 
pieces to the puzzle and contribute to the clarification of the complex process of 
aging. Our results may help to identify new targets and approaches in order to 
prevent age-related disability and help people live a long healthy life.  
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Due to the vital role of skeletal muscle in daily life activities, the deterioration of 
muscle mass and function (sarcopenia) leads to a decreased quality of life, 
increased hospitalization rates and the loss of independence. Over the coming 
decades, the prevalence of sarcopenia is expected to increase drastically in Europe, 
and these trends will not only be a burden for the older population. They will impose 
a tremendous financial load on society as a whole in terms of increased healthcare 
costs, which are expected to double for European countries such as The 
Netherlands (3). To make healthcare affordable and preserve a good quality of life, it 
is crucial to maintain people's health and physical independence at older age. A 
better understanding of the aging process itself can help us identify strategies to 
promote healthy aging and significantly impact society. 
 
To whom are the research results relevant?  
The research results of this thesis are relevant to different stakeholders. First of all, 
these results are of interest to researchers working in the field of aging and aging-
related diseases, as they contribute to a better understanding of how skeletal muscle 
metabolism and function change as we age. With this knowledge, researchers can 
investigate new targets and explore new avenues aimed at growing old in a healthy 
way. The new insights into the relationship between impaired muscle health and 
mitochondrial metabolism are also interesting to the food industry, as mitochondrial 
metabolism may be sensitive to nutritional intervention. This opens up new 
opportunities to develop nutritional strategies to prevent the age-related loss of 
physical function. The research results also support clear benefits of exercise 
training for older adults, which allow better recommendations, explanations, and 
motivations on how to maintain a healthy lifestyle. These recommendations can be 
adopted by the government and/or healthcare in general. Finally, these studies are 
of interest to the general public as they provide leads on how to preserve a healthy 
muscle function and a high quality of life while aging. 
Several communication strategies are applied to inform the various relevant 
stakeholders. The results are used for original scientific articles which have been 
submitted to international, peer-reviewed journals. Once these articles are published, 
the knowledge from these studies is shared with scientists worldwide. The studies 
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have also been presented at several conferences and symposia, which increases 
the visibility of the results and thereby contributes to new insights and ideas for 
future research. In addition, during regular expert meetings and project-based 
seminars, the results have been shared regularly with the industrial partners and 
collaborating universities within the TIFN Mitochondrial Health project. Being part of 
this TIFN consortium enhanced collaborations between academia and industry, 
thereby fostering translational research. Finally, the results can be communicated 
during general lectures to increase public awareness of the importance of healthy 
aging 
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En jawel, daar is hij dan, meer in zicht dan ooit: de eindstreep! Dit promotietraject 
voelde voor mij aan als een lange marathon met wat struikelblokken en doorbijt 
momenten maar ook veel goede coaches en trouwe supporters die me hebben 
geholpen dit doel te bereiken. Zonder deze mensen zou ik de eindstreep niet over 
zijn geraakt en ik wil dan ook de resterende adrenaline van deze eindspurt gebruiken 
om deze mensen te bedanken. 
Ik kan me de dag van mijn sollicitatie nog goed herinneren. De positie leek me 
enorm interessant en het zou ook betekenen dat ik na 2 jaren Milaan terug dichter bij 
mijn familie zou komen wonen. Mijn trouwe supporters kwamen daarom ook mee 
naar de sollicitatie. Ik was best zenuwachtig en eens aangekomen bij de 
universiteitssingel 50 (dankzij het goede zoekwerk van mama!), ging mijn broer voor 
de zekerheid even mee naar binnen om me niet als een kip zonder kop verloren te 
laten lopen. Toen ik uiteindelijk aankwam op het juiste secretariaat (bedankt broer!), 
werd ik ontvangen door twee vriendelijke dames, Désirée en Yolanda. Ik vertelde dat 
ze ik zenuwachtig was omdat ik deze PhD positie heel erg graag zou krijgen. Lieve 
Yolanda en Désirée, dat was de eerste van nog vele andere keren dat jullie mij 
wisten gerust te stellen en mij uit de nood hebben geholpen. Heel erg bedankt voor 
al jullie ondersteuning, betrokkenheid en lieve attenties. 
Joris, ik was enorm blij toen ik een paar dagen na mijn sollicitatie van jou het mailtje 
kreeg met het goede nieuws dat ik in september 2016 welkom was aan de start van 
dit PhD avontuur in de DMRG-groep. Van het begin en tot met het einde stond je me 
bij met raad en daad. Je was een fijne begeleider die niet enkel de focus lag op 
goede onderzoek prestaties maar ook snel ontdekte hoe ik als persoon in elkaar zit. 
Je begreep dat nee-zeggen niet één van mijn specialiteiten was en we hebben vaak 
samengezeten om na te gaan hoe ik meer gefocust en met voldoende energie de 
eindstreep zou kunnen halen. Dat liep niet altijd even vlotjes maar ik ben heel blij 
met het eindresultaat. Je kritische input maar ook positieve kijk hebben me helpen 
groeien als wetenschapper en als persoon en daar ben ik je enorm dankbaar voor. Ik 
wens je nog veel geluk toe. 
Patrick, ook jouw inzet was essentieel tijdens mijn promotietraject. Ik bewonder het 
enorm hoe goed en efficiënt jij bent in het opvolgen en sturen van de vele 
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verschillende projecten in DMRG. Jouw kritische blik op de data en manuscripten en 
je wetenschappelijke inzichten waren erg waardevol en leerrijk. Ik wens jou en de 
DMRG-groep nog veel succes toe.   
 
Riekelt, heel fijn dat jij ook deel uitmaakt van het promotieteam. Ik vond het enorm 
interessant om met jou onderzoeksgroep te mogen samenwerken. Het was leuk te 
zien hoe de samenkomst van verschillende expertises effectief tot mooie resultaten 
kan leiden. Ik heb hier veel uit geleerd en wil je bedanken voor je enthousiasme en 
waardevolle feedback tijdens mijn promotietraject. Ik wens jou en je 
onderzoeksgroep nog veel succes en nog meer fijne samenwerkingen met 
Maastricht toe!  
 
To the assessment committee and members of the corona: Stef Kremers, Annemie 
Schols, Jaap Keijer, Paul Coen, and Tanja Adam, thank you for taking the time to 
read and review my thesis and to be present during my dissertation.  
 
Georges, although we only saw each other during online meetings, it was a great 
pleasure for me to work together with you on the Mitochondrial health metabolomics. 
Your scientific enthusiasm is contagious! Our collaboration extended the Mitohealth 
project with fascinating new insights and beautiful figures. I am pleased I can 
complete my thesis with these results. Many thanks for all your effort. Rubén, Bauke 
and Michel, I also want to thank you for all the energy and enthusiasm you put into 
this collaboration. It is impressive how well you manage to work with these complex 
metabolomic data sets. I wish you guys all the best!   
 
Chris, thank you for our pleasant collaboration on the different projects in this thesis. 
Your ideas, effort, and the many many Caren measurements enhanced the 
uniqueness of our data set! I learned a lot from working with you and appreciate how 
you manage to report your scientific work as transparent as possible. It is impressive 
how many ideas and insights you have!  Wouter, also, thank you for helping us out 




Ciarán, many thanks for all your help during my PhD. It was a pleasure to have you 
on board the Mitohealth project. It is impressive how many ideas and how much 
knowledge you have. I enjoyed our scientific discussions, coffee breaks, pub 
quizzes, whiskey tastings, movement cooperation, and the magic hill in Dundalk. 
Thank you for your critical and valuable input on the manuscripts and your effort 
during the many clamps. I wish you all the best, some extra sleep sometimes, and 
good luck with your career.   
 
Vrijwel de meest gedreven deelnemers aan deze marathon waren de vrijwilligers die 
zich met volledige overtuiging opgaven om deel te nemen aan dit intensieve 
onderzoek. Jullie toewijding en inspanningen tijdens de vele testen gaf ons de kans 
deze unieke studie opzet uit te bouwen, met veel interessante en verassende 
inzichten als resultaat. Het was enorm leuk jullie bij elke test steeds een beetje beter 
te leren kennen. Bedankt voor jullie aanstekelijke enthousiasme en mooie 
levenswijsheden!   
Ook wil ik dank jullie wel zeggen aan de receptie (het onthaal voor de Vlamingen) 
van Universiteitssingel 50. Jullie weten onze deelnemers steeds met een vriendelijke 
glimlach en de nodige uitleg te ontvangen en dat is enorm fijn. Hans, bedankt voor al 
je hulp!  
 
Matthijs, ook jouw inzichten hebben me geholpen bij het uitvoeren van dit onderzoek 
en het interpreteren van de resultaten. Ik kan me nog erg goed herinneren dat je 
door de gangen riep: Oh no, what did we hire!? Toen je hoorde Rodrigo en ikzelf 
beide waren flauwgevallen tijdens onze eerste oefensessie bloedprikken (oeps). 
Jouw humor, betrokkenheid, en positieve ingesteldheid zijn van grote waarde voor 
de DMRG-groep. Ik wens je nog veel succes en vooral vele leuke fietstochtjes toe! 
Lena, wat was ik blij toen je aan boord sprong van het Mitohealth project! Jij hebt me 
enorm veel geleerd, van het aanvragen van ethische toetsing tot VO2-max testen en 
zoveel meer. Bedankt voor al je hulp en steun en de vele MR-scans die je voor de 
studie hebt uitgevoerd (ik ben vraag me af hoe het gaat met het ‘op en neer’ 
gewicht). Ik wens je nog veel geluk. Esther, bedankt voor jouw onmisbare hulp met 
de clamp data! 
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Yvonne, jij hebt me enorm veel geholpen bij het uitvoeren, de analyses en het 
afronden van de studie, bedankt daarvoor! Ik heb veel van jou geleerd! Ook wil ik 
graag Axel, Kim, Pandi en Marlies bedanken voor jullie hulp met de vele MR-scans. 
Heel fijn dat we ook op jullie konden rekenen! Julian en Vera, bedankt voor jullie 
inzet bij de MR-metingen en data-analyse. Jullie expertise vormt een grote 
meerwaarde voor de onderzoeken in de DMRG-groep.   
 
Gert, Esther, en Johanna, jullie werk is in alle onderzoeken binnen DMRG 
onmisbaar! Enorm bedankt voor het de vele vele biopten en plasma samples die 
jullie hebben verwerkt voor celkweek, western Blot, oxygraaf metingen, vezeltypering 
en nog veel meer! Ook bedankt voor het typeren van oneindig veel spiervezels en 
Johanna bedankt voor me de kneepjes van het oxygraven aan te leren (ik mis die 
schaapjes soms wel). Jullie hebben me vaak uit de nood geholpen en er was altijd 
tijd voor een gezellig babbeltje. Het was heel fijn jullie kantoor buren te mogen zijn!  
  
Jeroen, heel erg bedankt voor jouw hulp bij het uitwerken van de Activ-pal data. Ook 
bedankt voor jouw enthousiasme en uitmuntende BBQ-skills, die kwamen de groep 
zeker ten goede!  Het was leuk je collega te zijn en ik hoop dat je binnenkort nog 
eens langskomt op de fiets met kleine Jasper!   
 
Bas, dankjewel voor jouw medisch advies tijdens de studies! Niels, bedankt om 
steeds klaar te staan met raad en daad en bedankt voor de talloze clamps en 
spierbiopten. Ook bedankt aan Edmundo (muchas gracias!), Vera, Yvo, en Michiel 
voor jullie tijd en inspanning bij de vele spierbiopten. Jullie zijn onmisbaar in de 
groep en ik kan me inbeelden dat het niet altijd makkelijk is betrokken te zijn bij 
zoveel verschillende studies. Desondanks wisten jullie steeds de proefpersonen 
gerust te stellen met jullie nauwkeurige handelingen, duidelijke uitleg en goede 
zorgen. Dank jullie wel! 
 
Nynke, nog voor de start van ons promotietraject werd ons verteld dat wij 
kamergenootjes zouden worden. We mochten samen op Oroboros-cursus naar 
Oostenrijk en dat was een zeer mooi begin!  Het was heel leuk je kantoorgenootje te 
zijn. Dank je wel voor alle steun en gezelligheid.  Ik wens jou en Casper nog veel 
geluk en succes toe op jullie nieuwe avontuur! 
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Froukje, ik was enorm blij toen jij Fort-Belgium kwam versterken! Tijdens jouw eerste 
week gingen we opzoek naar jouw pasje dat je vergat in je MRUM-jasje dat al 
vertrokken was naar het washok. Vanaf toen was ik er helemaal van overtuigd dat ik 
het heel goed zou gaan vinden met jou en je heerlijke, Belgische efficiëntie. We 
hebben elkaar nog vaker uit de nood geholpen (vergeten sleutels, verloren pasjes, 
gesloten loopbruggen, dubbel geboekte proefpersonen, presentatie-stress, nood aan 
pepernoten, nood aan paaseitjes en nood aan Aperollekes) en daar kijk ik met veel 
plezier op terug. Dank je wel voor alles!   
Carlijn, je talent voor organisatie hebben me op vele vlakke wegwijs gemaakt in 
uitvoeren van humaan onderzoek en in het afwerken van mijn thesis. Dankzij jou 
vond ik nu ook de weg tot de onderzoeksgroep van Anesthesie en daar ben ik heel 
erg blij mee! Enorm bedankt voor alle hulp en aanmoedigingen (nie plooien eh!) en 
nog heel veel succes bij Medtronic!   
Anne, Froukje en Carlijn, mijn favoriete hardloopvriendjes! Vooral tijdens de laatste 
loodjes van deze marathon hebben jullie mij over de streep geholpen. Toen Covid 
kwam zijn onze loopafspraakjes enorm hard gestegen in frequentie en dat was voor 
mij heel fijn. De leuke routes, mooie natuur, avontuurlijke klimmetjes, klaagrondjes, 
en fijne gesprekken doen me steeds enorm veel deugd. Bedankt voor jullie lieve 
steun, jullie indrukwekkende navigatie vaardigheden, jullie luisterende oren en jullie 
goede raad. Anne en Vera, het was heel leuk om samen met jullie en te trainen voor 
onze eerste, echte marathon! Anne, ook wil ik jou bedanken voor je onvergetelijke 
kazou-concert, prachtig! Vera en Kay, ik kijk ernaar uit jullie aanstekelijke lach weer 
te kunnen horen tijdens onze loopjes! Of nog eens een wijntje doen is ook goed! Ik 
wens jullie veel geluk en een mooie carrière toe en ik wens mezelf nog vele leuke 
loopjes en reisjes toe met jullie!   
Charlotte, we hebben vaak zitten klagen tegen elkaar over de struggels van het PhD 
leven (heel zwaaar), maar gelukkig maken fijne wandelingen, free-runnen en lekkere 
wijntjes veel goed. Bedankt je steun en voor de vele keren dat je zo lekker voor me 
hebt gekookt! Nog veel succes met het afronden van je PhD, je kan het! 
Verder wil ik iedereen van de DRMG-groep bedanken. Dank jullie wel voor de 
gezelligheid, de helpende handen en de fijne samenwerkingen. Het was fijn en 
leerrijk deel uit te maken van deze groep en jullie hebben allemaal op één of andere 
manier bijgedragen aan dit boekje! 
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Ook wil ik de studenten bedanken die me tijdens hun master stage geholpen hebben 
bij het onderzoek; Pascal, Michelle, Daniel, Lina, en Collin. Bedankt voor de jullie 
inzet en enthousiasme. Ik wens jullie veel succes toe!  
Aan alle leden van VBW en HB: bedankt voor al jullie hulp en de prettige 
samenwerking. Een grote dank aan Harry, Loek, Marc, Paul, Stephanie, Gabby en 
Wendy voor alle MRUM en technische ondersteuning. Harry, dank je wel om ook het 
thuiswerken mogelijk te maken! Stephanie, zo fijn dat jij van aanpakken weet. 
Bedankt voor je hulp en heerlijke enthousiasme! 
Ik wil ook graag de financiële steun van TiFN en NWO bedanken waardoor ik dit 
onderzoek heb kunnen doen. Het was erg leerrijk om deel uit te mogen van het TiFN 
consortium met zowel academische als industriële experten en ik wil dan ook alle 
partners bedanken voor het delen van hun expertise en voor de kritische discussies 
tijdens onze meetings. Johan, Marjolein, en Jan, bedankt voor jullie waardevolle 
input op de manuscripten. Bart, Pol, en Carolien het was leuk om samen met jullie 
collega-promovendi in dit project te zitten en ik wens jullie het nog veel geluk toe.  
 
Also, many thanks to the doctors of the Republic of Juanfrasya! Juanfra and Asya, 6 
years ago we met each other years by coincidence in Milan and ever since it has 
been amazing to be your friend. I am so happy you also moved to the Netherlands, 
and it is always so lovely to meet you! You guys know hard it is to do a PhD, moeilijk, 
moeilijk moeilijk! Thank you for your friendship, good advice, and encouragement. At 
the moment that I'm writing this, I'm looking forward to celebrating together with you 
your wedding in Rotterdam! I hope you can see your family soon and I wish you 
cuties pies all the best and a fantastic honeymoon in the Galapagos!   
 
Dank je wel also to Evelyn and Juls! It was great to get to know you guys during your 
Dutch adventure, and I enjoyed the many moments of fun and special beers we had 
together. Evelyn, besides being a great colleague, you became a good friend, and I 
miss our magic carpet bike rides! Thank you so much for your support and 
friendship! It is a pity that we could not join your wedding, but it made me so happy 
to see you guys dancing and celebrating! I am looking forward to visiting you in 




Lieve Jan en Helma, ik vind het heel fijn dat jullie onze buren zijn. Bedankt voor al 
jullie hulp, interesse, lieve attenties en voor de goede zorgen voor ons huisje en 
onze plantjes. Ik wens jullie veel geluk toeben nog vele leuke reisjes naar Italië. 
Lieve Lenny en Carl, bedankt voor alle gezelligheid, de pizza’s van Maurizio en de 
waarschuwingen voor het hoge water! Ik woon hier heel graag! 
Dank je wel lieve Bente, jij leerde me de hilariteit van bessen en celorganellen en 
streven for life!! Anne, Melanie en An-Sofie jullie zijn van beach-beige goud! Bedankt 
voor jullie spandoeken op het vliegveld, de vele verrassingsfeestjes en zalige (300%) 
weekendjes. Onze therapeutische slappe lachbuien zijn opkikkering verzekerd en als 
ik de lotto won dan zou ik niet het interieur van de Spar veranderen of het te laat 
door hebben, nee, dan zou ik alvast een kamer gaan boeken in ons toekomstig 
bejaardentehuis. An-Sofie, kei-hell dank je wel voor al de tijd en moeite die je stak 
het ontwerp en het drukken van deze thesis. Jij zit vol talent en ik ben echt heel blij 
met het einderesultaat! Ik heb het heel erg getroffen met jullie als vriendinnen! Ik 
wens jullie het allerbeste en nog heel veel vriendenboekjes toe!!  
Marilux, dr. Letizia!! Grazie mille di tutto, sei fantastica! Poi, grazie mille alla mia 
bellissima famiglia italiana: Anna, Gianuzzo, Chiara, Giuseppe, Giulia Valentina, 
Davide, Chiara e Giuseppe (brakerke), senza dimenticare anche Pino, Enza, 
Claudio, Salvo e Riccio. Siete toppu fuuaitti! Dal primo incontro, anche senza capire 
una parola in italiano (tranne mangia mangia), mi avete fatto sentire come un pesce 
dentro l'acqua nella vostra bella Sicilia, perché la vostra ospitalità ed il vostro amore 
va oltre le parole! Sicuramente non è sempre facile che vostro Bettino stia qua in 
Olanda, ma vi voglio ringraziare per esserci stati sempre vicini nonostante la 
distanza. È sempre un gran piacere rivedervi e spero di festeggiare questo dottorato 
presto anche con voi. Sapete di essere sempre i beneventi nella nostra casuccia. 
Grazie per il vostro incorragiante supporto, vi auguro tutto il bene ed ancora 
tantissimi bei momenti insieme. 
 
Lieve oma, ik weet dat jij heel veel boeken hebt en dat jij je boeken enorm koestert. 
Ik ben er zeker van dat dit boekje je trots maakt op je poezewoefke en ik hoop een 
plekje in je exclusieve boekenkast te mogen bemachtigen. Ik heb enorm veel 




En dan is het nu tijd om de lieve, leuke Grevies te bedanken. Tom, Sarina, An, 
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